Development of bioluminescent sensors for interrogating cyclic di-nucleotide signaling by Dippel, Andrew B
UC Berkeley
UC Berkeley Electronic Theses and Dissertations
Title
Development of bioluminescent sensors for interrogating cyclic di-nucleotide signaling
Permalink
https://escholarship.org/uc/item/78n0480x
Author
Dippel, Andrew B
Publication Date
2019
 
Peer reviewed|Thesis/dissertation
eScholarship.org Powered by the California Digital Library
University of California
 
 
 
 
Development of bioluminescent sensors for interrogating  
cyclic di-nucleotide signaling 
 
By 
Andrew B Dippel 
 
 
A dissertation submitted in partial satisfaction of the 
requirements for the degree of 
Doctor of Philosophy 
in 
Chemistry 
in the 
Graduate Division 
of the 
University of California, Berkeley 
 
Committee in charge: 
 
Professor Ming C. Hammond, Co-Chair 
Professor Matthew B. Francis, Co-Chair 
Professor Michelle C. Y. Chang 
Professor Donald C. Rio 
 
 
Summer 2019 
 
 
  
 1 
 
Abstract 
Development of bioluminescent sensors for interrogating 
cyclic di-nucleotide signaling 
By 
Andrew B Dippel 
Doctor of Philosophy in Chemistry 
University of California, Berkeley 
Professor Ming C. Hammond, Co-Chair 
 
Bioluminescence is the spectacular natural phenomenon in which living organisms 
produce and emit light. Natural bioluminescent protein systems have been discovered 
and characterized in over 30 species, ranging from fireflies to fungi and bacteria. 
Significant effort has been put towards engineering and improving these natural systems 
so that they may be used as tools for interrogating biological processes. As opposed to 
fluorescence, because bioluminescence requires no excitation light to produce a signal, 
it has proven extremely useful for imaging in highly autofluorescent samples, such as 
within deep tissues of whole organisms. To date, however, most bioluminescent imaging 
systems have been developed solely for the study of eukaryotic systems, and few have 
focused on the study of bacteria. Bacteria naturally colonize highly diverse and complex 
environments, from gastrointestinal tracts to soil and plant surfaces, that have proven 
difficult to study with currently available fluorescent tools. To allow for the study of 
bacterial signaling within these complex environments, new bioluminescent sensors 
developed specifically for bacterial signaling are needed. 
Here, we describe the development and application of bioluminescent sensors for the 
bacterial cyclic di-nucleotide (CDN) signaling molecule cyclic di-GMP. Cyclic di-GMP is 
nearly ubiquitous in bacteria and plays a key role in the controlling motility and biofilm 
formation. As a first-generation bioluminescent sensor system, we developed intensity-
based bioluminescent sensors for cyclic di-GMP. These sensors proved useful as in vitro 
tools for studying cyclic di-GMP, however were not amenable to live cell imaging. To 
move beyond purely in vitro systems, we developed next-generation ratiometric 
bioluminescent sensors for cyclic di-GMP. This next-generation system led to significantly 
improved sensor properties and allowed for the imaging of small numbers of live bacterial 
cells in an animal tissue-like model system. Finally, to expand these sensor systems to 
CDNs other than cyclic di-GMP, we applied a novel directed evolution approach to find 
sensors that respond to cyclic GMP-AMP. The first round of directed evolution was not 
successful, but work is ongoing on this front. Collectively, the work presented here lays 
the groundwork for using bioluminescent sensor systems to interrogate signaling in 
bacteria in their natural environments, which was previously not possible.
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Chapter One 
 
Bioluminescence as a tool for studying 
biological systems 
 
 
 
 
 
 
Portions of this chapter have been published in: 
Wright, T. A., Dippel, A. B., Hammond, M. C. “Cyclic di-GMP signaling gone astray: 
cGAMP signaling via Hypr GGDEF and HD-GYP enzymes” In Chou, S.-H., Guilliani, N., 
Lee, V., Romling U. (ed), Microbial cyclic di-nucleotide signaling.  
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Luminescence is the spectacular natural phenomenon of the light emission by a 
substance. We see luminescence all over the world, from glow sticks, to “black light” 
paints, to fireflies. Broadly, the luminescence process occurs by the excited state of a 
molecule releasing energy – in the form of light – upon relaxation to the ground state. 
There are many sub-types of luminescence that are differentiated by the way in which the 
excited state intermediate is generated. The most common of these are 
photoluminescence and chemiluminescence. In photoluminescence, the excited state is 
generated by the absorption of light. The form of photoluminescence we are all familiar 
with, specifically, is fluorescence, and it is what causes “black light” paints to produce 
their characteristic glow when we shine light on them. In fluorescence, the compound that 
absorbs/emits light is called the fluorophore. Chemiluminescence, on the other hand, 
describes situations in which the excited state is generated by a chemical reaction, 
typically a redox reaction. One of the most common ways we see chemiluminescence is 
in glow sticks. When you “crack” a glow stick, you are mixing two compounds that react 
to form an excited state intermediate, which relaxes to give off the characteristic glow. 
Bioluminescence, such as what we see in fireflies, is a specialized type of 
chemiluminescence that is differentiated by the fact that the reaction is catalyzed by an 
enzyme. These enzymes, called luciferases, catalyze the oxidation of a small molecule, 
called a luciferin, to generate the excited state intermediate. While in North America we 
are probably most familiar with this phenomenon in fireflies, it has been evolved in many 
different organisms, including deep sea shrimp, sea pansies, jellyfish, click beetles, glow 
worms, and bacteria, to name a few. Luminescent systems, both fluorescent and 
chemiluminescent, beyond their wondrous visual qualities, have proven to be extremely 
versatile tools for studying biology.  
Advantages of bioluminescence imaging 
The discovery and development of the green fluorescent protein (GFP), for which 
the 2008 Nobel Prize was awarded, fundamentally changed the way we are able to 
visualize biomolecular process (Tsien, 1998). By producing a luminescent signal that is 
observable by a microscope, FPs can be used to watch processes that were previously 
invisible inside cells. Since the initial discovery and characterization of GFP, extensive 
efforts have been put towards the development and engineering of new FPs with ever-
improving properties (Rodriguez et al., 2017). These improved properties, from new 
protein classes, altered colored palettes, and improved brightness, have together led to 
an astonishing number of different FP-based research applications, and there is no end 
in sight to the improvements that can be engineered and discovered naturally in these 
systems (Brakemann et al., 2019). However, while FP and fluorescence-based systems 
have proven invaluable for interrogating biological processes in the “culture dish”, there 
are some inherent drawbacks to fluorescence-based systems that preclude them from 
being applicable to imaging in more complex biological systems, such as within tissues 
and whole organisms (Contag et al., 1998; Rathbun and Prescher, 2017; Weissleder and 
Ntziachristos, 2003).  
The limitations of fluorescence imaging generally arise due to the requirement of 
excitation light to produce a signal, and there are two main drawbacks to this: phototoxicity 
and autofluorescence. Firstly, the strong excitation light used in conventional 
fluorescence imaging to excite the fluorescent probes (small molecules or FPs) can lead 
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to phototoxicity and photobleaching in the biological samples being analyzed (Icha et al., 
2017). Phototoxicity generally arises due to reactive oxygen species (ROS) being 
generated from the probes themselves, or from natural biological compounds, such as 
flavins and porphyrins. These ROS, including superoxide radicals and hydrogen peroxide, 
can directly oxidize DNA, causing mutations, or oxidize proteins, making them non-
functional. This phototoxicity can produce unexpected side-effects that may ultimately 
reduce the reliability and reproducibility of the data obtained. Photobleaching, a related 
effect, occurs from the repeated excitation of fluorophore compounds. Once a fluorophore 
is photobleached, it is permanently degraded, and will no longer produce any fluorescent 
signal.  
Both phototoxicity and photobleaching are especially problematic in long-term 
imaging experiments due to the amount of excitation light used. One solution to 
phototoxicity issues is the use of advanced microscopes have that provide “gentler” 
illumination that conventional epifluorescence microscopes. These illumination schemes, 
such as those used in total internal reflection fluorescence (TIRF) microscopy and light 
sheet fluorescence microscopy (LSFM), illuminate only the focal plane being analyzed, 
rather than the entire sample, which reduces overall phototoxicity (Icha et al., 2017). 
LSFM is currently the gentlest fluorescence microscopy technique available, and a 
recently developed LSFM technique allowed for imaging cell nuclei for >7 hours at high 
temporal resolution with no noticeable photodamaging effects (Fadero et al., 2018). One 
downside to the cutting-edge nature of these techniques, however, is that the most 
powerful LSFM  microscopes are typically “homemade” and available to only a few labs 
worldwide (Power and Huisken, 2017). 
Secondly, the excitation light required for fluorescence imaging is incompatible 
with samples that are highly autofluorescent, or samples that are engineered to respond 
to specific wavelengths of light (i.e. optogenetic systems). In autofluorescent samples, 
the sample itself absorbs excitation light and produces a highly fluorescent background 
signal, which can obscure the desired signal produced by the fluorescent probe, 
complicating analysis. Examples of highly autofluorescent samples include blood and 
animal tissue (due to porphyrins, flavins), and plant tissue (due to chlorophyll, pigments) 
(Monici, 2005; Zipfel et al., 2003). Beyond being highly autofluorescent, animal tissues 
significantly absorb any excitation light <600 nm, which is in the range used for many 
conventional fluorophores. In deep tissues (>mm depth) this effect is even more 
pronounced: excitation light is significantly absorbed and scattered, which prevents the 
use of conventional fluorescent probes for imaging in deep-tissues of whole organisms. 
In optogenetic systems, on the other hand, samples are engineered to produce a 
biological response after light absorption. One commonly used example of this is the 
activation of channelrhodopsin-expressing neurons via excitation with blue light (Wietek 
and Prigge, 2016). Channelrhodopsins are typically incompatible with the use of 
fluorescent probes, as cross-excitation between fluorophores and the channelrhodopsin 
leads to undesired perturbation of the process under study. Currently available solutions 
to these problems include the use of near infrared (NIR) fluorescent probes and multi-
photon microscopy (MPM).  
NIR probes absorb and emit photons >650 nm, which are outside the range of 
autofluorescence of most biological samples, and outside the activation range for many 
 4 
 
optogenetic probes. Accordingly, NIR probes allow for a greatly improved signal to noise 
ratio compared to fluorescent probes in the visible range, and they have been used 
extensively in neuroimaging applications (Li et al., 2019). Similarly, red-shifted fluorescent 
probes have been used in combination with blue-light activated optogenetic systems 
(Shen et al., 2018). In MPM, fluorophore molecules are excited by absorption of multiple 
long-wavelength photons (~1300 nm or 1700 nm) which are not significantly absorbed or 
scattered by tissue. Accordingly, MPM is routinely used for imaging at depths beyond 1 
mm (Miller et al., 2017), and recent work has even used MPM with the genetically 
encodable Ca2+ biosensor, GCaMP6, to image activity of neurons deep within intact 
mouse brain (Ouzounov et al., 2017). While these advancements in probe and 
microscope development have significantly alleviated the problems of light absorption and 
autofluorescence in biological samples, these techniques still require high power 
excitation light to produce a signal, which can lead to phototoxicity and tissue damage in 
the samples under study. 
In contrast to fluorescence, chemiluminescence/bioluminescence can be used to 
generate a visible light signal without the need for external illumination, which neatly 
overcomes all of the above issues. Accordingly, several chemiluminescent and 
bioluminescent technologies have been developed in recent years that allow for analysis 
of samples that are not amenable to fluorescence imaging. In general, the advancement 
of these chemiluminescent systems mirrors that of FPs, with new colors, increased 
brightness, and improved properties continually being discovered and developed 
(Prescher and Contag, 2010; Yao et al., 2018). Here, I will describe the major innovations 
in these bioluminescent systems and how they have been applied to the development of 
sensors for analyzing biomolecular processes. 
Natural bioluminescent systems 
As mentioned previously, naturally occurring bioluminescent protein systems have 
evolved separately in many different organisms (Kaskova et al., 2016). In these systems, 
the luciferases (enzymes that catalyze bioluminescence reactions) have specific 
substrate molecules (luciferins), with the structures of both the luciferase enzymes and 
luciferin substrates often being highly divergent between each system. Of these many 
luciferase-luciferin systems, two have been extensively studied and utilized for bioimaging 
applications. These are the D-luciferin utilizing systems from beetles, and coelenterazine 
utilizing systems from marine organisms (Figure 1.1). 
Bioluminescent systems using D-luciferin, which was the first luciferin molecule 
discovered, have historically been the most extensively used for in vivo imaging (Zhao et 
al., 2005). The luciferase from the North American firefly, Photinus pyralis, is the founding 
member of D-luciferin utilizing systems. Firefly luciferase (FLuc) is a 61 kDa protein that 
oxidizes D-luciferin to produce a broad emission spectrum with a yellow-orange peak 
(λmax = 612 nm at 37 °C). This red-shifted emission has proven extremely useful for in 
vivo imaging as living tissue does not absorb significantly at wavelengths >600 nm. 
Luciferases from the luminous click beetle, Pyrophorus plagiophtalamus, that utilize D-
luciferin have also been widely used (Miloud et al., 2007). There are multiple variants of 
click beetle luciferases which are distinguished by the color of their emission. Two of the 
most commonly used variants, red click beetle luciferase (CBR) and green click beetle 
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luciferase (CBG), are 61 kDa proteins that produce emission maxima at 611 nm and 544 
nm, respectively. To catalyze the oxidation of D-luciferin, all beetle luciferases requires 
both ATP, Mg2+, and O2 as cofactors. This ATP dependence has made these luciferases 
valuable tools for the qualitative analysis of ATP levels in clinical samples, however it 
precludes the use of these luciferases in systems where ATP may be limiting, such as in 
extracellular spaces. 
Coelenterazine-utilizing luciferase systems, on the other hand, require only O2 to 
catalyze their bioluminescent reactions, and do not require ATP or Mg2+. The luciferase 
from the sea pansy Renilla reniformis is the founding member of coelenterazine-utilizing 
systems. Renilla luciferase (RLuc) is a 36 kDa protein that oxidizes coelenterazine to 
produce an emission maximum at 480 nm (Matthews et al., 1977). Although the emission 
of RLuc is more blue-shifted than FLuc, making it slightly less attractive for use in vivo, 
because it uses a completely different substrate, it can be used in combination with FLuc 
to perform dual-reporter imaging studies (Bhaumik et al., 2004). The luciferase from the 
marine copepod Gaussia princeps is another commonly used coelenterazine-utilizing 
luciferase (Tannous et al., 2005). Gaussia luciferase (GLuc) is a 20 kDa enzyme that 
similarly produces an emission maximum at 480 nm. GLuc is naturally secreted to the 
extracellular space, which can be a benefit for in vitro reporter assays, however 
membrane-bound variants have also been engineered for use in live animal imaging 
(Santos et al., 2009). 
Natural bioluminescent protein systems utilizing both D-luciferin and 
coelenterazine have proven extremely useful for many in vivo imaging applications. 
However, to expand the bioluminescent protein toolkit and permit the analysis of 
exceedingly hard-to-interrogate biological systems, a number of advancements have 
been made in engineering and optimizing these systems. In general, these advancements 
have come about as the result of a combination of enzyme evolution, luciferin analog 
development, and bioluminescence resonance energy transfer (BRET). 
Engineered bioluminescent systems 
 As mentioned previously, FLuc has been the most widely utilized bioluminescent 
reporter for in vivo imaging, largely due to its red-shifted emission spectra. Some 
drawbacks to FLuc, however, are its low catalytic activity and low thermal stability, which 
ultimately cause the enzyme to produce a lower than desired signal within biological 
samples. Accordingly, many efforts have focused on improving these properties via 
directed enzyme evolution, and there are multiple FLuc mutants available that exhibit 
improvements in these properties (Kaskova et al., 2016; Pozzo et al., 2018). Similar 
efforts have focused on engineering improved properties in RLuc, and have resulted in 
mutants with increased light output (RLuc8) (Loening et al., 2006) and red-shifted 
emission (RLuc8.6-535) (Loening et al., 2007). Directed evolution of natural luciferases 
is inherently limited by the emissive properties of the luciferin substrate, however, so 
considerable effort has also focused on developing new and improved luciferin substrates 
in parallel with directed evolution of the luciferase enzymes (Figure 1.2). 
 Improvements in D-luciferin substrate systems have focused on red shifting 
emission, improving signal intensity, and creating orthogonal luciferase-luciferin pairs for 
multi-component imaging (Jones et al., 2017; Kaskova et al., 2016; Rathbun and 
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Prescher, 2017; Rathbun et al., 2017). In recent years, D-luciferin analog development 
has focused on rigidifying the aromatic core (Evans et al., 2014; Mofford et al., 2014), 
extending the conjugated π system (Hall et al., 2018; Kuchimaru et al., 2016), or 
incorporating heteroatoms into the structure (Conley et al., 2012). The two most sensitive 
“D-luciferin” type systems engineered to date appear to be a mutant CBR luciferase 
(CBR2) paired with naphthyl luciferin analogs (Hall et al., 2018), and a mutant FLuc 
luciferase (Akaluc) paired with the AkaLumine luciferin substrate (Iwano et al., 2018). 
Akaluc has 28 amino acid substitutions relative to FLuc that result in an improved catalytic 
activity with its preferred substrate, AkaLumine, and improved thermostability and 
expression compared to FLuc. This luciferase-luciferin pair produces a bright signal with 
an emission maximum at 650 nm which was capable of imaging single cells within mice, 
and neurons in the deep brain of live monkeys. 
Improvements in coelenterazine substrate systems have similarly focused on 
improving substrate stability and solubility, red shifting emission, and improving signal 
intensity (Kaskova et al., 2016; Zhao et al., 2004). To specifically address substrate 
stability in vivo, Promega created EnduRen and ViviRen (Kaskova et al., 2016). These 
compounds contain protective esters that lead to reduced auto-oxidation in vivo 
compared to native coelenterazine. Additionally, in the cellular environment, these esters 
are cleaved by endogenous esterase enzymes, leading to a slow release of 
coelenterazine substrate and extended production of luminescent signal. More recent 
developments in coelenterazine analogs have focused on rigidifying and extending the 
conjugated π system (Hosoya et al., 2015; Nishihara et al., 2015), and incorporating 
heteroatoms into the structure (Yeh et al., 2017) to produce red-shifted emissions and 
increased signal intensity. One other problem unique to coelenterazine systems is 
solubility in aqueous solution, which both limits the amount of substrate that can be 
injected into animals for in vivo imaging, and affects the tissue distribution of substrate 
(Yeh et al., 2019a). Accordingly, efforts have been made to increase the solubility of 
coelenterazine analogues that allow for increased loading into animals (Yeh et al., 
2019b). Apart from these advances, one of the most significant improvements in 
coelenterazine substrate systems has been the development and engineering of the 
NanoLuc (NLuc) system from the deep sea shrimp Oplophorus gracilirostris (England et 
al., 2016; Hall et al., 2012). NLuc was evolved to utilize the coelenterazine analog 
furimazine, and has remarkable thermal stability and high pH and salt tolerance. NLuc 
produces signal intensity ~150-fold greater than either FLuc or RLuc under similar 
conditions, with an emission maximum at 460 nm. At only 19 kDa, NLuc is among the 
smallest of all commonly used luciferases, making it very useful for bioimaging in 
situations where larger luciferases are not amenable, such as in fusion proteins or 
viruses. Since its initial development, NLuc has served as the basis for much of the 
advancements in coelenterazine-utilizing bioluminescent systems. 
Beyond enzyme and substrate engineering, the emission wavelength and intensity 
of bioluminescent protein systems can be altered via bioluminescence resonance energy 
transfer (BRET) processes (Figure 1.2). By fusing an acceptor fluorophore to a luciferase, 
energy from the luciferase catalyzed reaction is transferred via a Förster resonance 
energy transfer (FRET) process to excite the attached fluorophore, producing an emission 
corresponding to the fluorophore, rather than the luciferase-luciferin pair. This efficiency 
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of this process is highly dependent upon both the spectral overlap of the luciferase donor 
and the fluorophore acceptor, as well as the proximity of the acceptor and donor in space. 
This technique has been applied extensively to coelenterazine utilizing systems 
specifically, as it allows for a red shifting of the luciferase emission without additional 
directed evolution/substrate engineering efforts. One of the early examples of this was 
BRET6, which fused red-shifted RLuc variants (RLuc8.6) to different red FPs to produce 
emission maxima up to 640 nm (Dragulescu-Andrasi et al., 2011). Besides leading to a 
red shifting of the luciferase emission, the BRET process can also lead to increased signal 
intensity overall. This effect was first observed in the development of Nano-lanterns, 
which fused RLuc8 to the yellow FP, Venus (Saito et al., 2012). The resulting protein, 
YNL, produced over 5x higher signal than RLuc8 alone, with an emission peak at 530 
nm. Different colored Nano-lantern proteins were subsequently developed by using 
different FP acceptors, showcasing the versatility of this technique (Takai et al., 2015).  
Since the development of NLuc, similar approaches have been applied to 
developing BRET systems with NLuc as the donor moiety to alter the emission for 
improved in vivo imaging properties. One of the first examples of this was in the 
development of enhanced Nano-lanterns (eNL), which fused NLuc to a variety of different 
colored FP acceptors to produce five bright color variants of NLuc with emission maxima 
up to 585 nm (Suzuki et al., 2016). The most red-shifted variants of NLuc developed to 
date are based on the fusion of a cyan excitable, orange emitting FP (CyOFP1) with NLuc 
(Chu et al., 2016). The resulting protein, Antares, has an emission peak at 584 nm and 
emits ~30% of its signal >600 nm. Antares2 was subsequently developed by replacing 
NLuc in Antares with teLuc, a teal-emitting NLuc mutant, resulting in ~4x more photon 
output >600 nm (Yeh et al., 2017). 
The discovery, development, and engineering of bioluminescent protein systems 
has led to huge improvements in the capabilities of bioluminescent imaging (BLI). Given 
the many options available in the bioluminescent protein “toolbox”, researchers now can 
more easily perform BLI experiments in a variety of different situations (Prescher and 
Contag, 2010; Rathbun and Prescher, 2017). While historically BLI has proven very useful 
for tracking cells and gene expression in animals (Contag et al., 1998), luciferase-based 
probes have also been developed that allow for imaging specific biological processes, 
such as the production of metabolites and second-messenger signaling molecules.   
Interrogating biology with bioluminescent imaging (BLI) systems 
 Luciferase-based bioluminescent sensors typically fall into one of three categories: 
complementation of split luciferase (CSL), BRET, or combination CSL-BRET sensors 
(Figure 1.3). In CSL systems, a sensor domain is used to split the luciferase protein into 
two nonfunctional halves, such that analyte binding results in a conformational change 
that reconstitutes the luciferase to produce a change in signal intensity. In BRET systems, 
the sensor domain is inserted between a fluorescent protein acceptor on one side and an 
intact luciferase donor on the other side. Analyte binding leads to a change in energy 
transfer efficiency between donor and acceptor, which is measured by a change in BRET 
ratio. CSL-BRET systems marry these two approaches and fuse a CSL-type sensor to an 
intact FP acceptor on the N- or C-terminus. These are functionally equivalent to CSL 
sensors in that analyte binding reconstitutes the luciferase to produce a change in signal 
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intensity (not a change in BRET), but the emission signal intensity is typically improved 
over standard CSL sensors due to efficient BRET. CSL biosensors generally produce 
large signal changes; however, their signal intensity can be low due to poor reconstitution 
of luciferase activity. BRET biosensors generally have high signal intensity and are 
ratiometric; however, their signal change upon analyte binding is typically small. A variety 
of bioluminescent sensors have been developed using both D-luciferin and 
coelenterazine-utilizing systems for a variety of signaling molecules. 
 Some of the first work on developing CSL-type sensors for signaling molecules 
was carried out by Promega using split FLuc (Fan et al., 2008). To develop a sensor for 
the second messenger cyclic AMP (cAMP), a cAMP-binding domain was inserted at 
different positions within FLuc with linkers of varying lengths flanking the binding domain. 
The structurally conserved domain undergoes a conformation change upon cAMP binding 
that ultimately results in reconstitution of luciferase activity. The optimized sensor 
construct displayed a ~100-fold increase in luminescence when bound to cAMP and was 
used to image cAMP dynamics in tissue culture. The sensor was further optimized via 
directed evolution after global random mutagenesis and linker mutagenesis (Binkowski 
et al., 2011). This led to drastic improvements in the sensitivity, dynamic range, and signal 
fold-change of the sensor, which improved its performance as a screening tool. To date, 
these sensors exhibit the largest signal fold-changes of any single-chain CSL-type 
biosensors (~3500-fold in vitro). Due to a reliance on ATP, however, FLuc is generally a 
less attractive choice for the development of biosensors, as ATP consumption can lead 
to unwanted effects in the system under study. Accordingly, CSL sensors based on 
coelenterazine-utilizing luciferases have also been developed. The first such example 
was a bioluminescent sensor for Ca2+ based on split RLuc (Kaihara et al., 2008). In this 
system, calmodulin (CaM) and the M13 peptide are inserted within RLuc at the 91/92 
position, and the calcium-induced interaction between CaM and M13 leads to a 
reconstitution of RLuc activity.  
 A subclass of CSL-type sensors based on Nano-lantern scaffolds have also been 
reported. In these CSL-BRET sensors the luciferase domain is split with a binding 
domain, as in CSL-type sensors, but an FP acceptor is also added to the N-terminus of 
the luciferase. While these sensors contain a FP acceptor and thus technically produce 
a BRET signal, the signal change produced by ligand binding is intensity-based, not 
ratiometric. However, as a result of high BRET efficiency in the YNL scaffold, the intensity 
of the signal produced is higher than standard split RLuc biosensors, making these 
sensors more amenable to single cell imaging applications. The first Nano-lantern-based 
sensors were developed from the YNL scaffold by splitting RLuc with different ligand 
binding domains (Saito et al., 2012). YNL-sensors were developed for Ca2+, cAMP, and 
ATP that produced up 4-fold increases in signal intensity upon ligand binding and were 
used for imaging in HeLa cells, Dictyostelium discoideum cells, and Arabidopsis plant 
leaves, respectively. A slightly modified version of the Ca2+ sensor was also used for 
monitoring drug effects in cardiomyocytes, which serve as a valuable model for 
pharmacological toxicity testing (Suzuki et al., 2018). Compared to fluorescence imaging 
in the same cells, there were no adverse effects due to phototoxicity or photobleaching.  
Second generation NL sensors for imaging Ca2+ were also developed based on 
the enhanced Nano-lantern scaffold (Suzuki et al., 2016). These sensors use split NLuc 
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rather than RLuc, and thus produce a higher intensity signal compared to the original 
YNL-based sensors. By using green, cyan, and orange emitting versions of these sensors 
with different affinities, Ca2+ dynamics could be simultaneously imaged in three distinct 
organelles in HeLa cells (Hossain et al., 2018). Due to the loss of signal that occurs as 
luminescent substrate is depleted, however, dynamics could only be monitored for up to 
three minutes. As seen in these examples, the bright signal and easily changeable 
emission wavelength of CSL-BRET designs have proven useful for single cell imaging in 
a variety of biological contexts. However, because the signal of CSL and CSL-BRET 
based sensors is based on a single emission, measurements are highly affected by the 
concentration of biosensor and luminescent substrate available, which makes 
quantitative, long-term measurements difficult. BRET-based biosensors, due to their 
ratiometric signal, help alleviate these issues, making quantitative, long-term, real-time 
imaging possible. 
 One of the first small molecule BRET sensors was developed for cAMP by 
inserting the human cAMP binding protein hEpac1 between a yellow FP, Citrine, and 
RLuc (Jiang et al., 2007). This sensor produced a ~70% change in BRET ratio in response 
to cAMP and was used for quantitative, real-time measurements of cAMP dynamics in 
eukaryotic cells. The first BRET sensor for Ca2+ was similarly developed by inserting the 
Ca2+-binding CaM-M13 motif between the yellow FP, Venus, and RLuc (Saito et al., 
2010). This sensor was optimized by altering the position of the donor and acceptor 
moieties in the scaffold and using circularly permuted variants of Venus, with the best 
construct exhibiting a 60% change in BRET ratio in response to Ca2+. This sensor was 
used to image Ca2+ dynamics in HeLa cells and in the plant pathogen, Pseudomonas 
syringae, within Arabidopsis plant tissue, showcasing the ability to image in highly 
autofluorescent samples.  
More recently, several BRET sensors have been developed that utilize the bright 
signal and high stability of NLuc. The first published example of this was in the 
development of dual readout BRET/FRET sensors for measuring Zn2+ (Aper et al., 2016). 
These sensors took advantage of previously engineered FRET sensors for Zn2+ which 
utilize a cyan FP (Cerulean) and yellow FP (Citrine) pair. By fusing NLuc to the Cerulean 
donor domain, sensors were generated that can produce a BRET signal in addition to 
their FRET signal, with BRET signal changes up 50%. These sensors allow for BRET-
based monitoring of Zn2+ cells in plate reader-based assays and in single cells in real 
time, and additionally allow for the flexibility of using a FRET readout when desired. 
BRET-based sensors utilizing NLuc were developed for Ca2+ by inserting the Ca2+-
sensitive troponin-C (TnC) sequence between Venus and NLuc (Yang et al., 2016). By 
testing a library of circularly permuted Venus and NLuc variants, the CalfluxVTN sensor 
was developed that exhibits a remarkable 1100% change in BRET ratio in response to 
Ca2+ when tested in vitro. Taking advantage of the BRET signal, this sensor was used to 
image Ca2+ fluxes in cultured cells after optogenetic stimulation of channelrhodopsins. 
These types of optogenetic experiments are difficult to perform with fluorescence-based 
probes due to cross-excitation that can occur between the fluorophore and optogenetic 
probe which leads to undesired perturbation of the process under study. 
The most recently developed BRET sensor utilizing NLuc, although not for small 
molecule sensing, is for monitoring membrane voltage (Inagaki et al., 2017). This sensor, 
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LOTUS-V, was developed by inserting a voltage sensing protein domain between NLuc 
and Venus which results in a ~23% change in BRET ratio upon membrane depolarization. 
This sensor was able to be used in combination with optogenetic tools to monitor changes 
in membrane voltage in cardiomyocytes. Remarkably, this sensor was applied to 
simultaneously imaging local brain activity in multiple interacting, moving mice (Inagaki et 
al., 2019). 
These examples showcase how bioluminescent sensor systems have advanced 
to allow for quantitative, real-time imaging of cellular signaling pathways in complex 
biological samples. As the capabilities of these systems have improved over the years, 
experimental setups have moved from purely in vitro to a variety of biological samples, 
including tissue culture, single cells, plant tissue, and freely moving mice. Importantly, 
however, these advancements in BLI have focused almost exclusively on eukaryotic 
signaling pathways, most notably cAMP and Ca2+ signaling. Bacteria contain many 
equally complex signaling pathways that would benefit from further biosensor 
development. Accordingly, many fluorescent sensor systems have been developed and 
applied to understand bacterial signaling systems. However, bacteria naturally colonize 
highly diverse and complex environments, from gastrointestinal tracts to soil and plant 
surfaces, where fluorescent biosensors are not applicable. To allow for the study of 
bacterial signaling within these more complex environments, new bioluminescent tools 
developed specifically for bacterial signaling are needed. 
Cyclic di-nucleotide signaling 
The bacterial signaling pathways that are of most interest to our lab are cyclic di-
nucleotide (CDN) signaling pathways. CDNs are a class of second messenger molecules 
formed by the cyclization of two nucleotide triphosphates (NTPs) to produce a cyclic, 
dimeric product of nucleotide monophosphates. Different combinations of NTPs produce 
different CDNs, which each have different biological roles and distinct signaling pathways 
(Krasteva and Sondermann, 2017). The three canonical CDNs present in bacteria are 
cyclic di-GMP (c-di-GMP), cyclic di-AMP (c-di-AMP), and cyclic AMP-GMP (cGAMP) 
(Figure 1.4), although additional CDNs containing pyrimidine nucleotides have recently 
been discovered (Whiteley et al., 2019). Recent work has also found that CDN signaling 
networks can be interconnected with other nucleotide signaling in certain bacteria (Wright 
et al., 2019), but it is unclear whether this is generalizable to all bacteria and CDN 
signaling pathways. To interrogate these complex signaling networks in bacteria, several 
genetically encoded tools have been developed (Table 1.1). 
The first genetically encoded tools for studying CDNs were reporter-based. In 
these systems, increased levels of CDN drive the production of a reporter gene that is 
under the control of a CDN-responsive transcription factor or RNA element (riboswitch). 
One benefit of these systems is that the reporter gene can be altered to produce different 
outputs, including LacZ activity, fluorescence, or bioluminescence. The downside, 
however, is that reporter systems are generally unable to monitor CDN dynamics at the 
fast time scale that signaling events take place, which is typically on the order of seconds 
to minutes. Once CDN levels have built up enough to “turn on” production of the reporter 
gene, it still takes time for the reporter to be translated and build up to high enough levels 
to produce an observable signal. The commonly used reporter gene superfolder GFP 
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(sfGFP), for example, takes ~15 minutes to mature after being translated (Balleza et al., 
2018). Additionally, even after CDN levels have decreased, the signal from the reporter 
remains until the cellular machinery degrades it, which takes at least 15-30 minutes even 
for “destabilized” reporters. Accordingly, any dynamics that occur on the timescale faster 
than these events are not able to be observed with reporters. 
To allow for the analysis of rapid signaling dynamics, several fluorescent biosensor 
systems have been developed for CDNs. For c-di-GMP in particular, these include 
protein-based FRET biosensors that have been used in Escherichia coli (Ho et al., 2013), 
Caulobacter crescentus, Salmonella typhimurium, and Pseudomonas aeruginosa 
(Christen et al., 2010) as well as RNA-based fluorescent (RBF) biosensors that have been 
used in E. coli and allow for the first time the ability to image c-di-GMP under anaerobic 
conditions (Wang et al., 2016). The rapid response of optimized RBF sensors (t1/2 ~ 1 
min) further allowed for the analysis of changes in c-di-GMP in E. coli in response to 
changes in extracellular zinc in real time (Yeo et al., 2017). Similar RBF sensors have 
also been developed for c-di-AMP and cGAMP. One drawback of fluorescent biosensors, 
however, is that due to a reliance on external illumination, these systems are incompatible 
with imaging in plant or animal tissue due to autofluorescence, and in long-term 
experiments due to phototoxicity. Accordingly, to allow for the analysis of CDN dynamics 
in more complex systems, new bioluminescent sensor systems are required.  
Of the currently known CDNs, our understanding of c-di-GMP would likely benefit 
the most from bioluminescent sensor development. C-di-GMP is a key regulator of 
bacterial physiology and behavior, coordinating diverse processes such as motility, 
biofilm formation, and virulence (Figure 1.5). First discovered as a stimulator of cellulose 
synthesis (Ross et al., 1987), c-di-GMP has since been found to be nearly ubiquitous in 
bacteria, with c-di-GMP signaling pathways often integrated with other global regulatory 
systems, such as phosphorylation networks and quorum sensing pathways (Jenal et al., 
2017; Romling et al., 2013). The intracellular levels of c-di-GMP are tightly regulated by 
diguanylate cyclase (DGC) and phosphodiesterase (PDE) enzymes that synthesize and 
degrade c-di-GMP, respectively. Many bacteria have an abundance of predicted DGC 
and PDE genes, suggesting unique c-di-GMP regulatory circuits are activated in response 
to different environmental cues, such as O2, metal ions, or light. Most notably, c-di-GMP 
signaling networks play critical roles in the pathogenicity of many bacteria, allowing them 
to adapt to and survive in the changing environmental conditions that are experienced 
during the infection of a host (Hall and Lee, 2018). To interrogate these complex c-di-
GMP signaling networks within bacteria in their natural environments, such as within an 
infected host, bioluminescent sensor systems such as those described for mammalian 
signaling earlier in this chapter would be valuable. 
The PilZ domain as a c-di-GMP receptor 
 To develop a bioluminescent sensor system for any signaling molecule, some sort 
of sensor/receptor domain for that molecule is required. As described previously, many 
bioluminescent sensor systems were developed for cAMP and Ca2+ which utilized natural 
and engineered protein sequences that selectively bind to cAMP and Ca2+. Importantly, 
these receptor domains must undergo large conformational changes upon binding to their 
target, which ultimately produces the signal change of the biosensor. Accordingly, to 
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develop a bioluminescent sensor system for c-di-GMP, a sensor domain is required that 
binds with high affinity and selectivity to c-di-GMP and undergoes a large conformational 
change upon binding. The c-di-GMP sensor domain that fits these criteria is the PilZ 
domain (Cheang et al., 2019; Chou and Galperin, 2016). 
The PilZ domain was first discovered as a c-di-GMP receptor after characterization 
of the YcgR protein from E. coli (EcYcgR) (Ryjenkov et al., 2006). EcYcgR is a 28 kDa 
protein that contains an N-terminal β-barrel domain (YcgRN domain) and a C-terminal PilZ 
domain. The PilZ domain is named after the type IV pilus control protein first identified in 
Pseudomonas aeruginosa, which is essential for type IV pilus biosynthesis (Alm et al., 
1996). Important to note, the PilZ protein from P. aeruginosa does not actually bind to c-
di-GMP, as it lacks the conserved c-di-GMP binding motifs. The PilZ domain structure 
itself is characterized by a β-barrel structure with a flexible N-terminal loop. EcYcgR exists 
as a monomer and binds to two molecules of c-di-GMP with an apparent affinity of ~840 
nM, with two highly conserved motifs (RxxxR and D/NxSxxG) in the PilZ domain 
contributing to binding. Importantly, it was found that c-di-GMP binding led to a large 
conformational change in the protein that caused it to migrate differently during size 
exclusion chromatography. This conformational change exerts a biological effect, as it 
was later discovered that EcYcgR interacts with flagellar machinery and acts as a 
“backstop brake” in response to increased c-di-GMP levels, leading to a suppression of 
motility (Paul et al., 2010). YcgR-like proteins (defined as having a YcgRN-PilZ domain 
architecture) are present in many bacteria and have similarly been found to interact with 
motor proteins, producing c-di-GMP dependent effects on flagellar motor output (Cheang 
et al., 2019). To determine the molecular mechanism of this conformational change, 
numerous structural studies of YcgR-like proteins have been performed. 
The first crystal structure of a PilZ-domain containing protein was of the YcgR-like 
protein PlzD (also VCA0042) from Vibrio cholerae (Benach et al., 2007). PlzD has a 
similar domain architecture to EcYcgR, containing a YcgRN domain and a C-terminal PilZ 
domain, and was crystallized as a homodimer. Structures of both the c-di-GMP bound 
(holo) and unbound (apo) protein were solved which revealed that a major change in 
interdomain interactions occurs upon ligand binding. In the apo structure, the C-terminal 
PilZ domain is essentially detached from the YcgRN domain, making no substantial 
interdomain contacts. In the holo structure, however, the two domains are found in much 
closer proximity, with c-di-GMP packed at the domain interface. This conformational 
change involves a 123° rotation of the PilZ domain toward the YcgRN domain, and 
converts the extended apo form to a much more compact holo form (Figure 1.6a). 
Structures of the YcgR-like protein PP4397 from Pseudomonas putida showed a very 
similar structural change upon c-di-GMP binding, suggesting that this conformational 
switching mechanism is conserved in YcgR-like proteins of this type (Ko et al., 2010). The 
key c-di-GMP:protein interactions in these proteins occur in the conserved RxxxR and 
D/NxSxxG motifs.  
The RxxxR motif is present at the N-terminal region of the PilZ domain, which 
serves as an inter-domain linker with the YcgRN domain, while the D/NxSxxG motif is 
present on a β-sheet platform ~30-40 residues away within the PilZ domain. In all 
structures of YcgR-like proteins, the side chains of conserved residues in these motifs 
make direct H-bonding interactions with c-di-GMP (Benach et al., 2007; Ko et al., 2010; 
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Subramanian et al., 2017). The conserved Arg in the RxxxR motif are particularly 
essential for c-di-GMP selectivity, as they make extensive H-bonding contacts and 
possible cation-π interactions with the guanine bases themselves (Figure 1.6b).  
Interestingly, PlzD was crystallized binding to a single molecule of c-di-GMP, 
whereas PP4397 and the YcgR-like protein DgrA from Bacillus subtilis were crystallized 
binding to an intercalated dimer of c-di-GMP. This difference appears to be controlled by 
the identity of the residue immediately prior to the RxxxR motif, termed “position-X”. In 
PlzD, this residue is a Leu, while in PP4397 and DgrA this residue is an Arg. The presence 
of a Leu or another small hydrophobic residue appears to sterically occlude the 2nd c-di-
GMP molecule from entering the binding pocket, while the presence of an Arg promotes 
an “arginine-fork” interaction with a 2nd molecule of c-di-GMP. Accordingly, mutation of 
position-X from Arg to Leu in PP4397 (R122L) coverts the binding stoichiometry from two 
to one, while mutation from Leu to Arg in PlzD (L135R) leads to an increased binding 
stoichiometry (not exactly one to two) (Ko et al., 2010). Unexpectedly, the crystal structure 
of the c-di-GMP-bound PlzD (L135R) mutant shows a completely different domain 
orientation compared to the wild-type. This change appears to be caused mainly by 
differences in the inter-dimer interactions, which highlights how a single residue change 
can produce significant changes in global structure. 
While YcgR-like proteins have been among the most well-studied PilZ-domain 
containing proteins, there is a large diversity in length and domain composition of PilZ-
domain containing proteins, including a large number of small, single-domain PilZ 
proteins as well as much larger multi-domain proteins (Cheang et al., 2019). The 
underlying theme, however, is that the c-di-GMP-induced conformational switching of PilZ 
proteins allows for them to serve as regulatory domains with diverse outputs, which 
ultimately enables c-di-GMP to control the activity of many different cellular targets. 
Looking forward, it will be interesting to discover whether there are equivalent, 
undiscovered PilZ-like domains for other CDNs. Ultimately, the unique characteristics of 
the PilZ domain, in YcgR-like proteins in particular, makes them an attractive choice for 
use in the design of bioluminescent sensors for c-di-GMP.  
Outlook 
 When starting my thesis work, I sought to develop a bioluminescent sensor system 
for c-di-GMP that would serve as a complementary technology to the RBF sensors that 
had already been developed in the lab, with the long term goal of enabling c-di-GMP 
imaging within mammalian tissues. My first foray into this led to the development and 
optimization of Nano-lantern-based sensors for c-di-GMP, which is described in Chapter 
2. In this work, I learned a lot about the complications of luminescence imaging, especially 
in bacteria, and the limitations of intensity-based biosensors. The phylogenetic screen of 
YcgR variants performed in collaboration with the Joint Genome Institute (JGI) produced 
some amazing results, however, that were invaluable to the further development of these 
biosensors.  
Inspired by the development of NLuc and other BRET-based sensors in the 
literature, I next sought to develop a ratiometric, luminescent sensor system for c-di-GMP, 
which is described in Chapter 3. Gratifyingly, I found that this design alleviates a lot of the 
issues in the original YNL-based sensors, even showing as a proof-of-concept that these 
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sensors work robustly for long-term imaging (at least 1 hour) within an animal tissue 
model, and require only ~103–104 bacterial cells to produce a visible signal. My hope is 
that our collaborators and other biologists will use these tools to study the c-di-GMP 
dynamics of bacteria over the different stages of host infection. Additionally, the 
ratiometric biosensor work unexpectedly led to the first luminescent sensors that respond 
to (3’3’)-cGAMP (and maybe (2’3’)-cGAMP), which should hopefully be applied to 
studying these CDN signals in the near future.  
Finally, as had long been a research goal of mine, I sought to evolve a YcgR-like 
protein to bind to new CDN targets. This work, described in Chapter 4, encountered 
numerous issues along the way that are not all described here. Although we did not get 
a clear “winner” at the end of this process, the research led to the development of a very 
robust screening methodology that I feel will give the desired results in the future, with 
careful consideration of the lessons learned here. This directed evolution should 
ultimately allow for the development of biosensors (both fluorescent and bioluminescent) 
for new CDN targets. A protein-based sensor for (2’3’)-cGAMP, in particular, would be 
extremely useful, as a lack of available tools has limited our understanding of the 
spatiotemporal dynamics of this signal. This sensor could be applied, for example, to 
studying the activation of cGAS in response to HIV infection. 
  
 15 
 
FIGURES 
 
Figure 1.1 Natural bioluminescent systems. Chemical structures and reaction 
schemes for the well-studied beetle and marine luciferases. 
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Figure 1.2 Engineered bioluminescent systems. Selected examples of new 
bioluminescent systems that have been developed via substrate engineering + directed 
evolution (left) and/or the use of bioluminescence resonance energy transfer (right). 
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Figure 1.3 Approaches for the development of luciferase-based bioluminescent 
sensor systems. Schematics of the three main categories of luciferase-based 
bioluminescent sensor systems. 
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Figure 1.4 Bacterial cyclic di-nucleotides. Chemical structures of the three canonical 
cyclic di-nucleotides found in bacteria. 
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Figure 1.5 Cyclic di-GMP signaling in bacteria. Overall pathway for canonical c-di-
GMP signaling in bacteria.  
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Figure 1.6 PilZ domain proteins as receptors for c-di-GMP. (a) Crystal structures of 
PlzD from V. cholerae in the apo (silver; PDB 1YLN) and holo (green; PDB 2RDE) states 
showing the large conformational change that occurs upon c-di-GMP binding. (b) Crystal 
structure of PP4397 from P. putida (PDB 3KYF) showing the key H-bonding interactions 
between conserved residues and c-di-GMP. 
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TABLES 
Table 1.1 Genetically encodable tools for analysis of CDN signaling 
aRS = riboswitch, TF = transcription factor.  
bCitations refer to initial work and noteworthy applications/improvements. 
 
  
CDN Categorya Readout Organism(s)b 
cyclic di-GMP 
RS-based biosensor Fluorescence Escherichia coli (Kellenberger et al., 2013; Wang et al., 2016) 
RS-based reporter 
LacZ activity 
Bacillus subtilis (Sudarsan et al., 2008) 
Escherichia coli (Zhou et al., 2016) 
Fluorescence 
Bacillus subtilis (Gao et al., 2014) 
Escherichia coli (Zhou et al., 2016) 
Luminescence Geobacter sulfurreducens (Hallberg et al., 2019) 
PilZ-based biosensor 
FRET 
Caulobacter crescentus (Christen et al., 2010) 
Pseudomonas aeruginosa PAO1 (Christen et al., 2010) 
Klebsiella pneumoniae (Christen et al., 2010) 
Salmonella Typhimurium (Christen et al., 2010; Mills et al., 2015) 
Escherichia coli (Ho et al., 2013) 
CSL-BRET Escherichia coli (see Chapter 2) (Dippel et al., 2018) 
BRET Escherichia coli in tissue model system (see Chapter 3) 
TF-based reporter 
Fluorescence Pseudomonas aeruginosa (Rybtke et al., 2012) 
Luminescence 
Pseudomonas aeruginosa (Irie et al., 2012; Pawar et al., 2016) 
Vibrio cholerae (Koestler and Waters, 2014; Srivastava et al., 
2011) 
cGAMP 
RS-based biosensor Fluorescence Escherichia coli (Kellenberger et al., 2015a) 
RS-based reporter Luminescence Geobacter sulfurreducens (Hallberg et al., 2019) 
cyclic di-AMP 
RS-based biosensor Fluorescence 
Escherichia coli (Kellenberger et al., 2015b) 
Listeria monocytogenes (Kellenberger et al., 2015b) 
RS-based reporter LacZ activity Bacillus subtilis (Nelson et al., 2013) 
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ABSTRACT 
Bacteria colonize highly diverse and complex environments, from gastrointestinal tracts, 
to soil and plant surfaces. This colonization process is controlled in part by the intracellular 
signal cyclic di-GMP, which regulates bacterial motility and biofilm formation. To 
interrogate cyclic di-GMP signaling networks, a variety of fluorescent biosensors for live 
cell imaging of cyclic di-GMP have been developed. However, the need for external 
illumination precludes the use of these tools for imaging bacteria in their natural 
environments, including in deep tissues of whole organisms and in samples that are 
highly autofluorescent or photosensitive. The need for genetic encoding also complicates 
the analysis of clinical isolates and environmental samples.  Toward expanding the study 
of bacterial signaling to these systems, we have developed the first chemiluminescent 
biosensors for cyclic di-GMP. The biosensor design combines the complementation of 
split luciferase (CSL) and bioluminescence resonance energy transfer (BRET) 
approaches. Furthermore, we developed a lysate-based assay for biosensor activity that 
enabled reliable high-throughput screening of a phylogenetic library of 92 biosensor 
variants. The screen identified biosensors with very large signal changes (~40 and 90-
fold) as well as biosensors with high affinities for cyclic di-GMP (KD <50 nM). These 
chemiluminescent biosensors then were applied to measure cyclic di-GMP levels in E. 
coli. The cellular experiments revealed an unexpected challenge for chemiluminescent 
imaging in Gram negative bacteria, but showed promising application in lysates. Taken 
together, this work establishes the first chemiluminescent biosensors for studying cyclic 
di-GMP signaling, and provides a foundation for using these biosensors in more complex 
systems. 
INTRODUCTION 
The second messenger 3’,5’-cyclic di-guanosine monophosphate (c-di-GMP) is the first 
discovered cyclic dinucleotide signaling molecule and has been found to be nearly 
ubiquitous in bacteria (Romling et al., 2013; Ross et al., 1987). Within cells, c-di-GMP 
levels are controlled by complex networks of diguanylate cyclases (DGCs) and c-di-GMP 
phosphodiesterases (PDEs) that work to tightly regulate the cellular concentration of this 
second messenger, often in response to extracellular signals (Hengge, 2009; Sarenko et 
al., 2017). These signaling networks coordinate a multitude of fundamental cellular 
functions, including the transition from sessile to motile states, virulence, and cell cycle 
control. To interrogate the dynamics of c-di-GMP within these complex signaling 
networks, we and others have developed biosensors for live cell imaging of c-di-GMP. 
These include protein-based FRET biosensors that have been used in E. coli (Ho et al., 
2013), C. crescentus, S. typhimurium, and P. aeruginosa (Christen et al., 2010; Mills et 
al., 2015), as well as RNA-based fluorescent biosensors that have been used in E. coli 
and allow for the first time the ability to image c-di-GMP under anaerobic conditions 
(Wang et al., 2016). 
One long-term goal in the field is to analyze c-di-GMP signaling in more complex 
settings, including bacteria colonizing the gut, and in clinical isolates, mixed cultures, or 
environmental samples (Koestler and Waters, 2014; Rossi et al., 2017). None of these 
applications have been shown with the fluorescent biosensor tools currently available. 
Due to its reliance on external illumination, fluorescent imaging is often incompatible with 
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imaging in deep tissues of animals and in long-term experiments due to phototoxicity. 
Additionally, fluorescent biosensors are difficult to apply to clinical isolates, mixed 
cultures, and environmental samples, because they haven’t been shown to work in 
complex lysates that exhibit increased autofluorescence and decreased signal due to 
sample dilution. One alternative technique that does not require external illumination to 
produce a signal is chemiluminescence imaging (Prescher and Contag, 2010). Thus, to 
expand the study of c-di-GMP signaling networks to these more complex systems, we 
sought to develop the first chemiluminescent biosensors for c-di-GMP. 
Chemiluminescent biosensors generally utilize luciferases, enzymes which 
catalyze the oxidation of small molecule luciferin substrates to produce light (Saito and 
Nagai, 2015). Luciferase-based biosensors typically fall into one of two categories: 
complementation of split luciferase (CSL) or bioluminescence resonance energy transfer 
(BRET)-based biosensors. In CSL systems, a sensor domain is used to split the luciferase 
protein into two non-functional halves, such that analyte binding results in a 
conformational change that reconstitutes the luciferase to produce a change in signal 
intensity (Fan et al., 2008; Hattori et al., 2013; Kaihara et al., 2008; Takenouchi et al., 
2016; Zhang et al., 2007). In BRET systems, the sensor domain is inserted between a 
fluorescent protein acceptor on one side and an intact luciferase donor on the other side, 
and analyte binding leads to a change in BRET efficiency between donor and acceptor 
(Biswas et al., 2008; Jiang et al., 2007; Saito et al., 2010; Yang et al., 2016). CSL 
biosensors generally produce large signal changes, however their signal intensity is often 
low due to poor reconstitution of luciferase activity. BRET biosensors generally have high 
signal intensity and are ratiometric, however their signal change upon analyte binding is 
typically small. To overcome these drawbacks, the Nagai lab combined the CSL and 
BRET approaches and used Nano-lantern (NL) or enhanced Nano-lantern (eNL) 
scaffolds to produce chemiluminescent biosensors with large signal changes (up to 4-fold 
with original NL and 6-fold with eNL) and good signal intensity for imaging (Saito et al., 
2012; Suzuki et al., 2016; Takai et al., 2015). They used these biosensors to perform 
single-cell imaging of Ca2+, cyclic AMP, and ATP in HeLa cells, D. discoideum cells, and 
Arabidopsis plant leaves, respectively (Saito et al., 2012). 
 In this work, we applied the CSL-BRET strategy to develop the first 
chemiluminescent biosensors for c-di-GMP. First, an insertion site for the E. coli c-di-GMP 
binding protein YcgR (EcYcgR) within the NL scaffold was found that generated a 
functional biosensor. Next, we mined sequence databases for diverse YcgR homologs 
and selected a set of 92 proteins for functional characterization within the biosensor 
scaffold. These phylogenetic variants were synthesized as codon optimized sequences 
for cloning into the NL scaffold. The resulting phylogenetic biosensor library was 
expressed and rapidly screened in a lysate-based assay for response to c-di-GMP. A 
large number of biosensors were identified with improved affinity, signal change, and 
stability compared to the initial EcYcgR biosensor. This new collection of 
chemiluminescent biosensors includes ones with the highest affinity for a protein-based 
c-di-GMP biosensor (<50 nM) and others with the largest signal change for a CSL-BRET 
biosensor (up to 90-fold). These biosensors were applied to measure c-di-GMP levels in 
live E. coli, and revealed challenges for chemiluminescence imaging in Gram-negative 
bacteria. Subsequently, we developed a bacterial lysate assay for diguanylate cyclase 
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activity using the biosensors. This work provides the first chemiluminescent biosensors 
for measuring c-di-GMP levels in bacteria and lays the groundwork for live cell imaging 
of c-di-GMP dynamics without external illumination. 
RESULTS 
Design of chemiluminescent biosensor for cyclic di-GMP. PilZ domain-
containing proteins bind c-di-GMP and have previously been used to generate genetically 
encoded FRET biosensors for c-di-GMP (Christen et al., 2010; Ho et al., 2013; Pultz et 
al., 2012). For the initial design, the PilZ domain-containing protein YcgR from E. coli 
(EcYcgR) was chosen as the sensor domain to insert into the yellow Nano-lantern (YNL) 
scaffold, which is an NL scaffold that uses Venus as the fluorescent acceptor (Figure 
2.1a). EcYcgR has previously been shown to bind to c-di-GMP with an affinity of ~800 
nM and undergo a large conformational change upon binding (Ryjenkov et al., 2006). 
 Four biosensors were designed that differed in either the split site of RLuc8 (91/92 
or 228/229) or the deletion/retention of a flexible N-terminal region of RLuc8 (1.0 or 1.1 
scaffold) (Figure 2.1b). These designs were chosen based on previously developed NL 
sensors (Saito et al., 2012). The four biosensors were constructed, expressed, and 
purified from E. coli, then tested for response to c-di-GMP. While all of the biosensors 
produced a chemiluminescent signal, only biosensors with EcYcgR inserted at the 91/92 
site of RLuc8 produced a c-di-GMP-dependent change in signal (Figure 2.1c). For further 
characterization, the biosensors were expressed and purified from E. coli co-expressing 
the c-di-GMP-specific phosphodiesterase PdeH (also called YhjH) to ensure that minimal 
to no c-di-GMP remain bound. The EcYcgR-91 biosensor has a dissociation constant (KD) 
for c-di-GMP of 615 ± 115 nM and gives a 2.6-fold change in chemiluminescent signal 
intensity upon binding (Figure 2.1d). The measured affinity for the biosensor is slightly 
improved compared to previously reported affinity values for EcYcgR alone (Ryjenkov et 
al., 2006) and the signal change and intensity are comparable to previously developed 
NL biosensors (Saito et al., 2012).  Additional in vitro binding tests with related 
compounds showed that the biosensor is highly specific for c-di-GMP (Figure 2.1d).  
Lysate-based assay of biosensor performance. One of the benefits of 
chemiluminescent biosensors compared to fluorescent or FRET-based biosensors is that 
because external illumination is not required, output signal is not compromised by solution 
autofluorescence. Accordingly, we find that biosensor activity can be reliably assayed in 
lysates of cells grown in complex media with no further purification. Growth and assay 
procedures were optimized to permit the use of small culture volumes and to produce 
consistent growth between wells, which led to the development of a 96-well plate format 
lysate activity assay for biosensor constructs (Figure 2.2). Importantly, by measuring in 
lysates rather than whole cells, new biosensor designs can be rapidly and reliably 
screened with any analyte of interest at a set concentration, including non-cell permeable 
compounds like c-di-GMP. 
Using this assay workflow, various mutants of EcYcgR were tested (Figure 2.3a). 
These mutations have been characterized in other YcgR proteins, and are predicted to 
alter the binding stoichiometry to c-di-GMP (M1; R113L mutant) (Ko et al., 2010) abolish 
binding to c-di-GMP (M2, R118D), or improve affinity for c-di-GMP (M3; S147A mutant) 
(Ryjenkov et al., 2006). A double mutant combination of M1 and M3 mutations (M4; 
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R113L, S147A) was also tested. While M2 severely reduced binding affinity as expected, 
the other mutations also led to decreased affinity or signal change (Figure 2.3b, c; 
Supplemental Notes). In addition, a small library of biosensors with different linkers 
flanking EcYcgR was analyzed using the lysate-based screen. It is well known that linker 
length and composition can produce large changes in the affinity and/or signal change of 
both CSL and BRET-type biosensors (Fan et al., 2008; Thestrup et al., 2014) but to our 
knowledge, this had not yet been tested in NL biosensors. Six different linker designs 
were tested spanning a length of 2–5 residues on either side of EcYcgR that were 
designed to be either flexible or rigid (Figure 2.3a). However, none of the new linker 
designs produced signal changes better than the original linkers used (Figure 2.3d; 
Supplemental Notes).  
 This 96-well format lysate-based activity assay enables biosensor constructs to be 
rapidly assessed without individually purifying each protein. A small library of EcYcgR 
mutants and linker variants was tested, but none showed improved biosensor 
performance. While a larger randomized library-based approach could lead to improved 
affinity or signal change, the biosensor would remain limited by the characteristics of the 
sensor domain, EcYcgR. Thus, we instead decided to focus on altering the sensor domain 
itself in the next round of optimization. 
Phylogenetic screen for improved c-di-GMP binding domains. Our lab has 
previously used phylogenetic libraries in the development of RNA-based fluorescent 
biosensors, and we have found that such an approach can lead to rapid improvements in 
biosensor characteristics (Su et al., 2016; Wang et al., 2016). A small number of YcgR 
proteins have been tested in FRET-based biosensors for c-di-GMP, with the best design 
exhibiting a –60.6% signal change and 195 nM affinity (Christen et al., 2010; Mills et al., 
2015). For a wider screen, all PilZ-containing proteins with domain architectures similar 
to EcYcgR (YcgR-PilZ and YcgR_2-PilZ) were obtained from the Pfam database. From 
this set of 840 sequences resulting from the bioinformatic query, 92 sequences were 
synthesized and cloned into the NL scaffold (Table 2.3) using the design found to work 
best with the EcYcgR sensor domain (91/92 insertion site, 1.0 scaffold). This set included 
34 sequences chosen from the genomes of candidate thermophilic bacteria, as we 
hypothesized that these would produce more stably folded biosensors. Additionally, c-di-
GMP binding to PilZ domains has been found to be largely entropically driven (Benach et 
al., 2007) so we expected that sensor domains from thermophiles may bind with higher 
affinity to c-di-GMP than those from mesophiles. Of the remaining 58 sequences, at least 
three were previously characterized YcgR proteins (Benach et al., 2007; Ko et al., 2010; 
Paul et al., 2010) and the remainder were chosen from a large variety of different bacterial 
genomes. 
All sequences were codon optimized for E. coli expression to aid screening. In 
addition, an mCherry fluorescent tag (Shaner et al., 2004) was introduced at the C-
terminus to measure the relative folding stability of each biosensor variant. During 
purification of EcYcgR biosensors, it was found that truncated proteins were produced at 
appreciable levels during expression, suggesting the degradation of improperly folded 
biosensors (Figure 2.4a). In contrast, the purified YNL had little-to-no truncated products. 
Thus, the ratio of mCherry fluorescence (C-terminal) to Venus fluorescence (N-terminal) 
provides a proxy for the relative amount of full-length biosensor in cells and can be 
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determined in a high-throughput manner via flow cytometry. This ratio for each 
phylogenetic variant was normalized to the ratio for the EcYcgR biosensor (mCh/Venus 
= 1). Library members with mCherry/Venus fluorescence ratios above 1 were considered 
more well-folded than EcYcgR, while library members with fluorescence ratios lower than 
1 were considered less well-folded (Figure 2.4b). The mCherry-tagged version of the 
EcYcgR biosensor was tested in the lysate-based assay and showed that the mCherry 
tag had little-to-no effect on biosensor performance (Figure 2.4c).  
To determine signal change and relative affinity for c-di-GMP, all candidate 
biosensors were tested in the lysate-based assay with two different concentrations of c-
di-GMP (Figure 2.5, 2.6a). Less than 10% (8 sequences) were inactive and produced low 
chemilumescent signal, likely due to poor expression and/or misfolding. Of the sequences 
that were active, over 40% (34 sequences) showed signal changes better than EcYcgR 
in response to 20 μM c-di-GMP (~1.86-fold). Two constructs showed signal changes of 
~17-fold and ~28-fold, which are larger than signal changes for previously developed NL 
biosensors (Saito et al., 2012; Suzuki et al., 2016). Interestingly, while the large majority 
of these variants all showed signal changes in the positive direction, 3 sequences showed 
signal changes in the negative direction, suggesting that they may undergo a different 
sort of structural rearrangement upon binding to c-di-GMP. Of all tested constructs, over 
60% (56 sequences) showed relative folding stability better than the EcYcgR biosensor, 
and 6 showed greater stability than the YNL scaffold itself. Out of the 31 thermophilic 
variants that were active, 25 showed better folding stability than EcYcgR, supporting the 
hypothesis that thermophilic sensor domains produce more well-folded biosensors in the 
NL scaffold. Taken together, this lysate-based screen of a large phylogenetic library of 
YcgR sensor domains resulted in multiple biosensors that exhibit the largest signal 
changes of any NL biosensors to date, as well as many biosensors that are more well-
folded and have larger signal change than the original EcYcgR biosensor. 
In vitro characterization of phylogenetic biosensor variants. From the 
screening panel, a subset of biosensors that displayed either increased affinity, large 
signal change, or rare negative signal change were chosen for re-screening and further 
analysis. For in vitro characterization, all phylogenetic biosensor variants were recloned 
without the mCherry tag and expressed, then purified from cells co-expressing PdeH to 
ensure that minimal to no c-di-GMP remain bound. Biosensors that showed maximal 
signal in response to 1 µM c-di-GMP in the original screen were predicted to have 
increased affinity; we further selected only biosensors that displayed positive signal 
change of at least 2.5-fold. Out of the 31 sequences with positive signal changes greater 
than EcYcgR, 9 met these criteria. Re-screening in the lysate-based assay with lower 
concentrations of c-di-GMP confirmed that all 9 sequences had affinities better than or 
equal to EcYcgR, while 7 of the sequences appeared to have affinities <200 nM (Figure 
2.6b). As purified proteins, these 7 sequences span a range of affinities, all <200 nM, with 
5 of the sequences exhibiting affinities <50 nM (Table 2.1). Interestingly, the CbYcgR 
biosensor showed a decrease in signal intensity at high concentrations of c-di-GMP, 
suggesting a secondary binding site (Figure 2.7a). 
The two biosensor variants that showed large signal changes in the lysate-based 
screen, DnYcgr and ToYcgR, demonstrated signal changes of ~40-fold and ~25-fold as 
purified proteins, respectively (Table 2.1; Figure 2.7a). These signal changes are about 
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10x higher than those seen in any previously developed NL biosensors. To our 
knowledge, the largest signal change reported for any rationally designed, single chain 
CSL-type biosensor was a 70-fold change for a cAMP biosensor (Fan et al., 2008). 
Interestingly, the largest signal change we characterized was for BtYcgR, which exhibited 
negative signal change and showed ~90-fold maximal decrease in chemiluminesence 
activity in response to c-di-GMP (Figure 2.7a). BtYcgR was among the most poorly folded 
variants as measured by the mCh/Venus fluorescence ratio, which may contribute to its 
large signal change. Of the other 2 biosensor sequences with negative signal changes, 
PtYcgR recapitulated the lysate-based results, while NtYcgR did not. The biosensors with 
negative signal changes could be useful for measuring decreases in c-di-GMP, for 
example, due to phosphodiesterase activity. 
The ligand selectivities for three of the high affinity biosensors were tested, and all 
retained high selectivity for c-di-GMP versus (3’3’)-cAG and pGpG (Figure 2.8a). Both 
CpYcgR and TbYcgR biosensors showed >100-fold selectivity against (3’3’)-cAG and no 
appreciable binding to pGpG. TuYcgR also showed >100-fold selectivity against (3’3’)-
cAG, but was slightly less selective against pGpG than the other biosensors were. 
Interestingly, our lab has shown that riboswitch-based biosensors for c-di-GMP have 
exquisitely selectivity against other cyclic di-nucleotides, with no appreciable binding, but 
~2000-fold selectivity against pGpG (Wang et al., 2016), which is the opposite trend to 
what is observed for these protein-based biosensors.  
Another key characteristic of these biosensors is signal intensity. CSL-type 
biosensors rely on the complementation of a split enzyme to produce signal, so their 
signal intensity is often only a fraction of the brightness of the non-split protein. In 
previously developed NL biosensors, for example, the brightest design achieved 35% of 
the intact YNL signal and was sufficient for single cell imaging experiments (Saito et al., 
2012). Two of our highest affinity biosensors variants, TuYcgR and CpYcgR, gave 
maximal signal intensities of ~40% and 30%, respectively, of the intact YNL signal (Figure 
2.8b). However, while total protein concentration was the same for each sample based 
on Venus domain absorbance (Nagai et al., 2002), the biosensor samples contained 
visible amounts of a truncated product including Venus, whereas the YNL sample was a 
single protein band (Figure 2.7b). Thus, the relative chemiluminescence intensities we 
measured likely underestimate the actual brightness of the biosensors. 
Finally, we measured the response time for one of the best-performing biosensors, 
CpYcgR. To test the kinetics of biosensor activation, c-di-GMP was co-injected with 
chemiluminescent substrate at time 0 into solutions containing the biosensor. To provide 
comparison to prebound or unbound controls, the CpYcgR biosensor was pre-incubated 
with or without c-di-GMP before substrate was injected at time 0. The t1/2 value for the co-
injected sample was 9-9.5 sec compared to the t1/2 value of 0.2 sec for prebound 
biosensor (Figure 2.8c). This experiment shows that the CSL-BRET biosensor undergoes 
a c-di-GMP-dependent conformational change that activates chemiluminescence in less 
than one minute, which is similar to the results for YcgR-based FRET biosensors used 
for live cell imaging (Christen et al., 2010). 
 Taken together, in vitro characterization of phylogenetic variants revealed a set of 
biosensors with good signal changes that span a range of affinities for c-di-GMP, 
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including several incorporating novel YcgR proteins that have <50 nM KD values. One 
biosensor showed positive signal changes of ~40-fold and another showed negative 
signal changes of ~90-fold, which are among the largest signal changes observed for any 
CSL-type biosensors. Finally, the biosensors showed strong signal intensities and fast 
activation in response to c-di-GMP. 
 Measuring cellular levels of c-di-GMP with chemiluminescent biosensors. As 
an initial test of our new NL biosensors for measuring c-di-GMP in live cells, we co-
expressed a subset of the mCherry-tagged biosensors in E. coli along with a diguanylate 
cyclase (WspR-D70E) or a phosphodiesterase (PdeH) to generate high or low levels of 
c-di-GMP, respectively. After overnight growth in autoinduction media, cells were pelleted 
and washed with PBS, then chemiluminescent substrate was added and total signal was 
measured in a plate reader. The mCherry fluorescence signal of the cells was also 
measured so that chemiluminescent signal intensity could be normalized to the amount 
of full-length biosensor (LUM/mCherry FL). However, to our surprise, the majority of 
biosensors did not show the expected signal increase with WspR-D70E (Figure 2.9a). 
Instead, several of them showed decreases in total signal when comparing WspR-D70E 
versus PdeH overexpressing cells, which was also observed for YNL alone. 
The result for YNL suggested that WspR-D70E overexpression could be 
decreasing substrate diffusion into cells due to increased biofilm formation, which is a 
phenotypic consequence of high c-di-GMP levels. Thus, we repeated the experiment but 
lysed the cells using the same protocol as the lysate-based assay before adding the 
chemiluminescent substrate. With no barriers to substrate diffusion, all the biosensors 
except for TuYcgR showed signal increases with WspR-D70E lysates versus PdeH 
lysates, whereas YNL showed no significant difference (Figure 2.9b). In addition, the 
normalized signal intensities were also much larger in cell lysates compared to live cells, 
which is consistent with substrate diffusion affecting the signal in intact cells. 
 Thus, we revised the plan to develop a rapid assay for measuring c-di-GMP levels 
in cell lysates instead. In this assay, the purified CpYcgR biosensor is added directly to 
lysed cells and signal is measured after addition of chemiluminescent substrate in a plate 
reader (Figure 2.9c). Due to E. coli having low endogenous levels of c-di-GMP (Sarenko 
et al., 2017) we could not detect differences in c-di-GMP lysate levels between cells 
expressing inactive enzyme (WspR-G249A, i.e. endogenous levels) or expressing a c-di-
GMP specific phosphodiesterase (PdeH). However, from these data we were able to 
observe clear differences in c-di-GMP lysate levels between cells expressing active 
diguanylate cyclases (WspR-WT, WspR-D70E, and PleD) and control cells containing 
empty vector. Notably, the signal strength and fold-change of the CpYcgR biosensor was 
almost identical in cell lysates and in buffer alone. 
DISCUSSION AND FUTURE DIRECTIONS 
This work represents, to our knowledge, the development of the first chemiluminescent 
biosensors for c-di-GMP. After initial validation of the NL biosensor design, a phylogenetic 
library of YcgR-like proteins was rapidly screened in a lysate-based assay to identify 
variants with improved biosensor characteristics. The two key benefits of this lysate-
based assay are that the biosensors can be screened without purification and for binding 
to any ligand of interest. We envision that a similar approach can be used to screen YcgR 
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mutants in a high-throughput manner to generate chemiluminescent biosensors for other 
cyclic dinucleotides, such as c-di-AMP, (2’,3’)-cGAMP, and (3’,3’)-cGAMP (Danilchanka 
and Mekalanos, 2013; Krasteva and Sondermann, 2017). 
The screen identified a panel of biosensor variants with improved affinity, signal 
change, folding stability, and signal intensity compared to the initial EcYcgR biosensor 
and other protein-based biosensors for c-di-GMP. While Nano-lantern-based biosensors 
have been used to make live cell measurements in eukaryotic systems, to our knowledge, 
they had not been applied in bacterial systems prior to this study. Our results suggest that 
changes in diffusion of the chemiluminescent substrate, coelenterazine-h, due to 
increased biofilm formation may be an issue for live cell experiments in bacteria, which 
can be overcome in part by performing measurements with the biosensors in cell lysates. 
Thus, we developed a rapid plate reader-based assay for measuring diguanylate cyclase 
activity in cell lysates, which could be applied to other types of complex samples, such as 
clinical isolates or microbial co-cultures. Future work will focus on developing ratiometric, 
rather than intensity-based, chemiluminescent biosensors using the panel of sensor 
domains discovered here to overcome limitations in bioavailability of substrate. An 
encouraging precedent is a ratiometric BRET system that has been employed to monitor 
chemotaxis receptor kinase activity in live E. coli (Shimizu et al., 2006). Ultimately, we 
aim to study c-di-GMP dynamics in biological systems for which fluorescent biosensors 
are less useful, such as in plant-pathogen interactions or intestinal bacteria in the gut. 
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FIGURES 
 
Figure 2.1 Initial design and characterization of EcYcgR biosensors. (a) BRET and 
CSL-BRET mechanism for the yellow Nano-lantern (YNL) scaffold (top) and for NL 
sensors for c-di-GMP, respectively (bottom). (b) Schematic of the domain structures of 
EcYcgR sensors. (c) Relative chemiluminescent signal intensity of EcYcgR sensors with 
or without c-di-GMP. Data are from at least 4 replicates represented as mean ± SD. (d) 
Biosensor binding affinity measurements for EcYcgR-91. Data are from 3 replicates 
represented as mean ± SD. 
  
 40 
 
 
Figure 2.2 Workflow for lysate-based biosensor assay. E. coli transformed with 
biosensor variants are grown in non-inducing media in deep-well plates to generate pre-
cultures. The following day, pre-cultures are used to inoculate auto-induction media and 
cultures are grown overnight. The next day, a small aliquot of cells is analyzed via flow 
cytometry to determine relative biosensor expression and stability. The remaining cells 
are harvested and lysed in screening buffer. Clarified lysates are mixed with c-di-GMP in 
an opaque white, 96-well plate, chemiluminescent substrate is added, and total 
chemiluminescent signal is measured to determine signal fold-changes. 
  
 41 
 
 
Figure 2.3 Lysate-based screen of EcYcgR biosensor mutant and linker variants. 
(a) Schematic of EcYcgR-91 biosensor showing different mutations to EcYcgR and the 
different linkers tested. (b) Signal change for EcYcgR-91 biosensors and mutants in the 
lysate-based assay. Data are from 2 biological replicates represented as mean ± SD. (c) 
Biosensor binding affinity measurements with purified EcYcgR-91 mutants. Data are 
presented as mean of 3 replicates. Error bars are omitted for clarity. (d) Signal change 
for EcYcgR-91 linker variants in the lysate-based assay. Data are from 2 biological 
replicates represented as mean ± SD. 
Supplemental Notes: 
EcYcgR mutations. The R113L mutation (M1) in YNL-EcYcgR was predicted to 
change the c-di-GMP binding stoichiometry from 2:1 to 1:1 as well as reduce affinity for 
c-di-GMP based on analysis of the corresponding mutant in the YcgR protein PP4397 
from P. putida (Ko et al., 2010). As expected, M1 showed reduced affinity in the lysate-
based assay (Figure 2.3b). Measurements with purified protein confirmed the reduced 
affinity and showed that binding stoichiometry was very slightly reduced compared to WT 
(Figure 2.3c). The oligomeric states of c-di-GMP are dependent on the ions present, with 
potassium (present at 100 mM in the binding assay buffer) promoting the formation of 
higher order oligomeric complexes, which may have complicated measurements of the 
binding stoichiometry (Ko et al., 2010; Zhang et al., 2006).  
 The R118D mutation (M2) in YNL-EcYcgR was predicted to knock out binding for 
c-di-GMP, as this residue should make key interactions with the phosphate linkage of c-
di-GMP. This mutation effectively ablated binding to c-di-GMP, as expected.  
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The S147A mutation (M3) in the YNL-EcYcgR scaffold was predicted to modestly 
improve affinity for c-di-GMP based on literature measurements (Ryjenkov et al. reported 
a KD change from 0.84 ± 0.16 µM to 0.69 µM for full-length EcYcgR (Ryjenkov et al., 
2006)), but our lysate-based measurements showed slightly reduced affinity instead. This 
discrepancy may be due to differences in the protein constructs, the assay methods 
(Ryjenkov et al. used equilibrium dialysis with purified protein), and buffer conditions. 
Interestingly, the corresponding mutant in PP4397 has a 4-fold reduced affinity as 
measured by ITC, which is in line with our result (Ko et al., 2010). 
Due to additive effects, the S147A/R113L double mutation (M4) showed poorer 
affinity than either M1 or M3 mutation alone. 
M1, M3, and M4 mutations to YNL-EcYcgR unexpectedly led to decreased signal 
changes (Figure 2.3c). These mutations to the c-di-GMP binding pocket may subtly alter 
the conformation of the bound or unbound state of the sensor domain. 
Linker screen. The different linker regions tested in YNL-EcYcgR all showed 
decreased signal changes compared to the original linker sequence used (Figure 2.3d). 
While no crystal structure is available for EcYcgR that would allow for a rational design of 
the linker regions, crystal structures of the homologous YcgR protein PP4397 from P. 
putida provide some degree of insight into the relative distance and orientation of the N- 
and C-termini in YcgR proteins. PP4397 was analyzed in the phylogenetic screen 
(sequence 2 in Figure 2.6a) and was found to behave very similarly to EcYcgR, which 
suggests that their overall structures are likely similar. In the apo x-ray crystal structure 
of full length PP4397 (PDB ID: 2GJG), the distance between Cα atoms of the N- and C-
termini is ~25.7 Å. This distance appears to be too long to be bridged by the original linker 
that gave a functional YNL-EcYcgR biosensor, which was 2 residues. However, we note 
that the first ~11 N-terminal residues and the last ~3 C-terminal residues are largely 
unstructured, so may serve as flexible linkers on their own. 
Prior to this structural analysis, we had designed new linkers to be either flexible 
or rigid with varying lengths from 2 to 5 residues. All of the linkers tested showed similarly 
decreased signal changes compared to the original linker, which suggests that they led 
to increased interaction of RLuc halves in the unbound state. These results indicate that 
shortening the linkers or truncating the YcgR protein may lead to improved signal change 
and/or brightness for YNL-EcYcgR, but these changes are unlikely to be directly 
translatable to other phylogenetic variants, which are of different lengths. Since the 
original linkers were applied successfully to YNL-EcYcgR and other Nano-lantern-based 
biosensors (Saito et al., 2012), they were carried forward to the phylogenetic screen. 
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Figure 2.4 Analysis of mCherry tag as measure of biosensor stability. (a) SDS-
PAGE of purified proteins showing presence of truncated protein products for NL 
biosensor constructs. (b) Normalized mCherry/Venus MFI ratios of cells expressing 
mCherry tagged NL constructs as measured by flow cytometry. Ratios are normalized to 
the ratio for EcYcgR-91-mCh and show that the ratio correlates with relative protein 
stability. Data are from 3 biological replicates represented as mean ± SD. (c) Signal 
change for NL constructs in the lysate-based assay show the mCherry tag has no 
negative effect on biosensor performance. Data are from 2 biological replicates 
represented as mean ± SD. 
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Figure 2.5 Lysate-based screen of phylogenetic biosensor variants identifies a 
panel of improved biosensor variants. Signal fold-change, defined as ratio of signal 
with 20 µM c-di-GMP to no c-di-GMP, was plotted with respect to biosensor stability (x-
axis), defined as ratio of mCherry/Venus mean fluorescence intensities (MFIs) 
normalized to the valuye for the EcYcgR biosensor. Pink data points correspond to 
sequence variants from thermophilic organisms, and gray data points correspond to 
sequence variants from mesophilic organisms. The original EcYcgR biosensor (blue 
triangle) and YNL (black square) are labeled for comparison. Circled data points 
correspond to variants chosen for further characterization. Inset: General scheme for 
biosensor variants showing the mCherry-tagged constructs used in the screen. 
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Figure 2.6 Lysate-based screen of phylogenetic library variants. (a) Signal fold-
change for the 84 active phylogenetic biosensor variants. Labeled sequences were 
chosen for further characterization due to apparent high affinity, large signal change, or 
negative signal change. See Table 2.3 for numbering. Data are from 2 biological 
replicates represented as mean ± SD. (b) Signal fold-change for selected high affinity 
variants. Selected variants were re-screened in the lysate-based assay with lower 
concentrations of c-di-GMP. Data are from 3 biological replicates represented as mean ± 
SD. 
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Figure 2.7 In vitro characterization of biosensor variants. (a) Same data as in Figure 
3b, but presented as signal fold-change. Values are normalized to no c-di-GMP for 
selected high affinity and high Δsignal variants, and values are normalized to 20 µM c-di-
GMP for negative Δsignal variants. Signal change data is summarized in Table 2.1. Data 
are from 3 replicates represented as mean ± SD. (b) SDS-PAGE of all purified biosensor 
variants used for in vitro characterization showing the presence of a truncated protein 
product that is fluorescent. 
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Figure 2.8 In vitro characterization of biosensor variants, continued. (a) Analysis of 
selectivity for high affinity biosensor variants. Data are from 3 replicates represented as 
mean ± SD. (b) Relative brightness of purified NL biosensors with or without c-di-GMP 
normalized to YNL. Data are from 3 replicates represented as mean ± SD. (c) Signal 
turn-on kinetics of CpYcgR biosensor. Chemiluminescence intensity traces are from one 
representative measurement. 
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Figure 2.9 Applying selected biosensors to detect cellular c-di-GMP levels. (a) 
Chemiluminescent signal intensities of live cells coexpressing mCherry-tagged NL 
biosensors and PdeH or WspR- D70E normalized to mCherry fluorescent signal. Data 
are from 3 biological replicates represented as mean ± SD. (b) Chemiluminescent signal 
intensities of lysates of cells coexpressing mCherry-tagged NL biosensors and PdeH or 
WspR-D70E normalized to mCherry fluorescent signal. Data are from 3 biological 
replicates represented as mean ± SD. (c) Measuring c-di-GMP levels by addition of 
CpYcgR to cell lysates. Cells are expressing various PDE or DGC enzymes. Data are 
from 3 biological replicates represented as mean ± SD. 
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MATERIALS AND METHODS 
General reagents and oligonucleotides. Cyclic dinucleotides were purchased 
from Axxora, LLC. Coelenterazine-h was purchased from NanoLight Technologies and 
stored as a ~6.15 mM stock in EtOH at –80 °C. Oligonucleotides used in molecular 
cloning were purchased from Elim Biopharmaceuticals.  
Molecular cloning. The pRSETB-Nano-lantern plasmid was a gift from Takeharu 
Nagai (Addgene plasmid # 51969). Plasmids encoding YhjH, WspR alleles, and PleD 
were available in our lab. For expression and purification, all biosensor constructs were 
cloned into the pRSETB plasmid between the NdeI and EcoRI sites with an N-terminal 
His-tag. Overlap-extension PCR was used to add the three N-terminal residues back to 
RLuc8 to create pRSETB-Nano-lantern (1.1). All NL biosensor constructs using EcYcgR 
were cloned into pRSETB using Gibson Assembly(Gibson et al., 2009) in which both linear 
backbone and insert fragments were amplified by PCR. The EcYcgR sequence was 
amplified from BL21 Star genomic DNA and mutant alleles were generated using site-
directed mutagenesis. For lysate or live-cell based experiments, YNL and EcYcgR 
biosensor constructs were amplified by PCR and ligated into pET21 and/or pET24 
plasmids between NdeI and HindIII sites and included a C-terminal His-tag. To create 
mCherry tagged versions of these plasmids, mCherry was amplified by PCR to add a 
flexible linker (GSGGSGGS) at the N-terminus then ligated between BamHI and HindIII 
sites of the empty plasmid to generate pET21-linker-mCherry and pET24-linker-mCherry. 
YNL and EcYcgR biosensor constructs were then amplified by PCR and ligated into the 
pET21- or pET24-linker-mCherry plasmid between NdeI and BamHI sites. 
Protein purification. E. coli BL21 (DE3) Star cells (Life Technologies) were 
transformed with the pRSETB vector encoding N-terminally His-tagged NL biosensor 
variants. Transformants were cultured in 2xYT medium at 37 °C until OD reached ~0.8–
1.0, followed by induction of protein expression with 0.1 mM IPTG for 20 h at 20 °C. Cells 
were collected and lysed by sonication in lysis buffer [50 mM Tris (pH 7.5), 150 mM NaCl, 
20 mM imidazole, 5% (v/v) glycerol] with 300 µg/mL lysozyme and 1 mM PMSF added. 
Clarified lysate was bound to Ni-NTA agarose (Thermo Scientific), and resin was washed 
with lysis buffer supplemented with 500 mM NaCl prior to elution with lysis buffer 
supplemented with 300 mM imidazole. Using Amicon Ultra-15 Centrifugal Filter Units 
(molecular weight cutoff 10 kDa; Millipore), the elution fractions were concentrated and 
dialyzed to storage buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 10% (v/v) glycerol]. 
Concentrated protein was flash frozen in liquid nitrogen then stored at -80 °C in small 
aliquots to prevent repetitive freeze-thaw cycles. Protein concentrations were determined 
using the absorption of Venus at 515 nm (extinction coefficient = 92200 M-1 cm-1). In 
stated cases, cells were co-transformed with the pCOLA-PdeH plasmid lacking a His-tag 
to enable purification of the biosensor without c-di-GMP bound. 
Phylogenetic library generation. YcgR sequence variants employed were 
selected using the Pfam database. Briefly, Pfam was searched for all PilZ-domain 
containing proteins with a domain architecture similar to EcYcgR (YcgR-PilZ), which were 
presumed to undergo conformational changes upon binding c-di-GMP. The query 
resulted in 840 total sequences (258 sequences with YcgR-PilZ, 582 sequences with 
YcgR_2-PilZ), then a subset of 92 sequences were chosen for synthesis and cloning into 
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the biosensor scaffold (pET21- and pET24-biosensor-mCherry). All sequences from 
suspected thermophilic organisms were given priority, and all remaining sequences were 
chosen from a large variety of bacterial genomes. The selected genes were codon 
optimized and ‘polished’ to remove DNA synthesis constraints using BOOST (Oberortner 
et al., 2017). Double stranded DNA was obtained from Gen9 (Gingko Bioworks). For 
cloning into the pET21 and pET24 derived vectors using Gibson cloning (Gibson et al., 
2009), 25 bp linkers at the beginning and end of the sequences were included. Eight 
colonies per construct were sequenced verified using PACBIO RSII system (Pacific 
Biosciences), and variant calling was performed using the GATK software package 
(McKenna et al., 2010). 
Chemiluminescence measurements. All chemiluminescence measurements 
were performed in opaque white, 96-well LUMITRAC 600 plates (Grenier). Briefly, 
proteins and ligands were added to assay buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 
10 mM DTT, 0.1% BSA] to the given final concentrations in 100 µL reaction volume, then 
incubated at 28 °C for at least 10 min to reach binding equilibrium. Unless otherwise 
noted, all affinity and kinetics measurements were made using 50 nM protein, and all 
signal change, brightness, and selectivity measurements were made using 100 nM 
protein. Chemiluminescent substrate was prepared by diluting coelenterazine-h to 60 µM 
in reagent buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 300 mM ascorbate], and allowing 
the solution to equilibrate to RT for at least 30 min. For equilibrated biosensor 
measurements, chemiluminescence at 28 °C was measured on a SpectraMax i3x 
platereader (Molecular Devices) by injecting 20 µL of chemiluminescent substrate, then 
integrating total chemiluminescent signal for 10 sec after a 3 sec delay. For biosensor 
kinetics measurements, chemiluminescence at 28 °C was measured over 3 min in 200 
ms intervals with 100 ms integration times starting at substrate injection. For c-di-GMP 
binding kinetics, c-di-GMP was co-injected with substrate for a final concentration of 2 µM 
c-di-GMP. 
Lysate-based assay for biosensor activity. Single colonies of BL21(DE3) star 
E. coli cells transformed with pET24-biosensor-mCherry plasmids were resuspended in 
500 μL of P-0.5G non-inducing media [0.5% glucose, 25 mM (NH4)2SO4, 50 mM KH2PO4, 
50 mM Na2HPO4, 1 mM MgSO4] (Studier, 2005) supplemented with 100 µg/mL 
kanamycin in 2.2 mL 96-well deep well plates (VWR), then grown at 37 °C, 325 rpm, for 
24 h to generate pre-cultures. A 5 µL aliquot of each pre-culture was used to inoculate 
500 µL of ZYP-5052 auto-induction media [25 mM (NH4)2SO4, 50 mM KH2PO4, 50 mM 
Na2HPO4, 1 mM MgSO4, 0.5% (v/v) glycerol, 0.05% glucose, 0.2% α-lactose, 1% 
tryptone, and 0.5% yeast extract] (Studier, 2005) supplemented with 100 µg/mL 
kanamycin in deep well plates. Two identical plates of auto-induction media were 
inoculated to permit aeration with shaking and to yield 1 mL of combined culture for each 
sample. Plates were grown at 37 °C, 325 rpm, for 20 h for biosensor expression. After 20 
h of growth, equivalent cultures were combined into a single plate. 
For flow cytometry analysis of biosensor expression and stability, 2 µL of each 
culture was added to 200 µL of phosphate-buffered saline (PBS) [137 mM NaCl, 2.7 mM 
KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4]. The mean fluorescence intensities were 
analyzed on an Attune NxT flow cytometer (Life Technologies). Venus fluorescence was 
measured with a 488 nm laser for excitiation and a 530/30 filter for emission. mCherry 
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fluorescence was measured with a 561 nm laser for excitation and a 620/15 filter for 
emission. 
For chemiluminescence measurements, the remaining culture was harvested in 
the deep-well plate by centrifugation at 4700 rpm for 10 min at 4 °C. Supernatant media 
was removed and each cell pellet was resuspended in 360 µL screening buffer [50 mM 
Tris (pH 7.5), 100 mM KCl, 5% glycerol, 2 mM EDTA, 300 µg/mL lysozyme, 1 mM PMSF]. 
Cells were gently lysed for 1 h at 4 °C and lysates were clarified by centrifugation at 4700 
rpm for 40 min at 4 °C. To obtain three samples, 90 µL aliquots of clarified lysates were 
pipetted into three wells of opaque white, 96-well LUMITRAC 600 plates (Grenier), being 
careful not to disturb the pelleted cell debris. Each aliquot was mixed with 10 µL of either 
buffer, 10 µM c-di-GMP, or 200 µM c-di-GMP [in 50 mM HEPES (pH 7.2), 100 mM KCl] 
to produce final concentrations of 0, 1 µM or 20 µM c-di-GMP. Mixtures were incubated 
at 28 °C for at least 10 min to allow binding to occur, then chemiluminescence was 
measured as described above. Signal fold-changes were calculated for at least two 
biological replicates by dividing the total chemiluminescence signal with added c-di-GMP 
by the total signal without added c-di-GMP.  
Cellular c-di-GMP measurements with biosensor co-expression. Single 
colonies of BL21(DE3) star E. coli cells co-transformed with pET21-biosensor-mCherry 
plasmids and pCOLA-PdeH or pCOLA-WspR-D70E were resuspended in 500 µL of P-
0.5G non-inducing media [0.5% glucose, 25 mM (NH4)2SO4, 50 mM KH2PO4, 50 mM 
Na2HPO4, 1 mM MgSO4] (Studier, 2005) supplemented with 100 µg/mL kanamycin and 
50 µg/mL carbenicillin in 2.2 mL 96-well deep well plates (VWR), then grown at 37 °C, 
325 rpm, for 24 h to generate pre-cultures. A 5 µL aliquot of each pre-culture was used 
to inoculate 500 µL of ZYP-5052 auto-induction media [25 mM (NH4)2SO4, 50 mM 
KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4, 0.5% (v/v) glycerol, 0.05% glucose, 0.2% α-
lactose, 1% tryptone, and 0.5% yeast extract] (Studier, 2005) supplemented with 100 
µg/mL kanamycin and 50 µg/mL carbenicillin in a deep well plate and grown at 37 °C, 
325 rpm, for 20 h to allow for protein expression. For live cell measurements, cultures 
were harvested by centrifugation, media was removed, and cell pellets were resuspended 
in 500 µL PBS. A 100 µL aliquot of each culture was transferred to an opaque white 96-
well plate, and the plate was incubated at 28 °C for 10 min. The mCherry fluorescence 
intensity was measured for each well, 20 µL chemiluminescent substrate was added 
manually to each well, and then total chemiluminescence was monitored over 10 min. 
Luminescent signal was calculated as the total chemiluminescence at 10 min divided by 
the mCherry fluorescence intensity to normalize differences in biosensor expression 
between biological replicates. 
For lysate measurements, cultures were harvested and clarified lysates were 
prepared as described for the lysate-based assay for biosensor activity, except each 
culture was resuspended in 240 µL screening buffer. A 100 µL aliquot of each clarified 
lysate was carefully pipetted into an opaque white 96-well plate, and the plate was 
incubated at 28 °C for 10 min. The mCherry fluorescence intensity was measured for 
each well, then chemiluminescent substrate was injected and chemiluminescence was 
measured as described in the lysate-based assay. Luminescent signal was calculated as 
the total chemiluminescence divided by the mCherry fluorescence intensity to normalize 
differences in biosensor expression between biological replicates.  
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Cellular c-di-GMP measurements with biosensor addition. Single colonies of 
BL21(DE3) star E. coli cells transformed with pCOLA plasmids encoding c-di-GMP-
related enzymes were resuspended in 500 µL of P-0.5G non-inducing media 
supplemented with 100 µg/mL kanamycin in 2.2 mL 96-well deep well plates (VWR), then 
grown at 37 °C, 325 rpm, for 24 h to generate pre-cultures. A 5 µL aliquot of each pre-
culture was used to inoculate 500 µL of ZYP-5052 auto-induction media supplemented 
with 100 µg/mL kanamycin in a deep well plate and grown at 37 °C, 325 rpm, for 20 h to 
allow for protein expression. Cultures were harvested and clarified lysates were prepared 
as described for the lysate-based assay, except each culture was resuspended in 120 µL 
screening buffer. For +lysate samples, a 50 µL aliquot of each clarified lysate was mixed 
with 50 µL of 100 nM biosensor in 2x assay buffer in an opaque white 96-well plate, and 
the plate was incubated at 28 °C for 10 min. Chemiluminescent substrate was injected 
and chemiluminesce was measured as described above. For +buffer samples, 50 µL of 
screening buffer was added instead of the lysate. 
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TABLES 
Table 2.1 Characteristics of selected biosensor variants 
Sequence K
D 
(nM)
a
  Δ signalb Hill coefficienta mCh/Venusc 
EcYcgR
d 354 ± 18 3 2.3 ± 0.23 1 
Selected for high affinity 
TmYcgR < 50 6.1 1.5 ± 0.04 1.7 
TuYcgR < 50 6.3 1.4 ± 0.04 2.7 
TbYcgR < 50 7.9 1.6 ± 0.1 1.4 
CpYcgR < 50 6.3 1.9 ± 0.1 1.7 
CbYcgR < 50 18.8 1.2 ± 0.04 0.73 
TcYcgR 59 ± 2 4.6 1.7 ± 0.1 1.6 
BvYcgR 105 ± 2 4.9 1.9 ± 0.05 2.7 
Selected for high signal change 
DnYcgR 303 ± 15 39.3 1.8 ± 0.1 0.61 
ToYcgR 379 ± 23 24.5 2.2 ± 0.2 1.1 
Selected for negative signal change 
PtYcgR < 50  –7.7 –1.8 ± 0.1 1.6 
BtYcgR 286 ± 17 –89 –2 ± 0.2 0.52 
a
Data are from 3 independent replicates represented as mean ± standard 
error.
 b
Data are the mean maximal signal change from 3 independent 
replicates; data presented in Figure S5a.
 c
Data are mean mCherry/Venus 
ratios normalized to EcYcgR from 3 biological replicates as measured in 
the lysate-based assay.
 d
Improved K
D
 and Δsignal compared to Figure 1d 
due to changes in buffer. 
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Table 2.2 Oligonucleotides used in this study 
Name Sequence (5' to 3') 
REV-RLuc228-YcgR-insert ACGATCTGCACCACGTCGGGCTTGCCGAGCTCGTCGCGCACTTTGTCCGC 
FWD-RLuc228-YcgR-insert GATCCCCCTGGTGAAGGGCCCATGGATGAGTCATTACCATGAGCAGTTCC 
REV-RLuc228-YcgR-vector AACTGCTCATGGTAATGACTCATCCATGGGCCCTTCACCAGGGGGATCTC 
FWD-RLuc228-YcgR-vector GGGAAAAAGCGGACAAAGTGCGCGACGAGCTCGGCAAGCCCGACGTGGTG 
FWD-RLuc91-YcgR-insert AGAGCGGCAACGGCAGCccatggATGagtcattaccatgagcagttcctg 
REV-RLuc91-YcgR-insert GTACTTGTAGTGGTCCAGCAGCCTGTAgagctcgtcgcgcactttgtccg 
FWD-RLuc91-YcgR-vector ggacaaagtgcgcgacgagctcTACAGGCTGCTGGACCACTACAAGTACC 
REV-RLuc91-YcgR-vector aggaactgctcatggtaatgactCATccatggGCTGCCGTTGCCGCTCTT 
FWD-Venus (-C10)-BamHi gtagtagGgatccgATGGTGAGCAAGG 
REV-Venus (-C10)-add RLuc N3 CCTTGCTGGCCATggtaccCCCGGCGG 
FWD-RLuc-add RLuc N3 ggtaccATGGCCAGCAAGGTGTACGACCCCGAGC 
REV-RLuc-EcoRI gtagtagGAATTcTTACTGCTCGTTCTTCAGCA 
FWD-Rluc91-YcgR-GS-insert AGAGCGGCAACGGCAGCggcagcATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-GS-insert GTACTTGTAGTGGTCCAGCAGCCTGTAgctgccgtcgcgcactttgtccg 
REV-Rluc91-ycgr-GS-vector aggaactgctcatggtaatgactCATgctgccGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-GS-vector ggacaaagtgcgcgacggcagcTACAGGCTGCTGGACCACTACAAGTACC 
FWD-Rluc91-ycgr-SEG-insert GCGGCAACGGCAGCagcgagggcATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-SEG-insert CTTGTAGTGGTCCAGCAGCCTGTAgccctcgctgtcgcgcactttgtccg 
REV-Rluc91-ycgr-SEG-vector aactgctcatggtaatgactCATgccctcgctGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-SEG-vector caaagtgcgcgacagcgagggcTACAGGCTGCTGGACCACTACAAGTACC 
FWD-Rluc91-ycgr-GGSG-insert GCAACGGCAGCggcggcagcggcATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-GGSG-insert GTAGTGGTCCAGCAGCCTGTAgccgctgccgccgtcgcgcactttgtccg 
REV-Rluc91-ycgr-GGSG-vector tgctcatggtaatgactCATgccgctgccgccGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-GGSG-vector agtgcgcgacggcggcagcggcTACAGGCTGCTGGACCACTACAAGTACC 
FWD-Rluc91-ycgr-AP-insert AGAGCGGCAACGGCAGCgcccccATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-AP-insert GTACTTGTAGTGGTCCAGCAGCCTGTAgggggcgtcgcgcactttgtccg 
FWD-Rluc91-ycgr-AP-vector ggacaaagtgcgcgacgcccccTACAGGCTGCTGGACCACTACAAGTACC 
REV-Rluc91-ycgr-AP-vector aggaactgctcatggtaatgactCATgggggcGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-APAP-insert GCAACGGCAGCgcccccgcccccATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-APAP-insert GTAGTGGTCCAGCAGCCTGTAgggggcgggggcgtcgcgcactttgtccg 
REV-Rluc91-ycgr-APAP-vector tgctcatggtaatgactCATgggggcgggggcGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-APAP-vector agtgcgcgacgcccccgcccccTACAGGCTGCTGGACCACTACAAGTACC 
FWD-Rluc91-ycgr-EAAAK-insert ACGGCAGCgaggccgccgccaagATGagtcattaccatgagcagttcctg 
REV-Rluc91-ycgr-EAAAK-insert GTGGTCCAGCAGCCTGTActtggcggcggcctcgtcgcgcactttgtccg 
REV-Rluc91-ycgr-EAAAK-vector tcatggtaatgactCATcttggcggcggcctcGCTGCCGTTGCCGCTCTT 
FWD-Rluc91-ycgr-EAAAK-vector gcgcgacgaggccgccgccaagTACAGGCTGCTGGACCACTACAAGTACC 
FWD-YcgR-R113L quikchange caccttatggtttgtacaactacgccgatatttccg 
REV-YcgR-R113L quikchange cggaaatatcggcgtagttgtacaaaccataaggtg 
FWD-YcgR-R118D-rth GAcatctccgccccactcc 
 56 
 
REV-YcgR-R118D-rth gaaatatcggcgtcgttgtacaaacc 
FWD-YcgR-S147A-rth Gcgttaggcggcatggg 
REV-YcgR-S147A-rth caaatcatacaggcggaaacg 
FWD-YNL-NdeI tattcacatATGGTGAGCAAGGGCGAGG 
REV-YNL-HindIII (no stop) cgtaagcttCTGCTCGTTCTTCAGCACTCTCTC 
REV-YNL-BamHI (no stop) ataggatccCTGCTCGTTCTTCAGCACTCTCTC 
FWD-mCherry w/ linker-BamHI ataggatccggcggcagcggcggcagcATGGTGAGCAAGGGCGA 
REV-mCherry-HindIII (no stop) tataagcttCTTGTACAGCTCGTCCATGCC 
FWD-YNL-pRSET insert GACGATGACGATAAGgatccgATGGTGAGCAAGGGCGAG 
REV-YNL-pRSET insert CCGGATCAAGCTTCGAATTcTTACTGCTCGTTCTTCAGCACTCTC 
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Table 2.3 Phylogenetic sequence variants. Orange highlighted organism names are 
predicted thermophiles. Any sequence without a number label (numbering used in 
Figure 2.6) produced very low luminescence activity in the lysate-based screen and was 
not included in any data shown. 
 
UniProt accession Description Organism Domain arch Length Number Name 
YCGRL_VIBCH 
Cyclic di-GMP 
binding protein 
VCA0042 
Vibrio cholerae serotype O1 
(strain ATCC 39315 / El Tor 
Inaba N16961) YcgR2-PilZ 252 1   
YCGR_PSEPK 
Flagellar brake 
protein YcgR 
Pseudomonas putida (strain 
KT2440) YcgR-PilZ 247 2   
YCGR_SALTY 
Flagellar brake 
protein YcgR 
Salmonella typhimurium 
(strain LT2 / SGSC1412 / 
ATCC 700720) YcgR-PilZ 244 3   
Q9HYP3_PSEAE 
Uncharacterized 
protein 
Pseudomonas aeruginosa 
(strain ATCC 15692 / DSM 
22644 / CIP 104116 / JCM 
14847 / LMG 12228 / 1C / 
PRS 101 / PAO1) YcgR-PilZ 263 4   
Q67PC2_SYMTH 
Putative 
uncharacterized 
protein 
Symbiobacterium 
thermophilum (strain T / IAM 
14863) YcgR2-PilZ 234 5   
R7RRU9_9CLOT Flagellar protein 
Thermobrachium celere 
DSM 8682 YcgR2-PilZ 223 6   
B5Y7A9_COPPD 
Type IV pilus 
assembly protein PilZ 
Coprothermobacter 
proteolyticus (strain ATCC 
35245 / DSM 5265 / BT) YcgR2-PilZ 233 7 Cp 
G0GFW8_SPITZ 
Type IV pilus 
assembly PilZ 
Spirochaeta thermophila 
(strain ATCC 700085 / DSM 
6578 / Z-1203) YcgR2-PilZ 369     
M1E4L7_9FIRM 
Type IV pilus 
assembly PilZ 
Thermodesulfobium 
narugense DSM 14796 YcgR2-PilZ 246 8   
G0GFW8_SPITZ 
Type IV pilus 
assembly PilZ 
Spirochaeta thermophila 
(strain ATCC 700085 / DSM 
6578 / Z-1203) YcgR2-PilZ 357     
B7GHM9_ANOFW 
Predicted 
glycosyltransferase 
Anoxybacillus flavithermus 
(strain DSM 21510 / WK1) YcgR2-PilZ 239     
B2A369_NATTJ 
Type IV pilus 
assembly PilZ 
Natranaerobius thermophilus 
(strain ATCC BAA-1301 / 
DSM 18059 / JW/NM-WN-
LF) YcgR2-PilZ 225 9 Nt 
A0A150LBE3_9BACI 
Uncharacterized 
protein Bacillus sporothermodurans YcgR2-PilZ 216 10 Bs 
A1HN17_9FIRM 
Type IV pilus 
assembly PilZ 
Thermosinus 
carboxydivorans Nor1 YcgR2-PilZ 211 11 Tc 
A0A124FJ12_9FIRM 
Type IV pilus 
assembly PilZ 
Thermoanaerobacterales 
bacterium 50_218 YcgR2-PilZ 220 12 Tb 
D5XFF1_THEPJ 
Type IV pilus 
assembly PilZ 
Thermincola potens (strain 
JR) YcgR2-PilZ 219 13   
A0A0S3QVC2_9AQUI 
Type IV pilus 
assembly PilZ 
Thermosulfidibacter takaii 
ABI70S6 YcgR2-PilZ 242 14   
B8CYP6_HALOH 
Type IV pilus 
assembly PilZ 
Halothermothrix orenii (strain 
H 168 / OCM 544 / DSM 
9562) YcgR2-PilZ 216 15   
D7CM20_SYNLT 
Type IV pilus 
assembly PilZ 
Syntrophothermus 
lipocalidus (strain DSM 
12680 / TGB-C1) YcgR2-PilZ 216 16   
B0K9S5_THEP3 
Type IV pilus 
assembly PilZ 
Thermoanaerobacter 
pseudethanolicus (strain 
ATCC 33223 / 39E) YcgR2-PilZ 209 17   
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I3VWB4_THESW 
Type IV pilus 
assembly PilZ 
Thermoanaerobacterium 
saccharolyticum (strain DSM 
8691 / JW/SL-YS485) YcgR2-PilZ 209 18   
K8EBV6_9FIRM 
Type IV pilus 
assembly PilZ 
Desulfotomaculum 
hydrothermale Lam5 = DSM 
18033 YcgR2-PilZ 227 19   
A0A090IV04_9BACI Glycosyltransferase Bacillus thermoamylovorans YcgR2-PilZ 220 20 Bt 
A8F4V2_PSELT 
Type IV pilus 
assembly PilZ 
Pseudothermotoga lettingae 
(strain ATCC BAA-301 / 
DSM 14385 / NBRC 107922 
/ TMO) YcgR2-PilZ 234 21   
F7YXY9_9THEM 
Type IV pilus 
assembly PilZ 
Pseudothermotoga 
thermarum DSM 5069 YcgR2-PilZ 227 22   
Q9X007_THEMA Flagellar protein 
Thermotoga maritima (strain 
ATCC 43589 / MSB8 / DSM 
3109 / JCM 10099) YcgR2-PilZ 229 23 Tm 
A5D0H5_PELTS Glycosyltransferase 
Pelotomaculum 
thermopropionicum (strain 
DSM 13744 / JCM 10971 / 
SI) YcgR2-PilZ 219 24 Pt 
D9S3A4_THEOJ 
Type IV pilus 
assembly PilZ 
Thermosediminibacter 
oceani (strain ATCC BAA-
1034 / DSM 16646 / JW/IW-
1228P) YcgR2-PilZ 212 25   
K4LH04_THEPS 
Type IV pilus 
assembly PilZ 
Thermacetogenium phaeum 
(strain ATCC BAA-254 / 
DSM 12270 / PB) YcgR2-PilZ 220 26   
A6LMY0_THEM4 
Type IV pilus 
assembly PilZ 
Thermosipho melanesiensis 
(strain DSM 12029 / CIP 
104789 / BI429) YcgR2-PilZ 220 27   
A0A101EVB1_9THEM 
Type IV pilus 
assembly PilZ Thermotoga sp. 50_1627 YcgR2-PilZ 227 28 Tu 
L0EE96_THECK 
Putative 
glycosyltransferase 
Thermobacillus composti 
(strain DSM 18247 / JCM 
13945 / KWC4) YcgR2-PilZ 217 29 To 
A3DCP7_CLOTH 
Type IV pilus 
assembly PilZ 
Clostridium thermocellum 
(strain ATCC 27405 / DSM 
1237 / NBRC 103400 / 
NCIMB 10682 / NRRL B-
4536 / VPI 7372) YcgR2-PilZ 224 30   
E6SJP9_THEM7 
Type IV pilus 
assembly PilZ 
Thermaerobacter 
marianensis (strain ATCC 
700841 / DSM 12885 / JCM 
10246 / 7p75a) YcgR2-PilZ 220 31   
Q2RKC8_MOOTA 
Glycosyltransferase-
like protein 
Moorella thermoacetica 
(strain ATCC 39073 / JCM 
9320) YcgR2-PilZ 219 32   
D1B6A2_THEAS 
Type IV pilus 
assembly PilZ 
Thermanaerovibrio 
acidaminovorans (strain 
ATCC 49978 / DSM 6589 / 
Su883) YcgR2-PilZ 227 33   
K8EH43_9FIRM 
Type IV pilus 
assembly PilZ 
Desulfotomaculum 
hydrothermale Lam5 = DSM 
18033 YcgR2-PilZ 208 34   
H2INW0_RAHAC 
Flagellar brake 
protein YcgR 
Rahnella aquatilis (strain 
ATCC 33071 / DSM 4594 / 
JCM 1683 / NBRC 105701 / 
NCIMB 13365 / CIP 78.65) YcgR-PilZ 248 35   
A0A080M6H4_9PROT 
Flagellar brake 
protein YcgR 
Candidatus Accumulibacter 
sp. SK-02 YcgR-PilZ 266 36   
A0A0R0ARV1_9GAMM 
Flagellar brake 
protein YcgR 
Stenotrophomonas 
panacihumi YcgR-PilZ 265 37   
A0A063BEK1_9BURK 
Flagellar brake 
protein YcgR Burkholderia sp. lig30 YcgR-PilZ 251 38   
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Q7CK58_YERPE 
Flagellar brake 
protein YcgR Yersinia pestis YcgR-PilZ 252 39   
H8GFW9_METAL 
Flagellar brake 
protein YcgR 
Methylomicrobium album 
BG8 YcgR-PilZ 239 40   
B4E8L7_BURCJ 
Flagellar brake 
protein YcgR 
Burkholderia cenocepacia 
(strain ATCC BAA-245 / 
DSM 16553 / LMG 16656 / 
NCTC 13227 / J2315 / 
CF5610) YcgR-PilZ 251 41   
S6B8T9_9PROT 
Flagellar brake 
protein YcgR 
Sulfuricella denitrificans 
skB26 YcgR-PilZ 257 42   
A0A0D5V569_9BURK 
Flagellar brake 
protein YcgR Paraburkholderia fungorum YcgR-PilZ 263 43   
YCGR_LARHH 
Flagellar brake 
protein YcgR 
Laribacter hongkongensis 
(strain HLHK9) YcgR-PilZ 271 44   
H1SBM0_9BURK 
Flagellar brake 
protein YcgR Cupriavidus basilensis OR16 YcgR-PilZ 233 45 Cb 
E1TCJ5_BURSG 
Flagellar brake 
protein YcgR 
Burkholderia sp. (strain 
CCGE1003) YcgR-PilZ 263 46   
D8IT03_HERSS 
Flagellar brake 
protein YcgR 
Herbaspirillum seropedicae 
(strain SmR1) YcgR-PilZ 251 47   
C5AEG4_BURGB 
Flagellar brake 
protein YcgR 
Burkholderia glumae (strain 
BGR1) YcgR-PilZ 250 48   
YCGR_NITEC 
Flagellar brake 
protein YcgR 
Nitrosomonas eutropha 
(strain C91) YcgR-PilZ 269     
YCGR_THIDA 
Flagellar brake 
protein YcgR 
Thiobacillus denitrificans 
(strain ATCC 25259) YcgR-PilZ 255 49   
A0A126T293_9GAMM 
Flagellar brake 
protein YcgR Methylomonas denitrificans YcgR-PilZ 249 50   
H5V7W3_ESCHE 
Flagellar brake 
protein YcgR 
Escherichia hermannii 
NBRC 105704 YcgR-PilZ 243 51   
YCGR1_DECAR 
Flagellar brake 
protein YcgR 1 
Dechloromonas aromatica 
(strain RCB) YcgR-PilZ 264 52   
A9MP65_SALAR 
Flagellar brake 
protein YcgR 
Salmonella arizonae (strain 
ATCC BAA-731 / CDC346-
86 / RSK2980) YcgR-PilZ 244 53   
E6WB98_PANSA 
Flagellar brake 
protein YcgR Pantoea sp. (strain At-9b) YcgR-PilZ 244 54   
S6ALU3_PSERE 
Flagellar brake 
protein 
Pseudomonas resinovorans 
NBRC 106553 YcgR-PilZ 264 55   
YCGR_METML 
Flagellar brake 
protein YcgR 
Methylotenera mobilis (strain 
JLW8 / ATCC BAA-1282 / 
DSM 17540) YcgR-PilZ 253 56   
L1LXK9_PSEPU 
Uncharacterized 
protein Pseudomonas putida CSV86 YcgR-PilZ 247 57 Pp 
A0A080MAN3_9PROT 
Flagellar brake 
protein YcgR 
Candidatus Accumulibacter 
sp. BA-91 YcgR-PilZ 259 58   
A0A0L0GIP1_9ENTR 
Flagellar brake 
protein YcgR Trabulsiella odontotermitis YcgR-PilZ 243 59   
A0A0K1K509_9BURK 
Flagellar brake 
protein YcgR Massilia sp. NR 4-1 YcgR-PilZ 253 60   
A0A024HEU5_PSEKB 
Flagellar brake 
protein YcgR 
Pseudomonas knackmussii 
(strain DSM 6978 / LMG 
23759 / B13) YcgR-PilZ 249 61   
A0A0S8DMJ3_9GAMM 
Flagellar brake 
protein YcgR 
Gammaproteobacteria 
bacterium SG8_47 YcgR-PilZ 252 62   
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Q97H69_CLOAB 
Uncharacterized 
protein, YPFA 
B.subtilis ortholog 
Clostridium acetobutylicum 
(strain ATCC 824 / DSM 792 
/ JCM 1419 / LMG 5710 / 
VKM B-1787) YcgR2-PilZ 222 63   
A0A0U9HJ89_9THEO 
C-di-GMP-binding 
flagellar brake protein 
YcgR 
Tepidanaerobacter 
syntrophicus YcgR2-PilZ 213 64   
A0A140LAQ7_9THEO 
Flagellar brake 
protein YcgR Fervidicola ferrireducens YcgR2-PilZ 212 65   
D4H107_DENA2 
Type IV pilus 
assembly PilZ 
Denitrovibrio acetiphilus 
(strain DSM 12809 / N2460) YcgR2-PilZ 219 66 Dn 
D3PCV1_DEFDS 
Type IV pilus 
assembly protein PilZ 
Deferribacter desulfuricans 
(strain DSM 14783 / JCM 
11476 / NBRC 101012 / 
SSM1) YcgR2-PilZ 223 67   
A8FEM7_BACP2 
Pilus assembly 
protein PilZ 
Bacillus pumilus (strain 
SAFR-032) YcgR2-PilZ 215 68   
W6N5K7_CLOTY Flagellar protein 
Clostridium tyrobutyricum 
DIVETGP YcgR2-PilZ 216 69   
A4J746_DESRM 
Type IV pilus 
assembly PilZ 
Desulfotomaculum reducens 
(strain MI-1) YcgR2-PilZ 221 70   
A0A151B6Q5_9CLOT 
Flagellar protein 
YcgR 
Clostridium tepidiprofundi 
DSM 19306 YcgR2-PilZ 217 71   
C6C102_DESAD 
Type IV pilus 
assembly PilZ 
Desulfovibrio salexigens 
(strain ATCC 14822 / DSM 
2638 / NCIB 8403 / VKM B-
1763) YcgR2-PilZ 229     
A6M180_CLOB8 
Type IV pilus 
assembly PilZ 
Clostridium beijerinckii 
(strain ATCC 51743 / NCIMB 
8052) YcgR2-PilZ 213     
R1AST9_9CLOT Flagellar protein 
Caldisalinibacter 
kiritimatiensis YcgR2-PilZ 222 72   
F7NL64_9FIRM 
Type IV pilus 
assembly PilZ 
Acetonema longum DSM 
6540 YcgR2-PilZ 215 73   
L0FC86_DESDL 
Putative 
glycosyltransferase 
Desulfitobacterium 
dichloroeliminans (strain 
LMG P-21439 / DCA1) YcgR2-PilZ 214 74   
R7C6C4_9CLOT 
Type IV pilus 
assembly PilZ Clostridium sp. CAG:62 YcgR2-PilZ 236 75   
A0A139D977_9FIRM Flagellar protein Halanaerobium sp. T82-1 YcgR2-PilZ 213 76   
R7R388_9FIRM Flagellar protein Roseburia sp. CAG:100 YcgR2-PilZ 255 77   
A0A0E3W3A0_9FIRM PilZ domain 
Syntrophomonas zehnderi 
OL-4 YcgR2-PilZ 216 78   
D5CSE9_SIDLE 
Type IV pilus 
assembly PilZ 
Sideroxydans lithotrophicus 
(strain ES-1) YcgR2-PilZ 311     
I8RFB4_9FIRM 
Type IV pilus 
assembly PilZ Pelosinus fermentans B4 YcgR2-PilZ 215 79   
Q24T82_DESHY 
Putative 
uncharacterized 
protein 
Desulfitobacterium hafniense 
(strain Y51) YcgR2-PilZ 200     
W1SJT3_9BACI 
Type iv pilus 
assembly pilz Bacillus vireti LMG 21834 YcgR2-PilZ 207 80 Bv 
A3WPA0_9GAMM 
Predicted 
glycosyltransferase Idiomarina baltica OS145 YcgR2-PilZ 233 81   
K8DYS2_9FIRM 
Putative Type IV 
pilus assembly PilZ 
Desulfotomaculum 
hydrothermale Lam5 = DSM 
18033 YcgR2-PilZ 209 82   
W0JLH8_DESAE 
Uncharacterized 
protein Desulfurella acetivorans A63 YcgR2-PilZ 224 83   
A0A0E4HD84_9BACL 
Type IV pilus 
assembly protein PilZ 
Paenibacillus riograndensis 
SBR5 YcgR2-PilZ 186 84   
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Table 2.4 Amino acid sequences of biosensor plasmids.  
Notes: His-tag, Venus ΔC10, RLuc8 (4-91), EcYcgR, RLuc8 (92-311), mCherry tag; 
phylogenetic biosensor variants use the same sequences, except the phylogenetic 
variant is used in place of EcYcgR. 
  
pRSET-YNL-
EcYcgR-91 
 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGD
ATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNY
KTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGV
QLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGGTKVYDPEQRKRMITGPQ
WWARCKQMNVLDSFINYYDSEKHAENAVIFLHGNATSSYLWRHVVPHIEPVARCIIPDLIGMGKSGKSGN
GSPWMSHYHEQFLKQNPLAVLGVLRDLHKAAIPLRLSWNGGQLISKLLAITPDKLVLDFGSQAEDNIAVL
KAQHITITAETQGAKVEFTVEQLQQSEYLQLPAFITVPPPTLWFVQRRRYFRISAPLHPPYFCQTKLADN
STLRFRLYDLSLGGMGALLETAKPAELQEGMRFAQIEVNMGQWGVFHFDAQLISISERKVIDGKNETITT
PRLSFRFLNVSPTVERQLQRIIFSLEREAREKADKVRDELYRLLDHYKYLTAWFELLNLPKKIIFVGHDW
GAALAFHYAYEHQDRIKAIVHMESVVDVIESWDEWPDIEEDIALIKSEEGEKMVLENNFFVETVLPSKIM
RKLEPEEFAAYLEPFKEKGEVRRPTLSWPREIPLVKGGKPDVVQIVRNYNAYLRASDDLPKLFIEGDPGF
FSNAIVEGAKKFPNTEFVKVKGLHFLQEDAPDEMGKYIKSFVERVLKNEQ*stop 
 
pET21/24-
YNL-
EcYcgR-91 
 
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQ
CFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSK
DPNEKRDHMVLLEFVTAAGGTKVYDPEQRKRMITGPQWWARCKQMNVLDSFINYYDSEKHAENAVIFLHG
NATSSYLWRHVVPHIEPVARCIIPDLIGMGKSGKSGNGSPWMSHYHEQFLKQNPLAVLGVLRDLHKAAIP
LRLSWNGGQLISKLLAITPDKLVLDFGSQAEDNIAVLKAQHITITAETQGAKVEFTVEQLQQSEYLQLPA
FITVPPPTLWFVQRRRYFRISAPLHPPYFCQTKLADNSTLRFRLYDLSLGGMGALLETAKPAELQEGMRF
AQIEVNMGQWGVFHFDAQLISISERKVIDGKNETITTPRLSFRFLNVSPTVERQLQRIIFSLEREAREKA
DKVRDELYRLLDHYKYLTAWFELLNLPKKIIFVGHDWGAALAFHYAYEHQDRIKAIVHMESVVDVIESWD
EWPDIEEDIALIKSEEGEKMVLENNFFVETVLPSKIMRKLEPEEFAAYLEPFKEKGEVRRPTLSWPREIP
LVKGGKPDVVQIVRNYNAYLRASDDLPKLFIEGDPGFFSNAIVEGAKKFPNTEFVKVKGLHFLQEDAPDE
MGKYIKSFVERVLKNEQKLAAALEHHHHHH*stop 
 
pET21/24-
YNL-
EcYcgR-91-
mCherry 
 
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQ
CFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGH
KLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSK
DPNEKRDHMVLLEFVTAAGGTKVYDPEQRKRMITGPQWWARCKQMNVLDSFINYYDSEKHAENAVIFLHG
NATSSYLWRHVVPHIEPVARCIIPDLIGMGKSGKSGNGSPWMSHYHEQFLKQNPLAVLGVLRDLHKAAIP
LRLSWNGGQLISKLLAITPDKLVLDFGSQAEDNIAVLKAQHITITAETQGAKVEFTVEQLQQSEYLQLPA
FITVPPPTLWFVQRRRYFRISAPLHPPYFCQTKLADNSTLRFRLYDLSLGGMGALLETAKPAELQEGMRF
AQIEVNMGQWGVFHFDAQLISISERKVIDGKNETITTPRLSFRFLNVSPTVERQLQRIIFSLEREAREKA
DKVRDELYRLLDHYKYLTAWFELLNLPKKIIFVGHDWGAALAFHYAYEHQDRIKAIVHMESVVDVIESWD
EWPDIEEDIALIKSEEGEKMVLENNFFVETVLPSKIMRKLEPEEFAAYLEPFKEKGEVRRPTLSWPREIP
LVKGGKPDVVQIVRNYNAYLRASDDLPKLFIEGDPGFFSNAIVEGAKKFPNTEFVKVKGLHFLQEDAPDE
MGKYIKSFVERVLKNEQGGSGGSMVSKGEEDNMAIIKEFMRFKVHMEGSVNGHEFEIEGEGEGRPYEGTQ
TAKLKVTKGGPLPFAWDILSPQFMYGSKAYVKHPADIPDYLKLSFPEGFKWERVMNFEDGGVVTVTQDSS
LQDGEFIYKVKLRGTNFPSDGPVMQKKTMGWEASSERMYPEDGALKGEIKQRLKLKDGGHYDAEVKTTYK
AKKPVQLPGAYNVNIKLDITSHNEDYTIVEQYERAEGRHSTGGMDELYKKLAAALEHHHHHH*stop 
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Table 2.5 Nucleotide sequences of biosensor plasmids. Corresponding nucleotide 
sequences of amino acid sequences presented in Table 2.4. 
pRSET-YNL-
EcYcgR-91 
 
ATGCGGGGTTCTCATCATCATCATCATCATGGTATGGCTAGCATGACTGGTGGACAGCAAATGGGTCGGGA
TCTGTACGACGATGACGATAAGgatccgATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCA
TCCTGGTCGAGCTGGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCC
ACCTACGGCAAGCTGACCCTGAAGCTGATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGT
GACCACCCTGGGCTACGGCCTGCAGTGCTTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCA
AGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACC
CGCGCCGAGGTGAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGA
GGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACA
AGCAGAAGAACGGCATCAAGGCCAACTTCAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTCGCC
GACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTA
CCAGTCCAAGCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCG
CCGGGggtaccAAGGTGTACGACCCCGAGCAGAGGAAGAGGATGATCACCGGCCCCCAGTGGTGGGCCAGG
TGCAAGCAGATGAACGTGCTGGACAGCTTCATCAACTACTACGACAGCGAGAAGCACGCCGAGAACGCCGT
GATCTTCCTGCACGGCAACGCCaCTAGCAGCTACCTGTGGAGGCACGTGGTGCCCCACATCGAGCCCGTGG
CCAGGTGCATCATCCCCGATCTGATCGGCATGGGCAAGAGCGGCAAGAGCGGCAACGGCAGCccatggATG
agtcattaccatgagcagttcctgaaacaaaatccgttagccgtcctgggcgtgttacgcgatttgcacaa
agccgcaattcctttgcgtctcagttggaatggcgggcagctgatcagcaaattactggcaataaccccgg
ataaactggtgctggatttcggcagtcaagccgaagacaacatcgccgtgctaaaggcacagcacattacc
attaccgccgaaactcagggtgcgaaagtcgagtttactgttgaacaactacagcagagtgaatacttgca
gcttccggcatttattaccgtaccgcctcccaccttatggtttgtacaacgacgccgatatttccgcatct
ccgccccactccatccgccttatttttgccagaccaaactggcggataacagtacgttacgtttccgcctg
tatgatttgtcgttaggcggcatgggcgcattactggaaacagcaaagcctgccgaattacaagaaggcat
gcgcttcgctcagattgaagtcaacatggggcaatggggtgtttttcactttgacgcccagttaatctcca
tcagcgagcgcaaagtgattgatggcaagaatgaaaccatcaccactccccgtctgagcttccgttttctt
aacgtcagcccgacggtggagcggcaattacagcggattattttctctctcgagcgagaagcccgggaaaa
agcggacaaagtgcgcgacgagctcTACAGGCTGCTGGACCACTACAAGTACCTGACCGCCTGGTTCGAGC
TCCTGAACCTGCCCAAGAAGATCATCTTCGTGGGCCACGACTGGGGCGCCgcCCTGGCCTTCCACTACgcC
TACGAGCACCAGGACAgGATCAAGGCCATCGTGCACatgGAGAGCGTGGTGGACGTGATCGAGAGCTGGGA
CGAGTGGCCAGACATCGAGGAGGACATCGCCCTGATCAAGAGCGAGGAGGGCGAGAAGATGGTGCTGGAGA
ACAACTTCTTCGTGGAGACCgTGCTGCCCAGCAAGATCATGAGAAAGCTGGAGCCCGAGGAGTTCGCCGCC
TACCTGGAGCCCTTCAAGGAGAAGGGCGAGGTGAGAAGACCCACCCTGAGCTGGCCCAGAGAGATCCCCCT
GGTGAAGGGCGGCAAGCCCGACGTGGTGCAGATCGTGAGAAACTACAACGCCTACCTGAGAGCCAGCGACG
ACCTGCCCAAGcTGTTCATCGAGggcGACCCCGGCTTCTTCAGCAACGCCATCGTGGAGGGCGCCAAGAAG
TTCCCCAACACCGAGTTCGTGAAGGTGAAGGGCCTGCACTTCctCCAGGAGGACGCCCCCGACGAGATGGG
CAAGTACATCAAGAGCTTCGTGGAGAGAGTGCTGAAGAACGAGCAGTAA 
 
pET21/24-
YNL-
EcYcgR-91 
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAA
CGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGCTGA
TCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGC
TTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCA
GGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACA
CCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG
GAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTT
CAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCG
GCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCAAGCTGAGCAAAGACCCCAAC
GAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGggtaccAAGGTGTACGACCCCGA
GCAGAGGAAGAGGATGATCACCGGCCCCCAGTGGTGGGCCAGGTGCAAGCAGATGAACGTGCTGGACAGCT
TCATCAACTACTACGACAGCGAGAAGCACGCCGAGAACGCCGTGATCTTCCTGCACGGCAACGCCaCTAGC
AGCTACCTGTGGAGGCACGTGGTGCCCCACATCGAGCCCGTGGCCAGGTGCATCATCCCCGATCTGATCGG
CATGGGCAAGAGCGGCAAGAGCGGCAACGGCAGCccatggATGagtcattaccatgagcagttcctgaaac
aaaatccgttagccgtcctgggcgtgttacgcgatttgcacaaagccgcaattcctttgcgtctcagttgg
aatggcgggcagctgatcagcaaattactggcaataaccccggataaactggtgctggatttcggcagtca
agccgaagacaacatcgccgtgctaaaggcacagcacattaccattaccgccgaaactcagggtgcgaaag
tcgagtttactgttgaacaactacagcagagtgaatacttgcagcttccggcatttattaccgtaccgcct
cccaccttatggtttgtacaacgacgccgatatttccgcatctccgccccactccatccgccttatttttg
ccagaccaaactggcggataacagtacgttacgtttccgcctgtatgatttgtcgttaggcggcatgggcg
cattactggaaacagcaaagcctgccgaattacaagaaggcatgcgcttcgctcagattgaagtcaacatg
gggcaatggggtgtttttcactttgacgcccagttaatctccatcagcgagcgcaaagtgattgatggcaa
gaatgaaaccatcaccactccccgtctgagcttccgttttcttaacgtcagcccgacggtggagcggcaat
tacagcggattattttctctctcgagcgagaagcccgggaaaaagcggacaaagtgcgcgacgagctcTAC
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AGGCTGCTGGACCACTACAAGTACCTGACCGCCTGGTTCGAGCTCCTGAACCTGCCCAAGAAGATCATCTT
CGTGGGCCACGACTGGGGCGCCgcCCTGGCCTTCCACTACgcCTACGAGCACCAGGACAgGATCAAGGCCA
TCGTGCACatgGAGAGCGTGGTGGACGTGATCGAGAGCTGGGACGAGTGGCCAGACATCGAGGAGGACATC
GCCCTGATCAAGAGCGAGGAGGGCGAGAAGATGGTGCTGGAGAACAACTTCTTCGTGGAGACCgTGCTGCC
CAGCAAGATCATGAGAAAGCTGGAGCCCGAGGAGTTCGCCGCCTACCTGGAGCCCTTCAAGGAGAAGGGCG
AGGTGAGAAGACCCACCCTGAGCTGGCCCAGAGAGATCCCCCTGGTGAAGGGCGGCAAGCCCGACGTGGTG
CAGATCGTGAGAAACTACAACGCCTACCTGAGAGCCAGCGACGACCTGCCCAAGcTGTTCATCGAGggcGA
CCCCGGCTTCTTCAGCAACGCCATCGTGGAGGGCGCCAAGAAGTTCCCCAACACCGAGTTCGTGAAGGTGA
AGGGCCTGCACTTCctCCAGGAGGACGCCCCCGACGAGATGGGCAAGTACATCAAGAGCTTCGTGGAGAGA
GTGCTGAAGAACGAGCAGaagcttgcggccgcactcgagcaccaccaccaccaccactga 
pET21/24-
YNL-
EcYcgR-91-
mCherry 
 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAA
CGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTGACCCTGAAGCTGA
TCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTGACCACCCTGGGCTACGGCCTGCAGTGC
TTCGCCCGCTACCCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCA
GGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACA
CCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTGGGGCACAAGCTG
GAGTACAACTACAACAGCCACAACGTCTATATCACCGCCGACAAGCAGAAGAACGGCATCAAGGCCAACTT
CAAGATCCGCCACAACATCGAGGACGGCGGCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCG
GCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCTACCAGTCCAAGCTGAGCAAAGACCCCAAC
GAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGggtaccAAGGTGTACGACCCCGA
GCAGAGGAAGAGGATGATCACCGGCCCCCAGTGGTGGGCCAGGTGCAAGCAGATGAACGTGCTGGACAGCT
TCATCAACTACTACGACAGCGAGAAGCACGCCGAGAACGCCGTGATCTTCCTGCACGGCAACGCCaCTAGC
AGCTACCTGTGGAGGCACGTGGTGCCCCACATCGAGCCCGTGGCCAGGTGCATCATCCCCGATCTGATCGG
CATGGGCAAGAGCGGCAAGAGCGGCAACGGCAGCccatggATGagtcattaccatgagcagttcctgaaac
aaaatccgttagccgtcctgggcgtgttacgcgatttgcacaaagccgcaattcctttgcgtctcagttgg
aatggcgggcagctgatcagcaaattactggcaataaccccggataaactggtgctggatttcggcagtca
agccgaagacaacatcgccgtgctaaaggcacagcacattaccattaccgccgaaactcagggtgcgaaag
tcgagtttactgttgaacaactacagcagagtgaatacttgcagcttccggcatttattaccgtaccgcct
cccaccttatggtttgtacaacgacgccgatatttccgcatctccgccccactccatccgccttatttttg
ccagaccaaactggcggataacagtacgttacgtttccgcctgtatgatttgtcgttaggcggcatgggcg
cattactggaaacagcaaagcctgccgaattacaagaaggcatgcgcttcgctcagattgaagtcaacatg
gggcaatggggtgtttttcactttgacgcccagttaatctccatcagcgagcgcaaagtgattgatggcaa
gaatgaaaccatcaccactccccgtctgagcttccgttttcttaacgtcagcccgacggtggagcggcaat
tacagcggattattttctctctcgagcgagaagcccgggaaaaagcggacaaagtgcgcgacgagctcTAC
AGGCTGCTGGACCACTACAAGTACCTGACCGCCTGGTTCGAGCTCCTGAACCTGCCCAAGAAGATCATCTT
CGTGGGCCACGACTGGGGCGCCgcCCTGGCCTTCCACTACgcCTACGAGCACCAGGACAgGATCAAGGCCA
TCGTGCACatgGAGAGCGTGGTGGACGTGATCGAGAGCTGGGACGAGTGGCCAGACATCGAGGAGGACATC
GCCCTGATCAAGAGCGAGGAGGGCGAGAAGATGGTGCTGGAGAACAACTTCTTCGTGGAGACCgTGCTGCC
CAGCAAGATCATGAGAAAGCTGGAGCCCGAGGAGTTCGCCGCCTACCTGGAGCCCTTCAAGGAGAAGGGCG
AGGTGAGAAGACCCACCCTGAGCTGGCCCAGAGAGATCCCCCTGGTGAAGGGCGGCAAGCCCGACGTGGTG
CAGATCGTGAGAAACTACAACGCCTACCTGAGAGCCAGCGACGACCTGCCCAAGcTGTTCATCGAGggcGA
CCCCGGCTTCTTCAGCAACGCCATCGTGGAGGGCGCCAAGAAGTTCCCCAACACCGAGTTCGTGAAGGTGA
AGGGCCTGCACTTCctCCAGGAGGACGCCCCCGACGAGATGGGCAAGTACATCAAGAGCTTCGTGGAGAGA
GTGCTGAAGAACGAGCAGggatccggcggcagcggcggcagcATGGTGAGCAAGGGCGAGGAGGATAACAT
GGCCATCATCAAGGAGTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGA
TCGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGTGACCAAGGGTGGC
CCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTACGGCTCCAAGGCCTACGTGAAGCACCC
CGCCGACATCCCCGACTACTTGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCG
AGGACGGCGGCGTGGTGACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAG
CTGCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCTC
CGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAAGCAGAGGCTGAAGCTGAAGGACGGCG
GCCACTACGACGCTGAGGTCAAGACCACCTACAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAAC
GTCAACATCAAGTTGGACATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGA
GGGCCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGaagcttgcggccgcactcgagcaccaccacc
accaccactga 
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INTRODUCTION 
The second messenger molecule cyclic di-GMP is a key regulator of bacterial physiology 
and behavior, coordinating diverse processes such as motility, biofilm formation, and 
virulence. First discovered as a stimulator of cellulose synthesis (Ross et al., 1987), c-di-
GMP has since been found to be nearly ubiquitous in bacteria, with c-di-GMP signaling 
pathways often integrated with other global regulatory systems, such as phosphorylation 
networks and quorum sensing pathways (Jenal et al., 2017; Romling et al., 2013). The 
intracellular levels of c-di-GMP are tightly regulated by diguanylate cyclase (DGC) and 
phosphodiesterase (PDE) enzymes that synthesize and degrade c-di-GMP, respectively. 
Many bacteria have an abundance of predicted DGC and PDE genes, suggesting unique 
c-di-GMP regulatory circuits are activated in response to different environmental cues. In 
many bacterial pathogens, including Pseudomonas aeruginosa, Clostridium difficile, 
Vibrio cholerae, and pathogenic strains of Escherichia coli, these complex c-di-GMP 
signaling networks allow the bacteria to adapt to and survive in the changing 
environmental conditions that are experienced during infection of a mammalian host (Hall 
and Lee, 2018). While multiple studies have examined the effects of c-di-GMP levels on 
virulence in these pathogens, there currently are no tools available that allow for the 
quantification of c-di-GMP in bacteria during stages of mammalian host infection. To 
interrogate these complex c-di-GMP signaling networks in bacteria over the course of the 
infection process, new analytical tools and needed for quantifying and imaging 
intracellular c-di-GMP levels within tissue over extended time frames. 
 Commonly used tools for analyzing intracellular c-di-GMP levels include 
phenotypic screens and mass spectrometry (MS) analysis of bacterial cell extracts. 
Phenotypic screens for motility and biofilm formation can serve as proxies for measuring 
intracellular c-di-GMP levels (O’Toole et al., 1999; Wolfe and Berg, 1989). These assays 
can be high throughput and are useful in screening genetic knockouts, however they have 
low sensitivity and provide indirect measurement of c-di-GMP that can be complicated by 
pleiotropic effects. MS-based analysis of c-di-GMP from bacterial cell extracts is highly 
sensitive and quantitative, however the multi-step sample preparation and long analysis 
time required leads to reduced throughput (Burhenne and Kaever, 2013; Petrova and 
Sauer, 2017; Spangler et al., 2010). In addition, neither phenotypic assays nor mass 
spectrometry-based analysis can provide real-time, dynamic measurements of c-di-GMP 
in cells. To overcome these issues, our lab and others have developed several genetically 
encodable fluorescent biosensors that can report on single-cell dynamics of c-di-GMP 
using fluorescence microscopy or flow cytometry (Christen et al., 2010; Ho et al., 2013; 
Wang et al., 2016). These tools are sensitive, can provide real-time measurements of c-
di-GMP dynamics, and are amenable to high throughput screening. Notable examples 
include protein-based FRET biosensors that have been used to image c-di-GMP 
dynamics during asymmetric cell division in Caulobacter crescentus (Christen et al., 
2010) and RNA-based fluorescent sensors that were used to visualize c-di-GMP changes 
in E. coli in direct response to an environmental signal, zinc (Yeo et al., 2017). 
One drawback of fluorescent biosensors, however, is that due to a reliance on 
external illumination, these systems are incompatible with imaging in deep tissues of 
animals and in long-term experiments due to phototoxicity and/or photobleaching. In a 
preliminary effort to expand the capabilities of genetically encodable tools for quantifying 
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c-di-GMP levels to overcome these issues, our lab developed the first chemiluminescent 
biosensors for c-di-GMP (Dippel et al., 2018) based on the yellow Nano-lantern (YNL) 
scaffold and a CSL-BRET mechanism (Saito et al., 2012). These YNL-YcgR biosensors 
provide nanomolar sensitivity for c-di-GMP with high selectivity, large signal changes, and 
a luminescent signal that is produced without external illumination. The sensors were 
used to develop a rapid, plate-reader based assay for measuring diguanylate cyclase 
activity in bacterial lysates. The intensity-based signal of these sensors is useful for in 
vitro activity assays with lysates or purified enzymes where biosensor and luminescent 
substrate levels can be controlled. However, in long-term imaging experiments and/or 
situations where luminescent substrate availability differs between samples, signal 
quantitation becomes complicated for intensity-based sensors. Accordingly, we 
encountered issues when applying the YNL sensors to live cell measurements of c-di-
GMP in bacteria (Dippel et al., 2018).  
This current study tests our hypothesis that altering the biosensor scaffold to 
produce a ratiometric rather than intensity-based signal would enable long-term, 
quantitative, live cell imaging of c-di-GMP in bacteria. Ratiometric BRET sensors using 
the engineered marine luciferase NanoLuc (NLuc) (Hall et al., 2012) have recently been 
developed for imaging Ca2+ (Yang et al., 2016), Zn2+ (Aper et al., 2016) and membrane 
voltage (Inagaki et al., 2017), however to our knowledge no sensors of this type have 
been applied to imaging in bacteria to date. In this work, we generate the first BRET 
biosensor scaffold that selectively responds to c-di-GMP and produces a ratiometric 
signal change. By engineering the biosensor scaffold, a suite of Venus-YcgR-NLuc (VYN) 
sensors is generated that provide extremely high sensitivity (KD < 300 pM) and large 
BRET signal changes (up to 109%). The tVYN-Tm∆ biosensor was applied to develop a 
plate reader-based assay to quantify c-di-GMP levels in bacterial extracts with sensitivity 
comparable to MS-based methods (LOD = 30 fmol). This assay is used to analyze V. 
cholerae extracts grown under a variety of conditions that mimic the infection cycle and 
reveal changes in c-di-GMP in response to changes in growth conditions.  
Finally, the VYN sensors are applied as genetically encodable tools for live cell 
measurements of c-di-GMP in E. coli, using both a plate reader and an IVIS small animal 
imaging system. As a proof-of-concept that VYN biosensors can image c-di-GMP levels 
during host infection, we show that the VYN biosensors also function in the context of a 
tissue phantom model. In this model, the tVYN-Nt∆ sensor produces measurable changes 
in BRET ratio between high and low c-di-GMP conditions with only ~103-104 biosensor-
expressing cells required for the measurement. Furthermore, the BRET signal remains 
stable for at least one hour after luminescent substrate addition, suggesting that VYN 
sensors could be used for long-term imaging of c-di-GMP dynamics during host infection. 
The VYN sensors developed here can serve as robust in vitro diagnostic tools for high 
throughput screening, as well as genetically encodable tools for monitoring the dynamics 
of c-di-GMP in live cells, and lay the groundwork for live cell imaging of c-di-GMP 
dynamics in bacteria during host infection, and other complex environments. 
RESULTS 
Design of BRET sensor for cyclic di-GMP. The starting BRET scaffold, V-NLuc, 
pairs the newly developed marine luciferase, NanoLuc (NLuc), with a truncation of the 
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monomeric yellow fluorescent protein, Venus, as the donor and acceptor moieties, 
respectively, similar to the previously developed YeNL (Suzuki et al., 2016). NLuc 
produces a glow-type luminescence with an emission maximum at 460 nm and an overall 
luminescent output ~100-150x that of the commonly used Renilla or firefly luciferases 
(Hall et al., 2012). Compared to the intensity-based yellow Nano-lantern (YNL) sensors 
for c-di-GMP previously designed by our lab that use a mutated version of Renilla 
luciferase as the donor moiety, the substitution of NLuc should produce significantly 
higher signal intensity, improved thermodynamic stability, and increased signal stability 
over time. Combined with the benefits of a ratiometric signal compared to an intensity-
based signal, these improvements should allow for imaging in more complex biological 
systems, including within tissues of live animals. The emission of NLuc overlaps well with 
the excitation of Venus, producing an efficient energy transfer in V-NLuc, as measured 
by the BRET ratio (530/460 nm) (Figure 3.1a). 
 To design a c-di-GMP sensor from the V-NLuc scaffold, a c-di-GMP-binding YcgR 
protein is inserted between Venus and NLuc (Figure 3.1b). YcgR-like proteins contain the 
c-di-GMP-binding PilZ domain at their C-terminus (Benach et al., 2007; Ko et al., 2010; 
Ryjenkov et al., 2006). These proteins typically undergo large conformational changes 
upon c-di-GMP binding (Benach et al., 2007), which can be harnessed for the generation 
of genetically encoded sensors for c-di-GMP (Christen et al., 2010; Dippel et al., 2018; 
Ho et al., 2013; Pultz et al., 2012). We predicted that the binding of c-di-GMP to this 
Venus-YcgR-NLuc (VYN) sensor would produce a change in energy transfer efficiency 
between Venus and NLuc, which could be measured by a change in the BRET ratio. 
Depending on the conformational state of the unbound sensor, the change could be from 
low to high BRET ratio upon binding, or vice versa, thereby producing positive or negative 
signal changes, respectively (Figure 3.1b).  
For initial testing of the sensor design, the full-length YcgR protein from 
Escherichia coli (EcYcgR) was inserted into the BRET scaffold with 3 amino acid linkers 
on either side to generate VYN-Ec. The sensor was purified from E. coli after co-
expression with the c-di-GMP-specific phosphodiesterase (PDE) PdeH to ensure the 
sensor did not co-purify with any endogenous c-di-GMP bound. Initial testing of the 
purified sensor showed that c-di-GMP binding induced a change from high to low BRET 
state, which corresponds to a negative change in BRET ratio (Figure 3.1c). In accordance 
with the ratiometric nature of the sensor, the BRET ratio of un-bound VYN-Ec remained 
stable even as overall signal intensity decreased due to consumption of luminescent 
substrate (Figure 3.2a, b). Further testing of purified VYN-Ec showed that it binds to two 
molecules of c-di-GMP with an apparent affinity (KD) of ~50 nM and a BRET signal change 
of -48% (Figure 3.1d). The sensor retains selectivity for c-di-GMP over structurally related 
CDNs (Figure 3.2c, d).  
 This initial VYN-Ec design successfully produced a BRET biosensor that binds with 
high affinity and selectivity to c-di-GMP and produces a significant signal change upon 
binding. The inclusion of NLuc in the scaffold results in the production of a bright and 
stable signal, and the ratiometric nature of the biosensor allows for long-term 
measurements compared to previous intensity-based YNL-YcgR sensors. These 
properties alone suggest that the VYN biosensor scaffold will prove to be useful for long-
term imaging of c-di-GMP dynamics in complex biological systems. Interestingly, the 
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affinity of the VYN-Ec sensor (KD~50 nM) is significantly higher compared to what was 
measured in the equivalent YNL-EcYcgR sensor (KD~350 nM) (Dippel et al., 2018) and 
previously reported affinity values for EcYcgR (KD~800 nM) (Ryjenkov et al., 2006). Since 
c-di-GMP binding to PilZ domains has been found to be largely entropically driven 
(Benach et al., 2007), this finding suggests that the VYN scaffold itself may be providing 
a degree of additional stability that results in a decreased entropic cost of binding c-di-
GMP, leading to increased binding affinity. Encouraged by the VYN-Ec results, we sought 
to further improve the properties of the sensor via phylogenetic screening and semi-
rational protein engineering. 
Optimization of VYN biosensors. Our lab has previously shown that using a 
phylogenetic screening approach in biosensor development can lead to rapid 
improvements in biosensor characteristics (Dippel et al., 2018; Su et al., 2016; Wang et 
al., 2016). More specifically, we have observed that swapping to different phylogenetic 
YcgR variants within the YNL scaffold produced drastic changes and improvements in 
the affinity, signal change, and stability of NL-based sensors for c-di-GMP (Dippel et al., 
2018). To examine the effects of these changes in the ratiometric VYN scaffold, four  
phylogenetic YcgR variants previously characterized in the YNL scaffold were selected 
for testing in the VYN scaffold. These YcgR variants were chosen because in the YNL 
scaffold they displayed high affinity, high stability, and large positive signal changes 
(TmYcgR, CpYcgR, and TbYcgR), or a moderate affinity and a moderate negative signal 
change (NtYcgR). Purified VYN sensors with TmYcgR, NtYcgR, and TbYcgR exhibited 
c-di-GMP dependent changes in BRET, while the VYN-Cp sensor appeared non-
responsive (Figure 3.3a). As expected, the functional sensors displayed higher affinities 
for c-di-GMP compared to VYN-Ec. While the success of three out of the four phylogenetic 
variants was promising, we sought to further improve the dynamic range of these sensors 
through semi-rational engineering of the VYN scaffold itself. 
Two routes were used to alter the signal change of the VYN sensors: composite 
linker truncation and circular permutation of Venus. Both strategies are commonly used 
to improve signal change in the development of ratiometric sensors (FRET and BRET), 
but it is difficult to predict the effects these changes will have on the resulting sensor 
(Deuschle et al., 2005; van Rosmalen et al., 2017). Accordingly, a small library of VYN 
variants was generated to screen for sensors with improved properties (Figure 3.3b). For 
linker truncation, rather than reduce the length of the already short 3 amino acid linkers 
in the original VYN scaffold, the “composite linkers” (defined as the N- and C-terminal 
residues of Venus, YcgR, and NLuc that are not necessary for fluorescence, ligand 
binding, or luminescence) were truncated. For the truncated VYN (tVYN) scaffold,  2 
additional C-terminal residues from Venus and 4 N-terminal residues from NLuc were 
removed (Suzuki et al., 2016). For YcgRΔ variants, the secondary structure prediction 
software SABLE was used to predict unstructured N- and C-terminal residues for removal 
(Table 3.3). For circular permutations of Venus, five variants were chosen that previously 
were shown to not disrupt Venus fluorescence (Table 3.4) (Nagai et al., 2004). 
A library of 39 VYN variants was constructed and tested in a lysate-based assay 
to determine biosensor performance in response to increasing concentrations of c-di-
GMP (0, 50 nM, and 5 µM). In this assay each individual sensor is co-expressed in E. coli 
with PdeH, cells are lysed, c-di-GMP is added to the lysate at specified concentrations, 
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and BRET ratios are measured. This assay allows for biosensor performance to be rapidly 
assessed without the need for protein purification. In Figure 3.3c, the log2(signal fold-
change) values for each sensor are reported to simplify the comparison of positive and 
negative signal change sensors. While no clear trends could be drawn between designs, 
the small set of linker truncations and circular permutations tested produced at least one 
BRET sensor for each YcgR protein with a signal change -30% or +50%, which should 
prove useful for quantitative measurements of c-di-GMP (Figure 3.4). For example, while 
the original VYN-Cp design showed no detectable signal change, the Vcp157-Cp sensor 
produced a reasonable -30% signal change. Interestingly, this screen also revealed that 
seemingly small alterations in the scaffold can produce large differences in the resulting 
signal fold-change. The switch from tVYN-Nt to tVYN-NtΔ, for example, produced a 
sensor with the same relative signal fold-change, but flipped from a positive to negative 
change in BRET ratios (Figure 3.1b). 
A subset of the sensors from the library was purified for further characterization in 
vitro (Table 3.1). The different sensors were found to span a range of affinities from < 300 
pM up to ~100 nM. The tVYN-Tm∆ sensor, to our knowledge, exhibits the highest affinity 
CDN:protein interaction ever measured. The binding of c-di-GMP to PilZ-domain 
containing proteins has been shown to be largely entropically driven (Benach et al., 2007), 
and therefore the affinity is highly temperature dependent. All of the YcgR variants tested 
aside from EcYcgR come from predicted thermophilic organisms, so we expect that these 
proteins may be evolved to bind with nanomolar to micromolar affinity at the elevated 
temperatures of the organisms’ natural environments.  
For certain sensors, the signal change measured in lysates differs from that 
measured using purified protein. The most dramatic example of this is for tVYN-TmΔ, 
which shows a -28% change in the lysate screen and much improved -56% change as 
purified protein. We investigated this discrepancy and found that the difference likely 
arises due to two reasons: the extremely high affinity of the sensor, and the generation of 
luminescent signal from truncated protein products. First, given the extremely high affinity 
of the sensor, it may be pre-bound to endogenous c-di-GMP present in lysates regardless 
of the co-expression of PdeH, thereby masking the full signal change. Accordingly, when 
performing the lysate assay without the co-expression of PdeH, the signal change values 
are suppressed even further (Figure 3.5a). Second, we observe different BRET ratios 
when testing sensor purified with an N-terminal versus a C-terminal affinity tag (Figure 
3.5b). When using a C-terminal affinity tag, truncated protein products containing NLuc 
are co-purified along with full length biosensor (Figure 3.5c) These protein products, 
which are also present in unpurified lysates, produce a high background of “non-specific” 
luminescent signal at 460 nm. This produces a corresponding decrease in BRET ratio 
that is independent of the c-di-GMP concentration, partially masking the signal change. 
Accordingly, when using an N-terminal affinity tag, these truncated protein products are 
not co-purified, resulting in generally larger BRET ratios and signal change. This finding 
highlights the fact that for these types of ratiometric sensors, increased “stability” of the 
scaffold is a highly desirable trait. 
By screening a library of VYN sensors containing phylogenetic YcgR variants and 
altered sensor scaffolds, we discovered multiple BRET sensors for c-di-GMP with 
improved signal change and affinity compared to the starting VYN-Ec sensor. Moreover, 
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we showed that for an individual YcgR sequence, only a small panel (6 to 9) of sensor 
scaffolds needs to be tested to generate at least one with useful properties. Combined 
with the lysate-based screening method, we predict that this approach could be used to 
easily generate additional BRET-based sensors where the affinity of the YcgR protein is 
tailored to the system under study. While we focused on high affinity YcgR variants here, 
lower affinity variants could prove to be useful for analysis of c-di-GMP in certain 
situations. Further characterization of selected sensors revealed extremely high affinity 
interactions with c-di-GMP and highlighted how the overall stability of the sensors must 
be taken into account when comparing data from the lysate screen to that from purified 
proteins. 
Quantification of c-di-GMP in Vibrio cholerae cell extracts. The quantification 
of intracellular c-di-GMP levels is routinely performed using mass spectrometry (MS)-
based analysis of bacterial cell extracts. These methods are highly sensitive and allow 
for the quantitation of c-di-GMP in the picomolar or femtomolar range, depending on the 
detection method used (Burhenne and Kaever, 2013; Petrova and Sauer, 2017; Spangler 
et al., 2010). However, the sample preparations steps, long analysis time, and expertise 
required to perform MS-based analysis of cell extracts has limited the accessibility of 
these types of experiments for many researchers and high-throughput screening projects. 
Given the extremely high affinity of the VYN sensors for c-di-GMP, we predicted that it 
would be possible to develop a simple and robust plate reader-based assay for 
quantification of c-di-GMP with sensitivity comparable to that of MS-based methods. In 
comparison to our YNL-YcgR sensors for c-di-GMP (Dippel et al., 2018), the ~100-fold 
increases in affinity should allow for analysis in sample-limited situations (e.g. clinical 
isolates), and in cells with very low c-di-GMP levels. This assay should allow for 
quantification of c-di-GMP levels in any type of bacterial cell extract that is typically 
analyzed via MS-based methods, and significantly reduce the cost and time required for 
analysis, making these types of experiments more readily accessible to the community. 
The tVYN-TmΔ sensor was selected for the development of this assay because it 
showed the highest affinity (<300 pM) and largest magnitude signal change (Δ ratio of –
1.04) out of all tested sensors in vitro. While the sensitivity was highest using 300 pM 
biosensor (Figure 3.6a), the extract quantitation assay was performed with 3 nM 
biosensor due to improved signal intensity and stability. Under these conditions, the limit 
of detection (signal-to-noise ratio 3:1) of the tVYN-TmΔ sensor was measured to be 30 
fmol, which is comparable to the most sensitive established LC-MS/MS-based methods 
(Figure 3.6b) (Burhenne and Kaever, 2013; Petrova and Sauer, 2017). One drawback of 
the biosensor assay is the limited linear range (~30 fmol to 400 fmol), however this can 
be alleviated by diluting any samples that fall outside of this range or using more 
biosensor. 
To directly compare the performance of our plate reader-based protocol to 
established LC-MS/MS methods, cell extract samples from V. cholerae were analyzed 
using both methods. Cell extracts were generated from three different strains of V. 
cholerae – wild-type (SWT), wild-type lacking six DGCs (SΔ6DGC), and rugose 
(RΔvpsI/II) – that were expected to produce endogenous, low, and high levels of c-di-
GMP respectively. Cells were grown under standard conditions in LB broth (see Materials 
& Methods) and extracts were generated to analyze total c-di-GMP content. Cell extracts 
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were analyzed with the biosensor and the expected differences in c-di-GMP were 
observed between the three strains (Figure 3.6c; Figure 3.7). The same samples were 
sent for analysis via LC-MS/MS and are results are pending. 
Encouraged by these results, we decided to analyze the c-di-GMP content of V. 
cholerae grown under a variety of different conditions that have either been shown to 
affect or are predicted to affect endogenous c-di-GMP signaling networks within the 
bacterium. These conditions include changes in media (LB vs. AKI), salinity (0 vs. 0.1 vs. 
0.3 M NaCl), pH (7 vs. 4), temperature (25 °C vs. 37 °C), O2 content (+/- O2), iron content 
(+/- bipyridyl), and the presence of mucin. Cells were grown under the specified conditions 
(see Materials & Methods for details), extracts were generated, and analyzed with the 
tVYN-TmΔ sensor to quantify total c-di-GMP content (Figure 3.6d; Figure 3.8). There 
were significant differences observed as a result of changes in media, salinity, pH, and 
O2 content.  
Utilizing the extremely high affinity (KD<300 pM) and selectivity of the tVYN-TmΔ 
biosensor, we developed a robust plate reader based assay for sensitive quantification of 
c-di-GMP in different sample types. The assay in its current form was optimized using a 
3 nM biosensor concentration, which provided an LOD of 30 fmol using pure c-di-GMP 
as a standard. The use of a lower concentration of biosensor leads to improved sensitivity, 
however the signal brightness and stability is reduced. The LOD of the biosensor assay 
is comparable to the most sensitive established LC-MS/MS methods, but is plate-based 
and significantly more rapid, which makes it more amenable to HTS applications. 
Theoretically, the biosensor signal could even be analyzed using a digital camera, which 
drastically reduces the cost of c-di-GMP quantification compared to MS-based methods 
(Johnsson et al., 2018). When applied to analysis of V. cholerae extracts, the biosensor 
assay was able to quantify changes in c-di-GMP concentration in response to changes in 
growth conditions. These results suggest that the biosensor assay will be generally 
applicable to the study of c-di-GMP in complex bacterial extract samples, including clinical 
isolates and mixed cultures. 
Live-cell measurements of c-di-GMP. In the prior development of YNL-based 
sensors for c-di-GMP we encountered difficulties in making live cell measurements, 
presumably due to changes in luminescent substrate availability and biosensor 
expression between different conditions that made normalization of the intensity-based 
signal not possible (Figure 3.9) (Dippel et al., 2018). We predicted that the ratiometric 
nature of the signal produced by the VYN sensors would alleviate these issues. To test 
VYN biosensor performance in live cells, a subset of sensors were co-expressed in BL21 
Star (DE3) E. coli with a PDE (PdeH – low c-di-GMP), an inactive diguanylate cyclase 
(DGC) as a control (WspR-G249A – endogenous c-di-GMP), or a constitutively active 
DGC (WspR-D70E – elevated c-di-GMP). After overnight growth in auto-induction media, 
the cells were pelleted, resuspended in PBS, luminescent substrate was added, and 
BRET ratios were measured in a plate reader (Figure 3.10). Encouragingly, many of the 
tested sensors showed significant changes in BRET ratio between low or endogenous c-
di-GMP conditions versus elevated c-di-GMP conditions, as expected. These results 
confirm that switching from an intensity-based signal to a ratiometric signal allows the 
sensors to work in a live cell context. 
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 Given the promising live cell measurements obtained in a plate reader, we sought 
to determine if the VYN sensors could function in an instrument routinely used for small 
animal imaging (Xenogen IVIS 100). One long-term goal is to be able to monitor c-di-
GMP levels of bacterial cells in real time during infection of an animal host. Our initial 
proof-of-concept experiment was to validate the signal intensity and BRET signal changes 
of our sensors using this instrumentation with conventional filter sets and settings. 
Selected sensors were co-expressed in BL21 (DE3) Star E. coli cells with WspR-G249A 
or WspR-D70E to produce endogenous or elevated c-di-GMP levels, respectively. After 
overnight growth in auto-induction media, the cells were prepared in the same manner as 
for plate reader experiments. Luminescent substrate was added, then images were 
captured sequentially using no emission filter and the available 500 and 540 nm emission 
filters on the IVIS. The total flux (photons/sec) from each well in the 540 nm and 500 nm 
filter images was used to calculate BRET ratios for each culture (Figure 3.11a).  
The raw BRET ratio values are different between IVIS and plate reader 
instruments, most likely due to the different emission filters, which are less optimal for the 
biosensor on the IVIS. However, the changes in BRET ratio between endogenous and 
elevated c-di-GMP conditions were faithfully reproduced for VYN-Ec and tVYN-NtΔ 
(Figure 3.11a). Luminescent signal was measurable with serial dilutions of cells down to 
20,000-fold dilution, however, in highly diluted samples the VYN-Ec sensor no longer 
exhibited the expected change in BRET ratio (Figure 3.12a). The tVYN-NtΔ sensor, 
however, exhibited robust BRET ratio changes in all cases, although the magnitude of 
the signal change was decreased in more diluted samples. It was unclear exactly what 
caused this effect, but the increasing dilutions appeared to subtly change the observed 
BRET ratio. This points to the fact that although the percent change in BRET ratio is 
similar between these two sensors, the larger magnitude of the BRET change in tVYN-
NtΔ is useful for overcoming any c-di-GMP-independent effects that may partially mask 
the full signal change under certain conditions.  
Live-cell measurements of c-di-GMP in a tissue-like phantom model. To 
further extend the proof-of-concept, tissue-like phantom materials were utilized to mimic 
the light absorption and scattering of living tissue (De Grand et al., 2006). Thus, plates 
containing the bacterial cells were covered with 1.5 mm thick tissue phantoms prior to 
image capture (Figure 3.13). Encouragingly, luminescent signal was detected for all 
samples, and measurable changes in BRET ratio were observed for VYN-Ec and tVYN-
NtΔ, as before (Figure 3.11b). BRET ratios were in general found to be lower due to the 
absorption of hemoglobin in the tissue-like phantom. Luminescent signal was detected 
with serial dilutions of cells down to 20,000-fold dilution, but with significantly reduced 
intensity compared to uncovered (Figure 3.12b). In highly diluted samples the VYN-Ec 
sensor no longer exhibited a measurable change in BRET ratio, but significant BRET ratio 
changes still were observed for the tVYN-NtΔ sensor in all cases (Figure 3.11c).  
Given these promising results, we sought to determine if the VYN sensors would 
also be useful for long term imaging of c-di-GMP within the tissue phantom model. For 
the 200-fold cell dilutions, luminescence was monitored for an hour after the initial addition 
of luminescent substrate (Figure 3.12c). While the signal intensity reduced over time as 
luminescent substrate was consumed, the BRET ratios remained remarkably constant 
over the entire time course.  
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To determine whether the amount of bacteria that were being monitored in the IVIS 
experiments is biologically relevant, the number of colony-forming units (CFUs) was 
measured for representative cultures co-expressing the tVYN-NtΔ biosensor and WspR-
G249A or WspR-D70E. Cells were prepared as before and then spotted onto LB/Agar 
plates containing no antibiotic, carbenicillin (Carb), kanamycin (Kan), or both Carb and 
Kan to determine if any plasmid loss occurred during growth (Figure 3.14). Results from 
the no antibiotic plates suggest that there are ~108 E. coli in each well for 2-fold diluted 
cultures, and down to ~106 and ~104 cells in the 200-fold and 20,000-fold diluted cultures, 
respectively. Results from antibiotic plates show that ~90% of cells have lost both the 
biosensor and WspR expression plasmids after overnight growth under these conditions. 
Thus, the actual number of bacteria producing luminescent signal in the IVIS is only 10% 
of the total. Given the signal observed 20,000-fold diluted cultures, the tVYN-NtΔ sensor 
is capable of imaging c-di-GMP levels in as few as ~103 biosensor-expression bacterial 
cells in a tissue-like model. 
These co-expression experiments demonstrate that VYN sensors can function as 
genetically encodable tools for monitoring c-di-GMP levels in live bacterial cells, as 
measured in both a plate reader and a conventional small animal imaging system. 
Additionally, as a proof-of-concept for future in vivo studies, we show that the VYN 
sensors can report on c-di-GMP levels in live E. coli when used in the context of a tissue 
phantom model. Furthermore, the BRET signal produced was remarkably stable for at 
least 1 hour after luminescent substrate addition, suggesting that VYN sensors could be 
used for long-term imaging of c-di-GMP dynamics during infection of animal hosts. Finally, 
we determined based on CFU measurements that the tVYN-Nt∆ sensor  is capable of 
imaging c-di-GMP levels in as few as ~103 biosensor-expression bacterial cells in our 
tissue-like model. It has been shown in a V. cholerae infection model of infant mice that 
there are 104 to 105 bacteria in the small intestine after infection, which suggests that the 
tVYN-NtΔ sensor could be useful for analyzing c-di-GMP dynamics in this system 
(Tamayo et al., 2010). 
DISCUSSION AND FUTURE DIRECTIONS 
Cyclic di-GMP signaling networks are key regulators of bacterial behavior, coordinating 
motility, biofilm formation, and virulence. In many bacterial pathogens, c-di-GMP networks 
allow the bacteria to adapt to and survive the changing conditions that are experienced 
during infection of a mammalian host. In recent years, the development of genetically 
encodable sensors specific for c-di-GMP has advanced our knowledge of c-di-GMP 
signaling networks. However, it has not been possible to monitor c-di-GMP levels in 
bacteria during host infection, which has hindered our understanding of how c-di-GMP 
affects virulence under medically relevant conditions. In pursuit of this goal, the VYN 
sensors developed here are, to our knowledge, the first ratiometric, luminescent sensors 
of their kind for analyzing c-di-GMP signaling, and should allow for quantitative imaging 
of c-di-GMP in bacteria during host infection.  
After initial validation of the VYN sensor scaffold, screening of a small library 
designed around phylogenetic variant YcgR proteins and semi-rational engineering of the 
biosensor scaffold resulted in a panel of biosensors that exhibit high affinity and large 
signal changes in response to c-di-GMP. We predict that the design strategies used here 
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should be generally applicable to the development of new VYN sensors using any desired 
YcgR-like protein sequence, allowing one to tailor the affinity of the VYN biosensor to a 
specific system under study. The highest affinity sensor identified here, tVYN-Tm∆, was 
used to develop a robust plate reader-based assay for quantification of c-di-GMP in cell 
extracts, with sensitivity comparable to that of established MS-based methods. While the 
linear range of the biosensor is reduced compared to LC/MS methods, we believe that 
the speed and ease of the plate reader-based measurements should make these types 
of cell extract experiments more accessible to the community. Beyond cell extracts, the 
VYN sensors should also be generally useful for any quantitative in vitro measurements 
of c-di-GMP, such as in monitoring enzyme kinetics or high throughput screening of 
activators/inhibitors of DGCs and PDEs (Opoku-Temeng et al., 2016; Sambanthamoorthy 
et al., 2012). 
When applied as genetically encoded tools, the VYN sensors exhibited significant 
changes in BRET ratio between endogenous and elevated c-di-GMP conditions in E. coli. 
These results confirm that switching from an intensity-based luminescent signal to a 
ratiometric luminescent signal cancels out variations in biosensor expression and/or 
luminescent substrate availability between samples, which simplifies signal quantitation. 
Finally, as a proof-of-concept that VYN biosensors can image c-di-GMP levels during host 
infection, we show that the VYN biosensors function in the context of a tissue phantom 
model. These types of tissue phantoms have recently been used as a benchmark to 
compare photon output of luminescent protein systems within deep tissues (Chu et al., 
2016). Importantly, we performed all experiments with the VYN scaffold using 
coelenterazine-h as the luminescent substrate, as opposed to furimazine, which is the 
preferred substrate for NLuc. Furimazine has been well characterized to produce higher 
luminescent output than coelenterzine-h (Hall et al., 2012). While the tissue phantom 
model used here does not account for in vivo substrate availability, previous reports have 
used NLuc and furimazine effectively to study the spread of pathogens in mice in real 
time, suggesting that substrate availability should not be a limitation in these experiments 
(Caine and Osorio, 2017; Silberstein et al., 2018; Sun et al., 2014; Tran et al., 2013). 
Additionally, BRET signal from the biosensor was found to be very stable for at least 1 
hour after the initial administration of luminescent substrate, which should prove useful 
for examining c-di-GMP dynamics on this time scale. More long-term experiments (days, 
weeks, etc.) could also be carried out by using repeated administration of luminescent 
substrate at the desired times, which would allow for the monitoring of c-di-GMP dynamics 
over the extended time scale of infection.  
In conclusion, the work here presents, to our knowledge, the first ratiometric, 
luminescent biosensors made specifically for studying bacterial signaling, as opposed to 
eukaryotic signaling. Rather than merely providing a luminescent readout for the 
presence of bacteria, the biosensors developed here should allow for the study of 
bacterial signaling pathways in biological systems in which fluorescent biosensors are 
less useful. Ultimately, we hope that the VYN biosensors developed here will serve as 
easy-to-use diagnostic tools for analyzing c-di-GMP in vitro, as well as useful genetically 
encodable tools for studying c-di-GMP dynamics in bacterial pathogens during host 
infection. 
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FIGURES 
 
 
Figure 3.1 Design and characterization of ratiometric VYN biosensors. (a) Schematic for 
BRET mechanism of V-NLuc scaffold and the domain structure of the protein. Normalized 
luminescence emission spectra of purified V-NLuc. Data from one representative measurement. 
(b) Two potential mechanisms for modulation of BRET ratios by c-di-GMP binding to VYN 
sensors. Schematic of VYN-Ec sensor shown below. (c) Normalized luminescence emission 
spectra of purified VYN-Ec in the presence and absence of c-di-GMP. Data from one 
representative measurement shows the biosensor follows mechanism ii. (d) Binding affinity 
measurements for purified VYN-Ec. Data are from 3 replicates represented as mean +/- SD. 
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Figure 3.2 Additional characterization of VYN-Ec sensor. (a) Luminescence signal intensity 
of VYN-Ec sensor over time. Luminescent substrate was added just prior to beginning of 
measurement. Data are from 3 replicates represented as mean +/- SD. (b) BRET ratio calculated 
from data shown in part (a). Data are from 3 replicates represented as mean +/- SD. (c) BRET 
ratios of VYN-Ec sensor in response to different cyclic di-nucleotides. Data are from 3 replicates 
represented as mean +/- SD. (d) Percent signal calculated from part (c). Data are from 3 replicates 
represented as mean +/- SD.  
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Figure 3.3 Optimization of VYN sensors for c-di-GMP. (a) BRET ratios of purified VYN sensors 
containing phylogenetic variant YcgR proteins in response to varying levels of c-di-GMP. Data 
are from 3 replicates represented as mean +/- SD. (b) Schematic representations of the domain 
architectures of altered VYN scaffolds, using TmYcgR as an example. Red regions highlight 
where truncations were made. (c) Signal fold-change (defined as BRET ratio with 5 µM c-di-GMP 
added divided by BRET ratio with buffer added and plotted as log2(fold-change)) of VYN sensor 
library screened in lysates. Grayed boxes = dim signal; crossed-out boxes = not tested; ns = no 
significant signal fold-change (P > 0.05 determined by Student’s t-test). Data are from 4 biological 
replicates represented as the mean. 
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Figure 3.4 Lysate-based screen of VYN biosensor library. BRET value measurements from 
VYN library lysate screening in response to c-di-GMP (data summarized in Figure 3.3c). Percent 
signal change values (comparing buffer to 5 µM c-di-GMP conditions) shown for variants that 
exhibited significant changes in BRET (P < 0.05 determined by Student’s t-test). Data are from 4 
biological replicates represented as the mean +/- SD. 
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Figure 3.5 Additional characterization of tVYN-TmΔ biosensor. (a) BRET values from the 
tVYN-TmΔ biosensor in the lysate-based assay with or without the co-expression of the c-di-
GMP specific phosphodiesterase, PdeH. Data are from 9 biological replicates represented as 
the mean +/- SD. (b) BRET values of tVYN-TmΔ in vitro after purification with a C-terminal or N-
terminal His6 tag. Data are from 3 replicates represented as mean +/- SD. (c) SDS-PAGE of the 
tVYN-TmΔ biosensor purified with a C-terminal or N-terminal His6 tag, showing the presence of 
truncated NLuc protein products. 
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Figure 3.6 Quantitation of c-di-GMP using tVYN-TmΔ biosensor. (a) Binding affinity 
measurements for purified tVYN-TmΔ using decreased biosensor concentration. Data are from 3 
replicates represented as mean +/- SD. (b) Standard curve for c-di-GMP quantitation using 
purified tVYN-TmΔ. Data are from 6 replicates represented as mean +/- SD. (c) Quantitation of c-
di-GMP in cell extracts of 3 different strains of V. cholerae using the tVYN-TmΔ biosensor. Data 
are from 3 biological replicates represented as the mean +/- SD. (d) Quantitation of c-di-GMP in 
cell extracts of SWT V. cholerae grown under different conditions using the tVYN-TmΔ biosensor. 
Asterisks (*) denote significant changes in c-di-GMP between growth conditions (P < 0.05 
determined by Student’s t-test). Data are from 3 biological replicates represented as the mean +/- 
SD. 
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Figure 3.7 Biosensor analysis of V. cholerae reference strains. BRET ratios measured in 
serial dilutions of V. cholerae extract using the tVYN-TmΔ biosensor, with each panel representing 
a separate biological replicate. Note differences in dilution factor for replicate 1 (left) compared to 
replicates 2 and 3 (middle and right). Data are from 2 technical replicates represented as the 
mean +/- SD. 
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Figure 3.8 Biosensor analysis of V. cholerae under different growth conditions. BRET ratios 
measured in serial dilutions of V. cholerae extract using the tVYN-TmΔ biosensor, with each panel 
representing a separate biological replicate. Note differences in dilution factor for replicate 1 (top) 
compared to replicates 2 and 3 (bottom). Data are from 2 technical replicates represented as the 
mean +/- SD. 
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Figure 3.9 Live cell imaging with luminescent biosensors. Schematic showing the difficulties 
encountered making live cell measurements using the intensity-based YNL scaffold, compared to 
the ratiometric VYN scaffold. 
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Figure 3.10 Live cell measurements of c-di-GMP using VYN sensors. BRET ratios of E. coli 
cells co-expressing VYN biosensors with PdeH, WspR-G249A, or WspR-D70E. Data are from 4 
biological replicates represented as mean +/- SD.  
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Figure 3.11 Live cell measurements of c-di-GMP using a tissue phantom model. (a) 
Luminescent images of 2-fold diluted E. coli cultures co-expressing VYN biosensors with WspR-
G249A or WspR-D70E captured by an IVIS Spectrum, and the BRET values calculated from the 
radiance each well. Maximum and minimum radiance values (photons/sec/cm2/steradian) 
captured for each image are shown. (b) Same as part (a), except plate was covered with a 1.5 
mm thick tissue phantom prior to image capture. (c) BRET ratios of serially diluted E. coli cultures 
co-expressing VYN biosensors with WspR-G249A or WspR-D70E calculated from the radiance 
of each well. Plate was covered with a 1.5 mm thick tissue phantom prior to image capture. For 
all graphs, data are from 3 biological replicates represented as mean +/- SD. Asterisks (*) denote 
significant changes in BRET ratio (*P < 0.05, **P < 0.005 determined by Student’s t-test). 
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Figure 3.12 Additional data for live cell measurements of c-di-GMP using a tissue phantom 
model. (a) BRET ratios of serially diluted E. coli cultures co-expressing VYN biosensors with 
WspR-G249A or WspR-D70E calculated from the radiance of each well. Images captured without 
a phantom cover. Asterisks (*) denote significant changes in BRET ratio (*P < 0.05, **P < 0.005 
determined by Student’s t-test). (b) Total flux of E. coli cultures co-expressing the tVYN-NtΔ 
biosensor with WspR-G249A at various dilutions with or without the added tissue phantom. (c) 
(Left) Radiance and (right) corresponding BRET ratios of 200-fold diluted E. coli cultures co-
expressing the tVYN-NtΔ biosensor with WspR-G249A over time. Luminescent substrate was 
added at time zero. For all graphs, data are from 3 biological replicates represented as mean +/- 
SD. 
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Figure 3.13 Tissue phantom imaging setup. (a) Schematic for imaging with a tissue phantom 
cover in the IVIS. (b) Representative photograph of plate covered with tissue phantom prior to 
imaging. (c) Representative images captured by the IVIS showing the ROI grids used for 
calculating total flux in each well. 
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Figure 3.14 CFUs in live-cell measurements of c-di-GMP. CFUs measured for E. coli co-
expressing the tVYN-NtΔ biosensor with WspR-G249A or WspR-D70E after overnight growth in 
auto-induction media. Data are from 2 biological replicates shown as the mean +/- SD. 
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MATERIALS AND METHODS 
General reagents and oligonucleotides. Cyclic dinucleotides were purchased 
from Axxora, LLC. Coelenterazine-h was purchased from NanoLight Technologies and 
stored as a ~6.15 mM stock in EtOH at -80 °C. Oligonucleotides used in molecular cloning 
were purchased from Elim Biopharaceuticals or the University of Utah HSC Core facility. 
Molecular cloning. The pNL(1.1) plasmid was obtained from Promega. Plasmids 
encoding PdeH, WspR alleles, and phylogenetic YcgR variants were previously available 
in the lab. The V-NLuc base scaffold was generated in the pRSETB plasmid using Gibson 
assembly (Gibson, 2011) with a pRSET-Venus∆C10 backbone and a NanoLuc insert 
amplified from pNL(1.1). The final vector was designed to contain a KpnI cut site between 
Venus∆C10 and NanoLuc and include an N-terminal His-tag. Base scaffolds were 
similarly generated in the pET21 plasmid containing a C-terminal His-tag. Biosensor 
constructs in pRSETB or pET21 were generated via Gibson assembly using KpnI digested 
base scaffolds and PCR amplified YcgR inserts. In general, pET24-YNL-YcgR biosensor 
plasmids previously generated in the lab (Dippel et al., 2018) were used as template for 
PCR amplification of YcgR sequences. Truncated biosensors (tVYN and YcgR∆ 
modifications) were created from the full-length scaffolds using ‘Round-the-horn’ 
mutagenesis and Gibson assembly, respectively. Venus circular permutations were 
created from the base V-NLuc scaffold via three-piece Gibson assembly ligations. 
Protein purification. Biosensors were purified as described previously, with minor 
modifications (Dippel et al., 2018). Biosensors were purified from either the pRSETB or 
the pET21 plasmid after co-transforming the sensor plasmid and the pCOLA-PdeH 
plasmid in E. coli BL21 Star (DE3) cells (QB3 MacroLab). Transformants were cultured 
in 2xYT media at 37 ºC to OD ~ 1.0 and protein expression was induced for 20 h at 18 ºC 
with IPTG (0.1 mM IPTG for pRSETB plasmids or 0.5 mM IPTG for pET21 plasmids). 
Lysates were prepared and the biosensors were purified via Ni-NTA affinity 
chromatography as previously described (Dippel et al., 2018). Elution fractions were 
concentrated and dialyzed to storage buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 10% 
(v/v) glycerol] using Amicon Ultra-15 Centrifugal Filter Units (10K MWCO; Millipore), and 
then flash frozen in liquid nitrogen and stored at -80 ºC. Final protein concentrations were 
determined using the absorption of Venus at 515 nm (extinction coefficient = 92200 M-1 
cm-1). All proteins were analyzed via SDS-PAGE to confirm purity. 
Chemiluminescence measurements with purified protein. Briefly, proteins and 
ligands were prepared in opaque white 96-well LUMITRAC 600 plates (Grenier) in assay 
buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 10 mM DTT, 0.1% BSA]. Unless otherwise 
noted, all measurements using purified protein were made using 3 nM sensor in 100 µL 
total reaction volume, then incubated at 28 ºC for at least 10 min to reach binding 
equilibrium. Chemiluminescent substrate was prepared by diluting coelenterazine-h to 60 
µM in reagent buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 300 mM ascorbate], and 
equilibrating the solution at RT for at least 30 min. Unless otherwise noted, all biosensor 
measurements were taken at 28 ºC in a SpectraMax i3x plate reader (Molecular Devices) 
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after manually adding 20 µL of chemiluminescent substrate. Emission intensities were 
measured at 460 and 530 nm for (200 ms integration) at 30 s intervals for 10 min after 
chemiluminescent substrate addition. In general, BRET ratios were calculated using 
emission values obtained 2 min after substrate addition. For emission spectrum 
measurements, emission intensities were measured over the range of 400-600 nm in 
steps of 2 nm. 
Lysate-based assay for biosensor activity. The lysate-based assay was carried 
out as previously described, with minor modifications (Dippel et al., 2018). Single colonies 
of BL21 Star (DE3) E. coli cells co-transformed with pET21-biosensor and pCOLA-PdeH 
plasmids were resuspended in 500 µL of P-0.5G non-inducing media [0.5% glucose, 25 
mM (NH4)2SO4, 50 mM KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4] (Studier, 2005) 
supplemented with 50 µg/mL carbenicillin and 100 µg/mL kanamycin in 2.2 mL 96-well 
deep-well plates (VWR). Precultures were grown at 37 ºC, 340 rpm for 24 h at which point 
5 µL of each was used to inoculate 500 µL of ZYP-5052 autoinduction media [25 mM 
(NH4)2SO4, 50 mM KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4, 0.5% (v/v) glycerol, 0.05% 
glucose, 0.2% α-lactose, 1% tryptone, and 0.5% yeast extract] (Studier, 2005) 
supplemented with 50 µg/mL carbenicillin and 100 µg/mL kanamycin. Cultures were 
grown in ZYP-5052 autoinduction media at 37 ºC, 340 rpm for 20 h to express the 
biosensors, then harvested by centrifugation at 4700 rpm for 10 minutes at 4 ºC. Lysates 
were prepared by removing the supernatant media and resuspending cell pellets in 500 
µL of screening buffer [50 mM Tris (pH 7.5), 100 mM KCl, 5% glycerol, 2 mM EDTA, 300 
μg/mL lysozyme, 1 mM PMSF]. Cells were incubated for 1 h at 4 ºC to gently lyse, and 
total lysates were centrifuged for 40 min at 4700 rpm at 4 ºC to generate clarified lysates.  
For chemiluminescence measurements, 5 µL of clarified lysate was mixed with 85 
µL screening buffer (-lysozyme, -PMSF) and 10 µL of either buffer, 500 nM c-di-GMP, or 
50 µM c-di-GMP [in screening buffer (-lysozyme, -PMSF)] in opaque white 96-well 
LUMITRAC 600 plates (Greiner) to generate final concentrations of 0, 50 nM, or 5 µM c-
di-GMP. Chemiluminescence was measured using the same method described for 
purified protein, except BRET ratios were calculated using emission values obtained 1 
min after substrate addition.  
Live cell measurements with biosensor co-expression. Single colonies of of 
BL21 Star (DE3) E. coli cells co-transformed with pET21-biosensor and pCOLA-PdeH, 
pCOLA-WspR-G249A, or pCOLA-WspR-D70E plasmids were resuspended and grown 
in the same manner as previously described for the lysate-based assay. After growth in 
ZYP-5052 autoinduction media, cells were centrifuged, supernatant media was removed, 
and cell pellets were resuspended in 500 µL PBS [137 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4 (pH 7.4)]. For chemiluminescence measurements, cells were 
diluted 2-fold with PBS in an opaque 96-well LUMITRAC 600 plate (Greiner) to a final 
volume of 100 µL. Chemiluminescent substrate was added and emission intensities were 
measured in the same way as described for purified protein. BRET ratios were calculated 
using emission values obtained 5 min after substrate addition.  
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Live cell measurements in tissue-like phantom model. Tissue-like phantoms 
were prepared as described previously.(De Grand et al., 2006) Briefly, the phantom 
solution mixture was prepared with 10% gelatin, 170 µM bovine hemoglobin, and 1% 
intralipid in TBS-azide buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.1% NaN3]. 
Phantoms were poured to the desired thickness of 1.5 mm between glass plates to ensure 
uniformity, then stored at 4 °C. 
Chemiluminescence measurements were carried out in a Xenogen IVIS 100 
Bioluminescent Imager. Cells were grown and prepared in the same way as the live cell 
co-expression experiments but were diluted 2-fold, 200-fold, and 20,000-fold in PBS in 
opaque black 96-well assay plates (CoStar). To image the plates, 20 µL of 
chemiluminescent substrate was added to each well and plates were placed in the 
chamber. Luminescent images were captured sequentially using no filter, a 500 nm filter, 
and a 540 nm filter within a 13 cm field of view. The instrument was set to auto-adjust 
settings to ensure maximum signal for each image (exposure time of 0.5-60 s, binning of 
1x-16x, f/stop of 1). For experiments with tissue-like phantoms, the wells were covered 
with a phantom immediately after addition of chemiluminescent substrate, and 
luminescent images were captured as before. For image analysis, a 12x8 ROI grid was 
applied to each image and used to calculate the flux (photons/s) for each individual well. 
For time course images, the same plate was repeatedly imaged for up to an hour after 
the initial addition of chemiluminescent substrate. 
To determine the total number of bacterial cells in the IVIS experiments, cells co-
expressing pET21-tVYN-NtΔ and pCOLA-WspR-G249A or pCOLA-WspR-D70E were 
grown as described above. After growth in ZYP-5052 autoinduction media, cells were 
centrifuged, supernatant media was removed, and cell pellets were resuspended in 500 
µL PBS. Resuspended cultures were serially diluted (10-4, 10-5, 10-6, and 10-7) with PBS 
and 10 µL of each serial dilution was spotted on LB/Agar plates containing no antibiotics, 
50 µg/mL carbenicillin, 50 µg/mL kanamycin, or 50 µg/mL of both carbenicillin and 
kanamycin. Each serial dilution was spotted in duplicate, and two biological replicates 
were used for each culture. Plates were incubated at 37 °C overnight, and colonies were 
counted to determine total CFUs/mL.  
Vibrio cholerae strains and growth conditions. Vibrio cholerae O1 El Tor A1552 
was used as our wild-type strain and two V. cholerae strains, Δ6DGC (Townsley and 
Yildiz, 2015) and RΔvpsI-II (Fong et al., 2010), were used as reference strains with low 
and high cellular c-di-GMP level, respectively. Strains were grown in Luria–Bertani (LB) 
medium [1% tryptone, 0.5% yeast extract, 0.2 M NaCl; pH 7.5] with constant shaking at 
200 rpm at 37oC unless otherwise indicated.  
To test the effects of salt concentration, LB supplemented with different 
concentrations of NaCl (0, 0.1, and 0.3M) were used (Shikuma et al., 2013). To test the 
effects of different growth temperature (Townsley and Yildiz, 2015) and oxygen 
availability, the diluted cultures were grown at 25 and 37 oC to OD600 ~0.5 or aerobically 
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and anaerobically (in a Vinyl Anaerobic Airlock Chamber, Coy Laboratory Products) to 
OD600 ~0.3. 
To test the effects of bile (Hung et al., 2006), mucin (Silva et al., 2003), and iron-
depleted conditions (Rogers et al., 2000), overnight-grown cultures were inoculated in a 
1:200 dilution in LB supplemented with different components [0.4% (w/v) of bovine bile 
(Sigma-Aldrich), 0.4% (w/v) of bovine submaxillary gland mucin (Sigma-Aldrich), or 200 
µM of 2,2’-dipyridyl (Alfa Aesar), respectively] and grown to OD600 ~0.5.  
To test virulence-inducing conditions, overnight-grown cultures were inoculated in 
a 1:200 dilution in LB and in a 1:100 dilution in AKI [1.5% Bacto peptone, 0.4% yeast 
extract, 0.5% NaCl, 0.3% NaHCO3]. LB cultures were grown overnight with shaking at 
220 rpm at 37 oC. AKI cultures were grown statically at 37oC for 4 hours followed by 
shaking at 220 rpm at 37 oC overnight (Iwanaga et al., 1986). 
To test the effect of acidic conditions, overnight-grown cultures were inoculated in 
a 1:200 dilution in LB (pH 7), grown to OD600 ~0.5, and centrifuged at 1500 x g for 7 
minutes. Cell pellets were adapted by resuspending in LB (pH 5.7) and incubating for 1 
hour. Adapted cells were centrifugated and resuspended in LB (pH 4) followed by 1 hour 
incubation (Merrell et al., 2002).  
Bacterial cell extract analysis. C-di-GMP extraction was performed as previously 
described with minor modification (Jones et al., 2015). Briefly, 1.5 mL of V. cholerae 
culture was centrifuged at 1500 x g for 7 minutes. Cell pellets were allowed to dry briefly 
then re-suspended in 1 mL extraction solution [40% acetonitrile, 40% methanol, 20% 
water], and incubated on ice for 5 minutes. Samples were centrifuged at 16,000 x g for 5 
minutes and 900 μL of supernatant was dried under vacuum and lyophilized. Samples 
were re-suspended in 100 µL of ddH2O and analyzed using the tVYN-TmΔ biosensor or 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) to determine intracellular 
c-di-GMP levels. Each extract analysis was performed with three biological replicates.  
For biosensor analysis, the re-suspended extracts were serially diluted with ddH2O 
and 20 µL of serially diluted extract was mixed with 80 µL of biosensor and assay buffer 
in opaque white 96-well LUMITRAC 600 plates (Grenier) to give final concentrations of 3 
nM biosensor and 1x assay buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 10 mM DTT, 
0.1% BSA]. Samples were incubated at 28 ºC for at least 10 min to reach binding 
equilibrium and chemiluminescence was measured as described for purified protein. 
BRET values were calculated using emission values obtained 5 minutes after substrate 
addition and each biosensor measurement was performed with two technical replicates. 
Mean BRET values that fell within the linear range of the biosensor (as determined by a 
standard curve with pure c-di-GMP) were used to calculate the total amount of c-di-GMP 
in each sample, and c-di-GMP amounts were normalized to total protein content. 
For LC-MS/MS analysis, NaCl was added to the resuspended samples to a final 
concentration of 184 mM.  Samples were analyzed via LC-MS/MS on a Thermo-Electron 
Finnigan LTQ mass spectrometer coupled to a surveyor HPLC (Thermo Scientific). The 
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Synergi Hydro 4u Fusion-RP 80A column (150 mm x 2.00 mm diameter; 4-μm particle 
size) (Phenomenex) was used for reverse-phase liquid chromatography. Solvent A was 
0.1% acetic acid in 10 mM ammonium acetate, solvent B was 0.1% formic acid in 
methanol. The gradient used was as follows: time (t) = 0–4 minutes, 98% solvent A, 2% 
solvent B; t = 10–15 minutes, 5% solvent A, 95% solvent B. The injection volume was 20 
μL and the flow rate for chromatography was 200 μL/minute. 
The amount of c-di-GMP in samples was calculated with a standard curve 
generated from pure c-di-GMP suspended in 184 mM NaCl. Concentrations used for 
standard curve generation were 50 nM, 100 nM, 500 nM, 2 μM, 3.5 μM, 5 μM, 7.5 μM, 
and 10 μM. The assay is linear from 50 nM to 10 μM with an R2 of 0.999. C-di-GMP levels 
were normalized to total protein content in each culture.  
To determine total protein content, 1.5 mL from each culture was pelleted, the 
supernatant was removed, and cells were lysed in 1 ml of 2% sodium dodecyl sulfate. 
Total protein in the samples was estimated with the BCA assay (Pierce) using bovine 
serum albumin (BSA) as standards. 
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TABLES 
Table 3.1 Characteristics of selected VYN sensor variants 
Notes: aData are from 3 replicates represented as mean ± SD. bAffinity measurements 
were made using 300 pM biosensor to determine KD values <3 nM. cBiosensor 
constructs were purified using an N-terminal His6 tag, as opposed to a C-terminal His6 
tag for all others. 
 
Sensor ∆ ratioa % changea K
D 
(nM)a Hill coefficienta 
tVYN-Tm∆b, c –1.04 –56% <0.3 –1.7 ± 0.03 
tVYN-Tmb –0.47 –50% 0.8 ± 0.03 –1.7 ± 0.1 
VYN-Tmb, c –0.67 –42% 0.8 ± 0.2 –1.5 ± 0.4 
Vcp229-Tmb –0.41 –44% 2.0 ± 0.1 –1.5 ± 0.1 
VYN-Tbc 0.38 33% 8.0 ± 0.4 2.4 ± 0.3 
tVYN-Tb 0.18 38% 12 ± 1 2.0 ± 0.3 
Vcp229-Nt 0.22 52% 14 ± 1 1.6 ± 0.1 
VYN-Ntc 0.39 45% 14 ± 4 1.4 ± 0.4 
Vcp173-Nt 0.04 17% 17 ± 4 2.0 ± 0.7 
tVYN-Nt 0.24 56% 20 ± 1 1.6 ± 0.2 
VYN-Ecc –0.58 –48% 50 ± 4 –1.5 ± 0.2 
tVYN-Nt∆ –1.01 –51% 54 ± 4 –1.7 ± 0.1 
Vcp157-Cp –0.39 –33% 96 ± 6 –1.9 ± 0.2 
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Table 3.2 Amino acid sequences of biosensor plasmids 
Notes: His-tag, VenusΔC10, NLuc, YcgR; phylogenetic biosensor variants use the same 
sequences, except the YcgR variant is used in place of TmYcgR (see Table S#); for 
tVYN and Vcp variants, the corresponding Venus and NLuc sequences were used in 
place of VenusΔC10 and NLuc (see Table S#) 
 
  
pRSET-VYN 
 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPMVSKGEELFTGVVPILVELDGDVNGHKFSVS
GEGEGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQ
ERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK
NGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLE
FVTAAGGTMVFTLEDFVGDWRQTAGYNLDQVLEQGGVSSLFQNLGVSVTPIQRIVLSGENGLKI
DIHVIIPYEGLSGDQMGQIEKIFKVVYPVDDHHFKVILHYGTLVIDGVTPNMIDYFGRPYEGIA
VFDGKKITVTGTLWNGNKIIDERLINPDGSLLFRVTINGVTGWRLCERILA*stop 
 
pRSET-VYN-
Tm 
 
MRGSHHHHHHGMASMTGGQQMGRDLYDDDDKDPMVSKGEELFTGVVPILVELDGDVNGHKFSVS
GEGEGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQ
ERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQK
NGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLE
FVTAAGGTGMEYYTELVNAKDVIRPGQNVIVEVSAPEDLEGQYKSSVHDVDFEKRVLTLSMPSF
RGRLVPLPRGTRCTVMILDSSAIYVFRTSVLESGRDEDGFPVTKVPFPGRLRKIQRRRFKRIKI
FLEGTYRVASRDEPPKRFVTRDFSAGGMLMVVEDILTPEQIIYVTLDLDEDLKLKDHPARVVRE
AGALETGERMYGVEFLNVPPALERKLVSFVFKKEIEMRNKERSESEGGTMVFTLEDFVGDWRQT
AGYNLDQVLEQGGVSSLFQNLGVSVTPIQRIVLSGENGLKIDIHVIIPYEGLSGDQMGQIEKIF
KVVYPVDDHHFKVILHYGTLVIDGVTPNMIDYFGRPYEGIAVFDGKKITVTGTLWNGNKIIDER
LINPDGSLLFRVTINGVTGWRLCERILA*stop 
pET21-VYN MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTT
LGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKG
IDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDG
PVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGGTMVFTLEDFVGDWRQTAGYNLDQVLE
QGGVSSLFQNLGVSVTPIQRIVLSGENGLKIDIHVIIPYEGLSGDQMGQIEKIFKVVYPVDDHH
FKVILHYGTLVIDGVTPNMIDYFGRPYEGIAVFDGKKITVTGTLWNGNKIIDERLINPDGSLLF
RVTINGVTGWRLCERILAKLAAALEHHHHHH*stop 
pET21-VYN-
Tm 
MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTT
LGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKG
IDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDG
PVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGGTGMEYYTELVNAKDVIRPGQNVIVEV
SAPEDLEGQYKSSVHDVDFEKRVLTLSMPSFRGRLVPLPRGTRCTVMILDSSAIYVFRTSVLES
GRDEDGFPVTKVPFPGRLRKIQRRRFKRIKIFLEGTYRVASRDEPPKRFVTRDFSAGGMLMVVE
DILTPEQIIYVTLDLDEDLKLKDHPARVVREAGALETGERMYGVEFLNVPPALERKLVSFVFKK
EIEMRNKERSESEGGTMVFTLEDFVGDWRQTAGYNLDQVLEQGGVSSLFQNLGVSVTPIQRIVL
SGENGLKIDIHVIIPYEGLSGDQMGQIEKIFKVVYPVDDHHFKVILHYGTLVIDGVTPNMIDYF
GRPYEGIAVFDGKKITVTGTLWNGNKIIDERLINPDGSLLFRVTINGVTGWRLCERILAKLAAA
LEHHHHHH*stop 
 100 
 
Table 3.3 Amino acid sequences of YcgR proteins 
Notes: Highlighted residues were removed for YcgRΔ variants 
 
  
EcYcgR 
 
MSHYHEQFLKQNPLAVLGVLRDLHKAAIPLRLSWNGGQLISKLLAITPDKLVLDFGSQAEDNIA
VLKAQHITITAETQGAKVEFTVEQLQQSEYLQLPAFITVPPPTLWFVQRRRYFRISAPLHPPYF
CQTKLADNSTLRFRLYDLSLGGMGALLETAKPAELQEGMRFAQIEVNMGQWGVFHFDAQLISIS
ERKVIDGKNETITTPRLSFRFLNVSPTVERQLQRIIFSLEREAREKADKVRD 
CpYcgR 
 
MAKRKEPKVGDRGILRVREPGETGVEYYSTRIEDVRDGLIACSQPMRGQVYVKILSSPVELTYL
KGDSVFSLMCEVIEQGKGDPPLIVLKPISGIYRSDRREYVRVPWMLDAELLFVKTFPADVKKFW
EDHSHESVRAVILDLSAGGCRLSLAEACMVGEKVLIRFTVPEPNPDTFLLPALIKRVEPGSEPG
VTNVGLQFVDVKDVIRDKLCRSVFCRQRELIKKGFYELEEE 
TmYcgR MEYYTELVNAKDVIRPGQNVIVEVSAPEDLEGQYKSSVHDVDFEKRVLTLSMPSFRGRLVPLPR
GTRCTVMILDSSAIYVFRTSVLESGRDEDGFPVTKVPFPGRLRKIQRRRFKRIKIFLEGTYRVA
SRDEPPKRFVTRDFSAGGMLMVVEDILTPEQIIYVTLDLDEDLKLKDHPARVVREAGALETGER
MYGVEFLNVPPALERKLVSFVFKKEIEMRNKERSESE 
NtYcgR MLKIGLSIKIRVDNKDYSSRIEDMDSDYLYISTPMEKGQLVHFSQGSKISVYIIVKGAVYNFEE
KIKEQIKSPVPLLKISKPDKLKKIQRRQFFRLEKKLPVKYKILDDDCESELSDTKDAYALDISG
GGLKLATQEIIPVNSFLELNFELNIDEGKNSNIHDIRCVGKIVRTQKVDTDRVSIYHYGVKFIS
LPSEIQDTIVRFIFNEQRKLRLKGRFSHAKRES 
TbYcgR MIKKEELKINQKVEVQIPDGSYKGNYSSRVEEIHPDGSIVLAAPFKRGVLIPLRKGDTVIVNFW
GQTAGYSFTTAVLETNYQDVPMIRVAAPSTVRRIQRRNFVRVPAWIPLVFSVSSDSDDPSEKKI
YRTETVNVSGGGLLIKSPFKLSEGVCLEMEIHLPKRGPVNARGQVVRVEEKREQSPMYLIGVAF
TEIAETDRTKIINFVFEKQREMRQKGLI 
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Table 3.4 Amino acid sequences for tVYN and Vcp variants 
Notes: For Vcp variants, an additional starting Met and an artificial linker (GGSGG) 
fusing the original N- and C- termini is added (added start codon, N-terminal portion, C-
terminal portion) 
 
  
Vcp50 
N: (50-239) 
C: (1-49) 
 
MTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAE
VKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGG
VQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYKG
GSGGMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLIC 
Vcp157 
N: (157-239) 
C: (1-156) 
 
MKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHM
VLLEFVTAAGITLGMDELYKGGSGGMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDAT
YGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKD
DGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITAD 
Vcp173 
N: (173-239) 
C: (1-172) 
 
MEDGGVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMD
ELYKGGSGGMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLP
VPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDT
LVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNI 
Vcp195 
N: (195-239) 
C: (1-194) 
 
MLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAAGITLGMDELYKGGSGGMVSKGEELFTGVV
PILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTTLGYGLQCFARYPD
HMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKGIDFKEDGNILGHK
LEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDGPV 
Vcp229 
N: (229-239) 
C: (1-228) 
 
MGITLGMDELYKGGSGGMVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKL
ICTTGKLPVPWPTLVTTLGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRA
EVKFEGDTLVNRIELKGIDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDG
GVQLADHYQQNTPIGDGPVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTAA 
VenusΔC12 MVSKGEELFTGVVPILVELDGDVNGHKFSVSGEGEGDATYGKLTLKLICTTGKLPVPWPTLVTT
LGYGLQCFARYPDHMKQHDFFKSAMPEGYVQERTIFFKDDGNYKTRAEVKFEGDTLVNRIELKG
IDFKEDGNILGHKLEYNYNSHNVYITADKQKNGIKANFKIRHNIEDGGVQLADHYQQNTPIGDG
PVLLPDNHYLSYQSKLSKDPNEKRDHMVLLEFVTA 
NLucΔN4 LEDFVGDWRQTAGYNLDQVLEQGGVSSLFQNLGVSVTPIQRIVLSGENGLKIDIHVIIPYEGLS
GDQMGQIEKIFKVVYPVDDHHFKVILHYGTLVIDGVTPNMIDYFGRPYEGIAVFDGKKITVTGT
LWNGNKIIDERLINPDGSLLFRVTINGVTGWRLCERILA 
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Table 3.5 Oligonucleotides used in this study 
Name Sequence 
REV-Venus-Nluc-vector 
CCAGTCCCCAACGAAATCTTCGAGTGTGAAGACCATggtaccCCCGGCGG 
FWD-Venus-Nluc-insert 
GTTCGTGACCGCCGCCGGGggtaccATGGTCTTCACACTCGAAGATTTCG 
FWD-Venus-Nluc-vector 
CGGCTGTGCGAACGCATTCTGGCGTAAgAATTCGAAGCTTGATCCGGCTG 
REV-Venus-Nluc-insert 
TTGTTAGCAGCCGGATCAAGCTTCGAATTcTTACGCCAGAATGCGTTCGC 
REV-VYN-YcgR-vector 
ttcaggaactgctcatggtaatgactCATccatggCCCGGCGGCGGTCAC 
FWD-VYN-YcgR-insert 
TCGTGACCGCCGCCGGGccatggATGagtcattaccatgagcagttcctg 
REV-VYN-YcgR-insert 
ACGAAATCTTCGAGTGTGAAGACCATgagctcgtcgcgcactttgtccgc 
FWD-VYN-YcgR-vector 
ggacaaagtgcgcgacgagctcATGGTCTTCACACTCGAAGATTTCGTTG 
FWD-TmYcgR-VYN-
insert TGACCGCCGCCGGGggtacaggtATGGAATATTATACCGAACTGGTGAAC 
REV-TmYcgR-VYN-insert AAATCTTCGAGTGTGAAGACCATggtaccaccTTCGCTTTCGCTGCGTTC 
FWD-CpYcgR-VYN-
insert GAGTTCGTGACCGCCGCCGGGggtacaggtATGGCGAAACGCAAAGAACC 
REV-CpYcgR-VYN-insert CGAGTGTGAAGACCATggtaccaccTTCTTCTTCCAGTTCATAAAAGCCT 
FWD-TbYcgR-VYN-insert CGCCGCCGGGggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
REV-TbYcgR-VYN-insert AAATCTTCGAGTGTGAAGACCATggtaccaccAATCAGGCCTTTCTGGCG 
FWD-VYN-Nt-YcgR-
insert GCCGCCGGGggtacaggtATGCTGAAAATTGGCCTGAGCATTAAAATTCG 
REV-VYN-Nt-YcgR-insert GAGTGTGAAGACCATggtaccaccagATTCGCGTTTCGCATGGCTAAAGC 
FWD-tVYN-rth CTCGAAGATTTCGTTGGGGACTG 
REV-tVYN-rth GGTaccGGCGGTCACGAACTCCA 
FWD-tVYN-TmYcgR 
delta flex CTGCTGGAGTTCGTGACCGCCGGTACaggtTATACCGAACTGGTGAACGC 
REV-tVYN-TmYcgR delta 
flex CCAACGAAATCTTCGAGggtaccaccTTCTTTGTTGCGCATTTCAATTTC 
FWD-Venus-pET21 insert TGTTTAACTTTAAGAAGGAGATATACATATGATGGTGAGCAAGGGCGAGG 
REV-Nluc-pET21 insert GTGCGGCCGCAAGCTTCGCCAGAATGCGT 
REV-Nluc-pET21 insert 2 CGGCCGCAAGCTTCGCCAGAATGCGTTCGC 
FWD-Tm-Nluc insert AAGAAGGAGATATACATATGggtacaggtATGGAATATTATACCGAACTG 
FWD-Venus-pET21 RTH ATGGACGAGCTGTACAAGAAGCTTGCGGCCGCACTC 
REV-Venus-pET21 RTH GCCGAGAGTGATCCCGGCGGCGGTCAC 
FWD-Tm-Nluc-RTH ATGGAATATTATACCGAACTGGTGAAC 
REV-Tm-Nluc-RTH ATGTATATCTCCTTCTTAAAGTTAAACAAAATTATTTC 
FWD-cp-linker GGTGGTTCCGGTGGTATGGTGAGCAAGGGCGAGG 
REV-cp-linker ACCACCGGAACCACCCTTGTACAGCTCGTCCATGCC 
FWD-vcp50 GTTTAACTTTAAGAAGGAGATATACATATGACCACCGGCAAGCTGCC 
REV-vcp50 CCAGTTCGGTATAATATTCCATacctgtaccGCAGATCAGCTTCAGGGTCAGC 
FWD-vcp157 GTTTAACTTTAAGAAGGAGATATACATATGAAGCAGAAGAACGGCATCAAGG 
REV-vcp157 CCAGTTCGGTATAATATTCCATacctgtaccGTCGGCGGTGATATAGACGTTG 
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FWD-vcp173 GTTTAACTTTAAGAAGGAGATATACATATGGAGGACGGCGGCGTG 
REV-vcp173 CCAGTTCGGTATAATATTCCATacctgtaccGATGTTGTGGCGGATCTTGAAG 
FWD-vcp195 GTTTAACTTTAAGAAGGAGATATACATATGCTGCTGCCCGACAACCAC 
REV-vcp195 CCAGTTCGGTATAATATTCCATacctgtaccCACGGGGCCGTCGC 
FWD-vcp229 GTTTAACTTTAAGAAGGAGATATACATATGGGGATCACTCTCGGCATGG 
REV-vcp229 CCAGTTCGGTATAATATTCCATacctgtaccGGCGGCGGTCACGAACTC 
REV-Nluc-HisTag CATAAGCTTCGCCAGAATGCGTTCGCA 
FWD-vcp-Nluc AAGCTGATCTGCggtaccATGGTCTTCACACTCGAAGATTTCG 
REV-vcp50-Nluc CGAGTGTGAAGACCATggtaccGCAGATCAGCTTCAGGGTCAGC 
REV-vcp157-Nluc TGTGAAGACCATggtaccGTCGGCGGTGATATAGACGTTGTGG 
REV-vcp173-Nluc GAGTGTGAAGACCATggtaccGATGTTGTGGCGGATCTTGAAG 
REV-vcp195-Nluc GAAATCTTCGAGTGTGAAGACCATggtaccCACGGGGCCGTCGC 
REV-vcp229-Nluc TTCGAGTGTGAAGACCATggtaccGGCGGCGGTCACGAACTC 
REV-VYN-Histag ATCTTCGAGTGTGAAGACCATggtaccCCCGGCGGCGGTCAC 
FWD-Ec-no vcp GCCGCCGGGggtacaggtATGagtcattaccatgagcagttc 
FWD-Ec-vcp50 CCTGAAGCTGATCTGCggtacaggtATGagtcattaccatgagcagttc 
FWD-Ec-vcp157 CTATATCACCGCCGACggtacaggtATGagtcattaccatgagcagttc 
FWD-Ec-vcp173 TCCGCCACAACATCggtacaggtATGagtcattaccatgagcagttc 
FWD-Ec-vcp195 ACGGCCCGTGggtacaggtATGagtcattaccatgagcagttc 
FWD-Ec-vcp229 GACCGCCGCCggtacaggtATGagtcattaccatgagcagttc 
REV-Ec-vcp TCGAGTGTGAAGACCATggtaccaccgtcgcgcactttgtccg 
FWD-Nt-no vcp GCCGCCGGGggtacaggtATGCTGAAAATTGGCCTGAG 
FWD-Nt-vcp50 CCTGAAGCTGATCTGCggtacaggtATGCTGAAAATTGGCCTGAG 
FWD-Nt-vcp157 CTATATCACCGCCGACggtacaggtATGCTGAAAATTGGCCTGAG 
FWD-Nt-vcp173 TCCGCCACAACATCggtacaggtATGCTGAAAATTGGCCTGAG 
FWD-Nt-vcp195 ACGGCCCCGTGggtacaggtATGCTGAAAATTGGCCTGAG 
FWD-Nt-vcp229 GACCGCCGCCggtacaggtATGCTGAAAATTGGCCTGAG 
REV-Nt-vcp TCGAGTGTGAAGACCATggtaccaccTTCGCGTTTCGCATGG 
FWD-Tb-no vcp GCCGCCGGGggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
FWD-Tb-vcp50 TGAAGCTGATCTGCggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
FWD-Tb-vcp157 CACCGCCGACggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
FWD-Tb-vcp173 CCACAACATCggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
FWD-Tb-vcp195 CGGCCCCGTGggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
FWD-Tb-vcp229 GACCGCCGCCggtacaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
REV-Tb-vcp TCGAGTGTGAAGACCATggtaccaccAATCAGGCCTTTCTGGCG 
FWD-Cp-no vcp GCCGCCGGGggtacaggtATGGCGAAACGCAAAGAAC 
FWD-Cp-vcp50 CCTGAAGCTGATCTGCggtacaggtATGGCGAAACGCAAAGAAC 
FWD-Cp-vcp157 CTATATCACCGCCGACggtacaggtATGGCGAAACGCAAAGAAC 
FWD-Cp-vcp173 TCCGCCACAACATCggtacaggtATGGCGAAACGCAAAGAAC 
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FWD-Cp-vcp195 ACGGCCCCGTGggtacaggtATGGCGAAACGCAAAGAAC 
FWD-Cp-vcp229 GACCGCCGCCggtacaggtATGGCGAAACGCAAAGAAC 
REV-Cp-vcp TCGAGTGTGAAGACCATggtaccaccTTCTTCTTCCAGTTCATAAAAGCC 
FWD-VYN-His tag TGTTTAACTTTAAGAAGGAGATATACATATGGTGAGCAAGGGCGAG 
REV-VYN-His tag 2 GTGCGGCCGCAAGCTTCGCCAGAATGCGTTCGC 
REV-Nt-VYN insert GTGAAGACCATggtaccaccAGATTCGCGTTTCGCATG 
FWD-tVYN Nt-insert GACCGCCGGTACaggtATGCTGAAAATTGGCCTGAG 
REV-tVYN Nt-insert CGAAATCTTCGAGggtaccaccAGATTCGCGTTTCGCATG 
FWD-tVYN Tb-insert GTGACCGCCGGTACaggtATGATTAAAAAAGAAGAACTGAAAATTAACC 
REV-tVYN Tb-insert CAACGAAATCTTCGAGggtaccaccAATCAGGCCTTTCTGGCG 
FWD-Nt delta-VYN insert CCGCCGGGggtacaggtAGCATTAAAATTCGCGTGG 
REV-Nt delta-VYN insert TCGAGTGTGAAGACCATggtaccaccCAGGCGCAGTTTGCG 
FWD-Tb delta-VYN insert GCCGCCGGGggtacaggtAAAGTGGAAGTGCAGATTCCG 
REV-Tb delta-VYN insert TCGAGTGTGAAGACCATggtaccaccCTGGCGCATTTCGCG 
FWD-Tm delta-vcp229 GACCGCCGCCggtacaggtTATACCGAACTGGTGAACGCG 
REV-Tm delta-vcp229 GAGTGTGAAGACCATggtaccaccTTCTTTGTTGCGCATTTCAATTTC 
FWD-Nt delta-vcp229 GACCGCCGCCggtacaggtAGCATTAAAATTCGCGTGGATAAC 
REV-Nt delta-vcp229 CGAGTGTGAAGACCATggtaccaccCAGGCGCAGTTTGCG 
FWD-Tb delta-vcp229 GACCGCCGCCggtacaggtAAAGTGGAAGTGCAGATTCCG 
REV-Tb delta-vcp229 CGAGTGTGAAGACCATggtaccaccCTGGCGCATTTCGCG 
FWD-Nt delta-vcp173 CCGCCACAACATCggtacaggtAGCATTAAAATTCGCGTGGATAAC 
FWD-Nt delta-tVYN insert CGTGACCGCCGGTACaggtAGCATTAAAATTCGCGTGG 
REV-Nt delta-tVYN insert CCAACGAAATCTTCGAGggtaccaccCAGGCGCAGTTTGCG 
FWD-Tb delta-tVYN 
insert TCGTGACCGCCGGTACaggtAAAGTGGAAGTGCAGATTCCG 
REV-Tb delta-tVYN insert CAACGAAATCTTCGAGggtaccaccCTGGCGCATTTCGCG 
FWD-Tm delta-tVYN 
insert TCGTGACCGCCGGTACaggtTATACCGAACTGGTGAACGC 
REV-Tm delta-tVYN 
insert CAACGAAATCTTCGAGggtaccaccTTCTTTGTTGCGCATTTCAATTTC 
FWD-tVYN Tm-insert TTCGTGACCGCCGGTACaggtATGGAATATTATACCGAACTGGTGAAC 
REV-tVYN Tm-insert CAACGAAATCTTCGAGggtaccaccTTCGCTTTCGCTGCGTTC 
FWD-Tm delta-VYN 
insert GCCGCCGGGggtacaggtTATACCGAACTGGTGAACGCG 
REV-Tm delta-VYN insert TCGAGTGTGAAGACCATggtaccaccTTCTTTGTTGCGCATTTCAATTTC 
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INTRODUCTION 
It has long been known that cytosolic DNA serves as a potent immune stimulant, however 
it was only recently discovered that this response occurs through the activation of cyclic 
GMP-AMP synthase (cGAS) and production of the cyclic dinucleotide second messenger 
2’,3’-cyclic GMP-AMP ((2’3’)-cGAMP) (Ablasser et al., 2013; Diner et al., 2013; Gao et 
al., 2013). Low nanomolar levels of (2’3’)-cGAMP can bind to and activate the stimulator 
of interferon genes (STING) receptor, which initiates interferon (IFN) and NF-kB immune 
responses (Chen et al., 2016). In this way, the presence of any aberrant cytosolic dsDNA, 
whether it is host-derived (from nuclear or mitochondrial leakage) or pathogen-derived 
(from DNA viruses, retroviruses, or bacteria) triggers the innate immune response. Many 
recent studies have raised interesting questions about the dynamics and localization of 
cGAS-STING signaling in response to infection and other pathophysiological conditions 
(Eaglesham et al., 2019; Yoh et al., 2015). Given its central role in innate immune 
signaling, the cGAS-cGAMP-STING pathway has rapidly become an attractive target for 
the development of cancer immunotherapy and autoimmune disease treatments 
(Corrales et al., 2015; Ramanjulu et al., 2018). 
 Despite the deluge of studies seeking to further understand the basic biology of 
the cGAS-cGAMP-STING signaling pathway, to our knowledge there are no tools 
currently available that permit the imaging of (2’3’)-cGAMP dynamics within live 
eukaryotic cells. Instead, luciferase reporters are commonly used that provide a 
luminescent readout based on the activation of STING and downstream production of 
IFN-β (Burdette et al., 2011; Kranzusch et al., 2013). The luciferase gene is placed under 
the control of an IFN-β promoter such that increased production of IFN-β leads to an 
increase in the production of luciferase. While these reporters have proven useful for 
fundamental studies of (2’3’)-cGAMP signaling, they provide only an indirect 
measurement of (2’3’)-cGAMP levels, are not quantitative, and do not report on the 
intracellular dynamics of (2’3’)-cGAMP. Given the high interest of the cGAS-cGAMP-
STING pathways as a drug target, we and others have also developed in vitro analytical 
tools that are amenable to high throughput screening of compounds that modulate the 
cGAS-cGAMP-STING pathway. These techniques include the RNA-based fluorescent 
biosensor developed by our lab (Bose et al., 2016), a RapidFire mass-spec-based assay 
(Vincent et al., 2017), a fluorescence polarization/antibody assay (Hepworth et al., 2017), 
and more recently a luminescence assay based on ATP substrate consumption (Lama et 
al., 2019). Based on our expertise with developing Nano-lantern (NL) type biosensors for 
c-di-GMP, we sought to develop a protein-based luminescent biosensor for (2’3’)-cGAMP 
that we hoped would be useful as both a genetically encodable tool for live cell imaging 
as well as a robust in vitro tool for high throughput drug screening. 
 In NL-based biosensors, a ligand sensor domain is used to split a luciferase protein 
(RLuc) into two nonfunctional halves, such that ligand binding results in a conformational 
change that reconstitutes luciferase activity and produces a change in luminescence 
intensity (Saito et al., 2012). To develop an NL-based biosensor for (2’3’)-cGAMP, a 
protein sensor domain was needed that binds with high affinity and selectivity to (2’3’)-
cGAMP and undergoes a conformational change upon binding. The only protein known 
to bind with high affinity and selectivity to (2’3’)-cGAMP is STING (Kranzusch et al., 2015). 
STING, however, binds to (2’3’)-cGAMP as a dimer or higher order oligomer, which 
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makes it not amenable to use in the NL-based scaffold (Shang et al., 2019). Inspired by 
a previous graduate student, Dr. Yichi Su’s, work in mutating a natural c-di-GMP binding 
riboswitch aptamer to a (2’3’)-cGAMP binding aptamer (Bose et al., 2016), we 
hypothesized that a similar approach could be applied to convert a natural c-di-GMP 
binding protein into a (2’3’)-cGAMP binding protein. Thus, we sought to use a directed 
protein evolution approach to evolve (2’3’)-cGAMP binding capabilities from a c-di-GMP 
binding YcgR protein. A benefit to this approach was that we could use the robust lysate-
based screening method previously developed to analyze phylogenetic YNL-YcgR 
biosensor libraries (Dippel et al., 2018). In this screen, the change in luminescent signal 
intensity that occurs upon ligand binding to YNL-YcgR sensors would serve as a readout 
for selecting mutant proteins that bind to (2’3’)-cGAMP. To our knowledge, this is the first 
example of using the signal change of a biosensor as a selection strategy for the directed 
evolution of novel binding capabilities in a protein. 
 This chapter describes the ongoing work towards the generation of mutant YcgR 
proteins that bind to (2’3’)-cGAMP. Given the large number of clones that need to be 
assayed during library screening and accordingly the large amount of CDN ligands that 
are required for screening, a protocol was first optimized that allowed for the enzymatic 
synthesis and purification of CDN ligands on a large (tens of milligrams) scale. This 
protocol was found to work very well for natural CDNs, however it can also be applied to 
unnatural CDNs, albeit with reduced yields. A library cloning strategy was then optimized 
that allowed for the rapid generation of single site saturation mutagenesis (SSM) libraries. 
These libraries provide high diversity at the amino acid level with low codon redundancy, 
thereby decreasing the overall cost of library screening. The lysate-based biosensor 
screening process developed previously was further optimized for screening large 
numbers of clones (200+ clones/day) and then applied to screening 16 different SSM 
libraries of YNL-TbYcgR for binding to (3’3’)-cGAMP, an intermediate ligand, in an 
interative saturation mutagenesis (ISM) process. After 2 rounds of screening, 11 mutants 
were purified and characterized in vitro. Unexpectedly, none of the purified mutants 
showed the expected increases in affinity for (3’3’)-cGAMP. This appears to be due to 
surprising differences in signal fold-change observed between binding to c-di-GMP 
versus (3’3’)-cGAMP. The work here lays the groundwork for future studies on using a 
biosensor-based approach for the directed evolution of novel binding capabilities in YcgR 
proteins. 
RESULTS 
 Enzymatic synthesis and purification of CDNs. To generate the large quantities 
of CDN ligand that are necessary for library screening, target ligands were enzymatically 
synthesized and purified where possible, as this helps to reduce the overall cost of library 
screening. Using enzymatic methods, all of the canonical CDNs and a number of non-
canonical CDNs can be generated (Launer-Felty and Strobel, 2018; Li et al., 2014; Rao 
et al., 2009). While the overall scale of enzymatic CDN synthesis is small compared to 
chemical synthesis (milligram versus gram scale, respectively) (Gaffney et al., 2010), the 
speed and ease provided by enzymatic synthesis was attractive. 
 Initial efforts for large-scale CDN synthesis and purification focused on the target 
(2’3’)-cGAMP. Large-scale reactions of cGAS (~5-10 mL) were set up to generate (2’3’)-
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cGAMP, and the product was purified using a silica plug with 5 mM NH4HCO3/15% 
H2O/85% EtOH as the mobile phase, following published protocols (Li et al., 2014). This 
method produced good yields of target (~76%) with reasonable purity (~90%). This 
product was used to determine the approximate affinity of the YNL-CpYcgR biosensor for 
(2’3’)-cGAMP. The YNL-CpYcgR sensor was chosen in part because it binds with very 
high affinity to c-di-GMP, suggesting that it may also have some affinity for (2’3’)-cGAMP. 
Surprisingly, the biosensor exhibited an unexpected decrease in signal intensity in the 
presence of large amounts of (2’3’)-cGAMP (>250 uM) (Figure 4.1a), potentially due to 
residual solvent and/or impurities present in the silica plug purified product. In order to 
further purify the product, three additional purification steps were attempted: removal of 
volatile salts by repeated lyophilization, conversion to sodium salt via ion exchange resin, 
reversed-phase HPLC purification, or combinations of these routes. The purity of these 
products was compared to that of commercial product via testing with YNL-CpYcgR 
(Figure 4.1b). While repeated lyophilization alone did not alleviate the negative signal 
change effect, additional ion exchange or HPLC purification steps appeared to produce 
signal changes comparable to those observed with commercial product. Any differences 
between the purified products and the commercial product were likely due to error in the 
concentration calculation for the purified (2’3’)-cGAMP products (LC/MS was not available 
at the time to assist with determining purity of samples). While the exact cause of this 
negative signal change effect was not made clear, it was most likely due to the presence 
of residual silica particles that carried through after the silica plug purification, which were 
removed by ion exchange or HPLC purification. To avoid any future issues and to ensure 
high product purity, HPLC purification alone was used as the purification scheme going 
forward. 
 Given the low affinity of the wild-type YcgR proteins for (2’3’)-cGAMP (>>100 µM), 
we hypothesized it would be simpler to use an intermediate ligand on the path towards 
generating a YcgR mutant that binds to (2’3’)-cGAMP (Figure 4.2a). Based on chemical 
structures, either (3’3’)-cGAMP or (2’3’)-c-di-GMP could likely serve as useful 
intermediates in the path from c-di-GMP binding to (2’3’)-cGAMP binding, as they differ 
in only the nucleobase or linkage structure, and not both (Figure 4.2b). In this manner, a 
screen could be conducted to select for mutants that bind to a mixed linkage CDN (i.e. 
(2’3’)-c-di-GMP), while in parallel, a screen could be conducted to select for mutants that 
bind to a mixed base CDN (i.e. (3’3’)-cGAMP). These mutants could be combined and 
used as starting scaffolds to conduct a screen for mutants that bind to the desired ligand, 
(2’3’)-cGAMP. After having optimized the method for enzymatic synthesis and purification 
of (2’3’)-cGAMP, both (2’3’)-c-di-GMP and (3’3’)-cGAMP were targeted for synthesis and 
purification.  
 Given that (2’3’)-c-di-GMP is not the preferred product of any known CDN 
synthases, conditions need to be optimized for enzymatic synthesis. Previous results 
have shown that human cGAS (hcGAS), which naturally produces (2’3’)-cGAMP, will 
produce (2’3’)-c-di-GMP when provided with only GTP as substrate, albeit with very low 
yields (Ablasser et al., 2013). Mouse cGAS (mcGAS) is generally more active, and 
accepts non-natural substrates such as dNTPs or phosphorothioate NTPs to produce a 
variety of mixed-linkage CDN products (Li et al., 2014). Given the increased promiscuity 
and enzymatic activity of mcGAS, it was chosen for synthesis of (2’3’)-c-di-GMP rather 
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than hcGAS. Reaction conditions were optimized to promote the production of (2’3’)-c-di-
GMP (Figure 4.3). Elevated pH and the use of Mn2+ led to increased yields of (2’3’)-c-di-
GMP, although after HPLC purification the total isolated yields were very small (~5%).  
To enzymatically produce (3’3’)-cGAMP, the cyclic GMP-AMP synthase, DncV, 
from Vibrio cholerae was used (Launer-Felty and Strobel, 2018). Large-scale synthesis 
was performed following established protocols, and HPLC purification was carried out 
using the same conditions optimized for (2’3’)-c-di-GMP, which provided good separation 
of the 3 CDN products produced by DncV. This method resulted in good isolated yields 
(~70%) with very high purity (>99%). Given the excellent yields possible for (3’3’)-cGAMP, 
it was ultimately chosen as the first target for screening. 
 Selectivity of phylogenetic YcgR variants. To determine the ideal starting 
scaffold for directed evolution of (3’3’)-cGAMP binding (and eventually (2’3’)-cGAMP 
binding), the relative affinity and selectivity of four phylogenetic YcgR variants – CpYcgR, 
TmYcgR, TbYcgR, and CbYcgR – within the YNL biosensor scaffold was determined for 
different CDNs. These sensors all exhibit high affinity for c-di-GMP (<50 nM) with large 
signal fold-changes (>6-fold) and good stability (Dippel et al., 2018). We sought to 
determine which YcgR protein was least selective against mixed-base/mixed-linkage 
CDNs (i.e. most promiscuous binder), as we hypothesized that the most promiscuous 
starting scaffold would require fewer mutations to create a version that binds to (3’3’)-
cGAMP/(2’3’)-cGAMP with high affinity. Theoretically, these mutations could then be 
transferred to the other YcgR proteins to create multiple sensors capable of binding 
cGAMP.  
The relative affinity/selectivity of these sensors was tested using c-di-GMP, (2’3’)-
c-di-GMP, (3’3’)-cGAMP, and (2’3’)-cGAMP to see the effects of mixed bases and mixed 
linkages on binding (Figure 4.4, 4.5). Relative affinity data suggest that for all sensors, 
the mixed-linkage isomer of c-di-GMP [(2’3’)-c-di-GMP] is more well tolerated than the 
mixed-base isomer [(3’3’)-cGAMP], and that the additive effects of mixed-base and 
mixed-linkage lead to very high selectivity (>2000-fold) against (2’3’)-cGAMP (Table 4.1). 
Accordingly, all sensors exhibited very poor affinity for (2’3’)-cGAMP (KD >>100 µM, the 
highest concentration tested). Gratifyingly, this confirmed our hypothesis that either (2’3’)-
c-di-GMP or (3’3’)-cGAMP could serve as intermediates on the path towards (2’3’)-
cGAMP binding (Figure 4.2a). The four YcgR variants exhibited different relative 
selectivities towards the tested CDNs, with YNL-TbYcgR sensor being the least 
selective/most promiscuous binder overall. Based on these results, YNL-TbYcgR was 
chosen as the starting scaffold towards the evolution of improved cGAMP binding. 
 Generation of saturation mutagenesis libraries. Having chosen YNL-TbYcgR 
as the starting scaffold, a strategy was developed for the generation of mutant YcgR 
libraries. Given the throughput of the lysate-based screen (up to ~800 samples/day limited 
by manual loading of plates and plate reader read time), we decided to use a focused site 
saturation mutagenesis (SSM) approach, as it limits library size and the overall screening 
cost compared to using random mutagenesis. To maximize the probability of obtaining 
additive and/or cooperative mutations, genes from the initial SSM libraries that exhibited 
desired properties would then be used as templates for additional rounds of SSM library 
generation and screening (Reetz and Carballeira, 2007). This approach, known as 
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iterative saturation mutagenesis (ISM), has been shown to be an efficient strategy for 
directed evolution of enzymes with enhanced thermostability, enantioselectivity, or 
altered substrate profiles, but to our knowledge had not been applied to evolve new ligand 
binding in protein receptors (Reetz, 2011).  
In choosing sites for the generation of SSM libraries within YNL-TbYcgR, the highly 
conserved residues of the PilZ domain were purposefully avoided, as mutations at these 
sites would likely ablate all CDN binding (Benach et al., 2007; Chou and Galperin, 2016; 
Ko et al., 2010; Ryjenkov et al., 2006). Instead, libraries were focused on the less well-
conserved residues that surround the binding pocket and make contacts with c-di-GMP. 
This type of semi-rational library design process is known as CASTing (combinatorial 
active site saturation test) and results in the creation of smaller “smarter” libraries that 
reduces the cost of library screening (Chica et al., 2005; Reetz and Carballeira, 2007; 
Steiner and Schwab, 2012). We hypothesized that cGAMP was likely to bind as a 
monomer, so the structural model was based mainly on the crystal structure of VCA0042 
bound to a monomer of c-di-GMP (Figure 4.6a) (Benach et al., 2007). One of the key 
mutations in YcgR-like proteins that appears to promote monomer binding over dimer 
binding is at “position X”, which is the residue immediately prior to the highly conserved 
RxxxR motif. In VCA0042 this residue is a Leu (L135), while in many PilZ domain-
containing proteins it is an Arg. Mutation to a Leu or other small hydrophobic residue 
appears to sterically occlude the 2nd c-di-GMP molecule from entering the binding pocket, 
while the presence of an Arg promotes an “arginine-fork” interaction with a 2nd molecule 
of c-di-GMP (Ko et al., 2010). It was unclear which orientation cGAMP would adopt in the 
binding pocket (adenine base on “top” or “bottom”), so SSM regions were chosen that 
would theoretically interact with the altered base at either position. With these 
considerations, eight total residues were chosen for SSM library creation (Figure 4.6b).  
  Given the throughput that is possible in the lysate-based screen (~800 
samples/day), we had to carefully choose a method of SSM library creation that would 
allow for rapid screening of these 8 different sites as well as the future libraries needed 
for the ISM process (Reetz and Carballeira, 2007). In order to get sufficient library 
coverage at a single site (>95% coverage), approximately 3x the number of variants 
encoded in the library must be screened (Patrick et al., 2003) (Figure 4.7a). With this in 
mind, SSM libraries were generated using the 22c trick method, as it produces a library 
that encodes all 20 possible amino acids with very little redundancy (22 codons), thereby 
reducing the number of clones that need to be screened for good coverage (Acevedo-
Rocha et al., 2015; Kille et al., 2013) (Figure 4.7b). The 22c trick method uses a defined 
mixture of three primers to create a degeneracy of 22 codons that encode all 20 amino 
acids. The Tang method was also considered as it produces a similar library diversity with 
zero redundancy (20 codons encoded), but it requires an additional primer per site and 
would not significantly reduce the screening effort required (Tang et al., 2012). 
 SSM libraries were generated at each of the 8 sites using an “around the horn” 
mutagenesis type approach. In this method, non-overlapping primers are used to amplify 
the entire plasmid via PCR, and mutations are encoded on only a single primer (5’ end of 
the forward primer or the 3’ end of the reverse primer). The linear PCR product is ligated 
to form circularized DNA which can then be transformed into cells. QuikChange 
mutagenesis, which is also commonly used for library creation, uses long, overlapping 
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primers and encodes the mutation on both primers. QuikChange additionally requires 
transformed cells to repair the nick is the PCR product, generally leading to reduced 
transformation efficiency. Using the around the horn approach rather than QuikChange 
allowed for the use of short oligo sequences and standard chemically competent cells in 
the transformations, which simplified the generation of the mutant libraries. Pooled 
libraries for each site were sequenced and characterized using the “Quick Quality Control” 
(QQC) method to determine the approximate quality of the library (Sullivan et al., 2013). 
This method provides a statistical value that represents how well the library diversity (as 
measured by peaks in a sequencing chromatogram) matches that of an “ideal” library, 
with a Q value close to 1 meaning better library diversity. In general, Q values >0.7 
suggest that the library is of high enough quality for screening (Sullivan et al., 2013). In 
our hands, the cloning methods described here consistently produced libraries with Q 
values of 0.70-0.85, which are suitable for screening. 
 Lysate-based screening of TbYcgR 22c libraries. The 8 different SSM libraries 
were individually screened as mCherry-tagged biosensors in lysates with buffer, 1 µM c-
di-GMP, or 5 µM (3’3’)-cGAMP added. The mCherry tag was used so that the luminescent 
signal for each clone could be normalized to the mCherry fluorescence, thereby 
accounting for differences in biosensor expression/stability. The 1 µM c-di-GMP condition 
was included to provide a way to normalize to the fully saturated signal for each clone. 
The starting affinity wild-type YNL-TbYcgR for c-di-GMP is <50 nM, so it was 
hypothesized that 1 µM would always lead to a saturating signal, even for mutants with 
reduced c-di-GMP affinity. The 5 µM (3’3’)-cGAMP concentration was chosen because 
this is the approximate affinity of wild-type YNL-TbYcgR for (3’3’)-cGAMP (Figure 4.4, 
4.5). Accordingly, WT controls would show ~50% signal with 5 µM (3’3’)-cGAMP 
compared to the fully saturated c-di-GMP signal, while any clones with increased affinity 
would show >50% signal and any clones with decreased affinity would show <50% signal. 
For each library, 90 mutant clones were screened alongside 6 WT controls to 
ensure sufficient library coverage and a measure of reproducibility. While only ~66 clones 
are needed for 95% coverage in these libraries, this assumes the absence of any frame 
shifts/indels that may have been produced during cloning that result in a truncated protein 
product. About 5-10% of all clones exhibited very low luminescent signal, suggesting 
these clones were producing truncated or mis-folded protein product. Accordingly, by 
oversampling and screening 90 clones per site, we ensure sufficient library coverage with 
minimal additional effort.  
The max signal fold-change (Δsignal) for each clone was calculated based on the 
signal for 1 µM c-di-GMP compared to buffer (Figure 4.8). To determine relative affinities 
for (3’3’)-cGAMP, the signal for 1 µM c-di-GMP was assumed to be saturating and used 
to calculate the % signal with (3’3’)-cGAMP over c-di-GMP for each clone. The WT YNL-
TbYcgR sensor exhibited a Δsignal max of ~5.2 and a % signal of ~64% with 5 µM (3’3’)-
cGAMP under the lysate screen conditions (average of 48 lysate measurements across 
multiple days/plates) (Figure 4.8a). Mutant clones exhibited signal fold-change and % 
signal values that varied significantly from site to site (Figure 4.8b). To remove any clones 
that had drastically reduced affinity for c-di-GMP from the analysis, % signal values were 
not calculated for any clones that showed Δsignal values for 1 µM c-di-GMP less than 2. 
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Additionally, clones exhibiting very low luminescent signal were completely excluded from 
analysis – the luminescent signal cutoff was defined as being <1% that of the WT.  
Clones with significantly improved signal change (> ~10-fold) and/or improved % 
signal with (3’3’)-cGAMP over c-di-GMP (> ~75%) were selected for re-screening. Most 
libraries showed only a few clones with % signal values >75%, however the R100 site 
library produced many clones with % signal values >100%, including some with >200% 
values (Figure 4.9, 4.10). These surprising results suggested that the affinity/selectivity in 
these clones was altered such that (3’3’)-cGAMP was preferred over c-di-GMP (i.e. 1 µM 
c-di-GMP is not saturating but 5 µM cGAMP is), which was a desired outcome. An 
alternate explanation is that the mutants bind to c-di-GMP and cGAMP in a different 
manner, leading to different max Δsignal values depending on the ligand, which was an 
undesired outcome. From this first round of screening, 40 clones were selected that had 
improved % signal with (3’3’)-cGAMP over c-di-GMP, and 22 clones were selected that 
had improved Δsignal values. 
The 62 selected clones were subjected to re-screening under identical conditions, 
but with 4 biological replicates used for each measurement. All selected R100 site 
mutants were additionally screened against 10 µM c-di-GMP to determine if 1 µM c-di-
GMP was saturating. For these clones the 1 µM c-di-GMP condition did indeed appear to 
be saturating, suggesting that the reason % signal values were >100% was due to 
differential binding/signal change between c-di-GMP and (3’3’)-cGAMP. This unexpected 
property appeared to be unique to the R100 site mutants. All clones that showed 
statistically significant improvements for the desired properties were then isolated and 
sequenced. A total of 9 unique sequences were found that appeared to have improved 
properties (4 with improved Δsignal and 5 with improved % signal with (3’3’)-cGAMP over 
c-di-GMP) (Figure 4.11, Table 4.2).  
Following the first round of SSM library screening, two single mutant sequences 
that displayed favorable combinations of Δsignal and % signal (N102W and R100V) were 
then used as parent templates to generate additional SSM libraries (Table 4.2). SSM 
libraries were generated at sites R100 (for N102W template only), N102 (for R100V 
template only), V136, S137, and V174 as these sites produced mutants with 
improvements in Δsignal and % signal (Table 4.2). Sites G139, L142, and R175 were 
dropped at this round because these libraries produced few to no major improvements in 
the first round of SSM library screening. Double mutant libraries were screened in lysates 
as before, except the single mutant parent was used as the “WT” control in each case, 
and lysates were screened with 2.5 µM (3’3’)-c-di-GMP added, rather than 5 µM, to 
increase the stringency of selection (Figure 4.12). Clones that showed improved % signal 
with (3’3’)-cGAMP over c-di-GMP (> ~60%; 31 clones) and/or improved signal change (> 
~15-fold; 14 clones) were subjected to re-screening with additional biological replicates. 
After re-screening, clones that showed statistically significant improvements for the 
desired properties were isolated and sequenced. A total of 11 unique sequences were 
found that appeared to have improved properties (Figure 4.13, Table 4.2). Double 
mutants that were generated from the N102W parent template exhibited increases in a 
single property  compared to the parent (3 with improved % signal, 3 with improved 
Δsignal), whereas double mutants generated from the R100V parent template all 
exhibited increases in both properties compared to the parent sequence (5 clones). 
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Interestingly, four mutations that had appeared in the first round of screening appeared 
again here (R100M, N102R, V136Q, and S137Q) suggesting that these mutations are 
indeed having significant effects on % signal and Δsignal. 
In vitro characterization of TbYcgR mutants. Two rounds of iterative saturation 
mutagenesis and screening identified 5 single and 8 double mutant sequences that 
exhibited improved % signal with (3’3’)-cGAMP over c-di-GMP in the lysate-based screen. 
This property suggests these mutants were promising candidates for evolved (3’3’)-
cGAMP binding protein domains/biosensors. The relative (3’3’)-cGAMP affinities of the 5 
single mutants were first measured in lysates. The mutants were screened with varying 
concentrations of (3’3’)-cGAMP and compared to the WT sequence (Figure 4.14). The 
N102W, R100V, R100L, and R100K mutants all showed increased % signal values for 
(3’3’)-cGAMP compared to the WT sequence, suggesting that they had improved affinity 
for cGAMP, as expected. The R100M mutant exhibited % signal values for (3’3’)-cGAMP 
over c-di-GMP >100%, suggesting that this mutation may lead to differential binding 
between (3’3’)-cGAMP and c-di-GMP, which was not desired. 
Selected mutants were re-cloned into the pRSET vector without the mCherry tag, 
expressed, and purified for in vitro characterization. Each protein was tested for binding 
to c-di-GMP (up to 1 µM) and (3’3’)-cGAMP (up to 10 µM) to determine relative affinity 
and selectivity. To our surprise, the single mutants (N102W and R100V) that were 
isolated from the first round of library screening actually exhibited poorer affinity for (3’3’)-
cGAMP than the WT sequence, but similar affinity for c-di-GMP (Figure 4.15; Table 4.3; 
Table 4.4). These decreases in (3’3’)-cGAMP affinity were completely unexpected, as the 
% signal with (3’3’)-cGAMP over c-di-GMP for these mutants was greater than for the WT 
in the lysate screen. The reason this does not translate to an increase in (3’3’)-cGAMP 
affinity, it appears, is that the mutants exhibit different max fold-change values for c-di-
GMP compared to (3’3’)-cGAMP, with (3’3’)-cGAMP producing larger Δsignal values 
(Table 4.3; Table 4.4). The R100M mutant, as noted previously, is an extreme case of 
this differential binding, whereas the N102W and R100V mutants show more subtle 
differences. Also of note, the Hill slope of the R100V mutant is ~1, suggesting that the 
mutation to a small hydrophobic at this residue indeed promotes the binding of monomeric 
c-di-GMP in TbYcgR, as hypothesized.  
Similar affinity results were observed in all the remaining double mutants, with no 
mutant showing significantly improved (3’3’)-cGAMP affinity compared to wild-type 
(Figures 4.16, 4.17, 4.18). Unfortunately, these results suggest that because all (3’3’)-
cGAMP binding data was normalized to c-di-GMP signal, the screen inadvertently 
selected mutants that exhibited differences in Δsignal between the two ligands, rather 
than the desired improvements in (3’3’)-cGAMP binding affinity. 
DISCUSSION AND FUTURE DIRECTIONS 
The work here represents, to our knowledge, the first attempts at evolving a YcgR protein 
to bind a new CDN ligand, with the ultimate goal being to develop protein-based 
biosensors for CDN targets that currently have no known receptors. Furthermore, to our 
knowledge, this represents the first example of using a biosensor scaffold as the readout 
for ligand binding in directed evolution library screening. It comes as no surprise then, 
that some unexpected difficulties were encountered along the way. 
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This library screening process taught us some valuable lessons about ligand 
binding to YcgR proteins and the complicating factors that arise when using 
conformational change (∆signal) as a readout for ligand binding. One of the most 
surprising aspects of the mutant YNL-TbYcgR library screening process was the profound 
effects that single mutations had on the behavior of the biosensors. For example, we 
observed that the S137Q mutation alone produced a biosensor with a 53-fold signal 
change (Table 4.2), compared to a ~5.2-fold signal change in the wild-type protein, albeit 
with reduced c-di-GMP binding affinity. Prior work characterizing the YcgR-like protein 
PlzD from V. cholerae showed that a single L135R mutation (at “position-X”) produced a 
completely different inter-domain structure in the c-di-GMP bound state compared to the 
WT (Ko et al., 2010), which may be similar to the effects we observed in TbYcgR mutants. 
Early efforts in engineering CSL-type sensors for cAMP similarly found that global 
mutagenesis and directed evolution of the biosensor scaffold (including binding domain) 
could lead to dramatic improvements in signal change with only a few mutations 
(Binkowski et al., 2011), however that approach used random mutagenesis rather than 
targeted SSM. In future studies it would be interesting to see if the mutations that were 
discovered in TbYcgR (see also V136Y, V136Q) are transferrable to other YcgR proteins 
to produce similar effects, or if they are unique to TbYcgR. Additionally, it would be 
interesting to see if these TbYcgR mutants can be transferred to one of the ratiometric 
VYN biosensor scaffolds to produce improved changes in BRET ratio.   
Equally surprising was the differences we observed in signal fold-change for 
mutant TbYcgR proteins binding to c-di-GMP versus (3’3’)-c-di-GMP. When starting this 
screening process, it was assumed that because both ligands would likely bind to the 
same region of the protein, the ∆signal values would be similar for both binding events. 
While small differences could be expected, the magnitude of the differences that were 
observed in selected mutants was surprising. Small changes to protein sequence 
(R100M, N102W/R100G, N102W/R100T – see Figures 4.15 and 4.16) produced very 
large differences in ∆signal for the two ligands. Looking back at the initial selectivity 
screen, there were actually subtle differences in max ∆signal for c-di-GMP versus (2’3’)-
c-di-GMP, suggesting that these differences might be common in all YcgR proteins 
(Figure 4.4). This effect is likely due to subtle differences in binding interactions and 
reorganization of the binding pocket around the two different ligands, and potentially 
differences in the binding stoichiometry for the two different CDNs. Unfortunately, 
because all (3’3’)-cGAMP binding data was normalized to c-di-GMP in this screen, we 
inadvertently selected for extreme cases of this phenomenon (you get what you screen 
for!). In future studies, this problem could potentially be solved by using an additional high 
concentration of (3’3’)-cGAMP for normalization, as opposed to c-di-GMP. 
Despite the outcome, the library generation and screening methods developed 
here have proven to be very robust. Using the cloning methods described, high quality 
SSM libraries can rapidly and cheaply be generated. The workflow for screening libraries 
was highly optimized (up to 800 samples/day), and screening 8 different SSM libraries 
took only ~2 weeks. Any clones subjected to re-screening consistently reproduced what 
was seen in the original screen. Additionally, the results observed under lysate screen 
conditions were replicated by the purified mutant constructs, suggesting the high quality 
of the lysate screen data, even with single replicates. These details emphasize the fact 
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that although this library screening campaign did not successfully produce mutants with 
the desired characteristics, this same methodology could be repeated with small changes 
to the protocol (i.e. different [CDNs] for normalization) on the same exact libraries, or 
slightly modified libraries (i.e. different YcgR, VYN scaffold), with minimal effort. 
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FIGURES 
 
Figure 4.1 Binding measurements with enzymatically synthesized (2’3’)-cGAMP. (a) 
Luminescence signal fold-changes of YNL-CpYcgR sensor in response to (left) 
commercial c-di-GMP stocks and (right) increasing concentrations of silica-plug purified 
(2’3’)-cGAMP. Data are from 3 replicates represented as mean ± SD. (b) Luminescence 
response of YNL-CpYcgR sensor in response to (2’3’)-cGAMP with increasing levels of 
purity. 3x lyo. = lyophilized three times, +HPLC = additionally purified via reverse-phase 
HPLC, +50W = additionally converted to Na+ salt with ion exchange resin, comm. = 
commercial product. Data are from 3 replicates represented as mean ± SD. 
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Figure 4.2 Intermediate target strategy for evolution of a (2’3’)-cGAMP binding 
protein. (a) Schematic of the 2 potential routes to (2’3’)-cGAMP binding using mixed-
linkage [(2’3’)-c-di-GMP] or mixed-base [(3’3’)-cGAMP] CDNs as intermediates. (b) 
Chemical structures of the three CDNs. 
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Figure 4.3 Optimization of (2’3’)-c-di-GMP synthesis by mcGAS. Integrated peak 
areas (A254) of GTP (left) and (2’3’)-c-di-GMP (right) measured by LC-MS after overnight 
incubation with mcGAS under the specified conditions. Data are from 2 replicates 
represented as mean ± SD. 
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Figure 4.4 CDN selectivity of YNL-YcgR variants. Luminescence signal fold-changes 
of YNL-YcgR sensors in response to increasing concentrations of different CDNs. Data 
are from 3 replicates represented as mean ± SD. 
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Figure 4.5 CDN selectivity of YNL-YcgR variants, continued. Data from Figure 4.4 
represented as % Signal (compared to 100 µM c-di-GMP) instead of signal fold-change. 
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Figure 4.6 CASTing the c-di-GMP binding pocket of a PilZ domain. (a) Crystal 
structure of VCA0042 bound to c-di-GMP (PDB 2RDE). Orange colored residues 
represent highly conserved residues that are critical for c-di-GMP binding. Green colored 
residues represent regions that were targeted for mutagenesis. (b) Labeling scheme for 
saturation mutagenesis library creation based on VCA0042 numbering. 
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Figure 4.7 Considerations for saturation mutagenesis library creation. (a) Equation 
for estimating fractional library completeness (Patrick et al., 2003). (b) Schematic showing 
the reduced codon redundancy in the “22c trick” library. Reprinted with permission from 
Kille et al., 2013. Copyright 2013 American Chemical Society. 
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Figure 4.8 Lysate screening results of YNL-TbYcgR SSM libraries. (a) Luminescent 
signal fold-change and % signal measurements for wild-type YNL-TbYcgR during library 
screening. Each dot represents a single biological replicate (n = 48), black bars represent 
the mean of all replicates. Measurements were taken from multiple plates across multiple 
days of the library screening process. (b) Luminescent signal fold-change and % signal 
measurements for individual clones from the saturation mutagenesis libraries. Each dot 
represents a single clone (~90 per site), black bars represent the mean of all clones at 
that site. 
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Figure 4.9 Percent signal with cGAMP over c-di-GMP versus signal fold-change of 
YNL-TbYcgR mutants. Lysate screening data from Figure 4.8 plotted as % signal vs. 
signal fold-change for individual clones. 
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Figure 4.10 Percent signal with cGAMP over c-di-GMP versus signal fold-change of 
YNL-TbYcgR mutants, zoomed in. Plot from Figure 4.9 with R100 site data removed to 
more clearly show distribution of mutants. 
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Figure 4.11 Percent signal with cGAMP over c-di-GMP versus signal change of 
sequenced YNL-TbYcgR mutants. Lysate screening data of sequenced YNL-TbYcgR 
mutants. Data are from 4 biological replicates represented as mean. a% signal value 
>100% are due to differences in signal fold-change for c-di-GMP versus (3’3’)-cGAMP. 
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Figure 4.12 Percent signal with cGAMP over c-di-GMP versus signal change of 
double mutant YNL-TbYcgR libraries. (a) Lysate screening data of SSM libraries using 
N102W as the parent template. Each point represents data from a single clone. (b) Lysate 
screening data of SSM libraries using R100V as the parent template. Each point 
represents data from a single clone.   
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Figure 4.13 Percent signal with cGAMP over c-di-GMP versus signal change of 
sequenced YNL-TbYcgR double mutants. Lysate screening data of sequenced YNL-
TbYcgR double mutants. Data are from 4 biological replicates represented as mean. 
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Figure 4.14 Relative (3’3’)-cGAMP affinity of selected YNL-TbYcgR mutants. (a) 
Luminescence signal fold-changes of YNL-TbYcgR mutants in response to (3’3’)-cGAMP 
and c-di-GMP, measured in lysates. Data are from 4 biological replicates represented as 
mean ± SD. (b) Percent signal of of YNL-TbYcgR mutants in response to (3’3’)-cGAMP, 
with 1 µM c-di-GMP signal normalized to 100%. Data are from 4 biological replicates 
represented as mean ± SD. 
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Figure 4.15 Binding affinity and selectivity of YNL-TbYcgR single mutants. Affinity 
measurements of purified single mutant YNL-TbYcgR biosensors. Data are from 3 
replicates represented as mean ± SD. 
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Figure 4.16 Binding affinity and selectivity of YNL-TbYcgR N102W double mutants. 
Affinity measurements of purified double mutant YNL-TbYcgR biosensors containing 
N102W parent mutation. Data are from 3 replicates represented as mean ± SD. 
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Figure 4.17 Binding affinity and selectivity of YNL-TbYcgR R100V double mutants. 
Affinity measurements of purified double mutant YNL-TbYcgR biosensors containing 
R100V parent mutation. Data are from 3 replicates represented as mean ± SD. 
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Figure 4.18 Binding affinity measurements of YNL-TbYcgR R100V double mutants. 
Affinity measurements of purified double mutant YNL-TbYcgR biosensors containing 
R100V parent mutation. Data are from 3 replicates represented as mean ± SD. 
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MATERIALS AND METHODS 
General reagents and oligonucleotides. Commercial cyclic dinucleotide stocks 
were purchased from Axxora, LLC. Coelenterazine-h was purchased from NanoLight 
Technologies and stored as a ~6.15 mM stock in EtOH at –80 °C. Oligonucleotides used 
in molecular cloning were purchased from Elim Biopharmaceuticals or the University of 
Utah HSC Core Facility. 
Molecular cloning. All initial site-saturation mutagenesis libraries were generated 
by around-the-horn style mutagenesis on the wild-type pET24-YNL-TbYcgR-mCherry 
template (see below for further details). For libraries containing 2 mutations, the 
corresponding single mutant pET24-YNL-TbYcgR-mCherry plasmid was used as the 
template. For protein purification, mutant TbYcgR sequences were amplified by PCR from 
the corresponding mutant pET24 template and cloned into the pRSET-YNL-TbYcgR 
scaffold between SacI and NcoI sites using Gibson cloning (Gibson, 2011). 
Protein purification. Biosensor protein was purified as previously described 
(Dippel et al., 2018). E. coli BL21 (DE3) Star cells (Life Technologies) were co-
transformed with the pRSETB vector encoding N-terminally His-tagged NL biosensor 
variants and the pCOLA-PdeH plasmid lacking a His-tag to enable purification of the 
biosensor without c-di-GMP bound. Transformants were cultured in 2xYT medium at 37 
°C until OD reached ~0.8–1.0, followed by induction of protein expression with 0.1 mM 
IPTG for 20 h at 20 °C. Cells were collected and lysed by sonication in lysis buffer [50 
mM Tris (pH 7.5), 150 mM NaCl, 20 mM imidazole, 5% (v/v) glycerol] with 300 µg/mL 
lysozyme and 1 mM PMSF added. Clarified lysate was bound to Ni-NTA agarose (Thermo 
Scientific), and resin was washed with lysis buffer supplemented with 500 mM NaCl prior 
to elution with lysis buffer supplemented with 300 mM imidazole. Using Amicon Ultra-15 
Centrifugal Filter Units (molecular weight cutoff 10 kDa; Millipore), the elution fractions 
were concentrated and dialyzed to storage buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 
10% (v/v) glycerol]. Concentrated protein was flash frozen in liquid nitrogen then stored 
at -80 °C in small aliquots to prevent repetitive freeze-thaw cycles. Protein concentrations 
were determined using the absorption of Venus at 515 nm (extinction coefficient = 92200 
M-1 cm-1). 
CDN synthase enzymes were purified as previously described with minor 
modifications (Kranzusch et al., 2014). His-tagged human cGAS (MBP-hcGAS), DncV 
(MBP-DncV), or mouse cGAS (SUMO-mcGAS) were transformed into E. coli BL21 (DE3) 
Star cells and transformants were cultured in ZYP-5052 auto-induction media [25 mM 
(NH4)2SO4, 50 mM KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4, 0.5% (v/v) glycerol, 0.05% 
glucose, 0.2% α-lactose, 1% tryptone, and 0.5% yeast extract] (Studier, 2005) at 37 °C, 
250 rpm for ~8 hours, followed by growth for an additional ~20 hours at 18 °C. Cells were 
collected and lysed by sonication in lysis buffer [20 mM HEPES (pH 7.5), 400 mM NaCl, 
30 mM imidazole, 1 mM TCEP, 10% (v/v) glycerol] with 300 µg/mL lysozyme and 1 mM 
PMSF added. For cGAS purification, clarified lysate was supplemented with 50 µg/mL 
DNaseI and 10 mM MgCl2 and incubated at 25 °C for 30 minutes to degrade any bound 
dsDNA. Clarified lysate was bound to Ni-NTA agarose (Thermo Scientific), and resin was 
washed with lysis buffer supplemented with 1 M NaCl prior to elution with lysis buffer 
supplemented with 300 mM imidazole. Using Amicon Ultra-15 Centrifugal Filter Units 
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(molecular weight cutoff 10 kDa; Millipore), the elution fractions were concentrated and 
dialyzed to storage buffer [20 mM HEPES (pH 7.5), 250 mM KCl, 1 mM TCEP, 10% (v/v) 
glycerol]. Concentrated protein was flash frozen in liquid nitrogen then stored at -80 °C in 
small aliquots to prevent repetitive freeze-thaw cycles. Protein concentrations were 
determined using A280 (MBP-hcGAS ε = 117230 M-1 cm-1, MBP-DncV ε = 119750 M-1 cm-
1, SUMO-mcGAS ε = 45380 M-1 cm-1). 
Large scale enzymatic CDN synthesis and purification. MBP-DncV was used 
for large scale synthesis of (3’3’)-cGAMP as previously described, with minor 
modifications (Launer-Felty and Strobel, 2018). A total of 2.5 µM enzyme was prepared 
in DncV reaction buffer [50 mM Tris (pH 7.5), 100 mM NaCl, 10 mM MgCl2] with 1 mM 
ATP and 1 mM GTP (up to 10 mL scale reaction). The reaction was split into 1 mL aliquots 
and incubated at 37 °C for 3 hours, then at 70 °C for 10 min to quench. Precipitated 
components were removed by centrifugation (13200 rpm, 10 min), the supernatants were 
combined and filtered to remove residual particles, and then lyophilized. The lyophilized 
reaction was resuspended in ddH2O (~10% of starting reaction volume) and the desired 
product was purified after separation on an Agilent 1260 Infinity HPLC using an Agilent 
Polaris 5 C18-A 250 x 10 mm column equipped with a Polaris 5 C18-A 50 x 10 mm guard. 
Reaction components were separated using a gradient of 100% solvent A to 95% solvent 
A over 15 minutes at 50 °C with a flow rate of 5 mL/min, solvent A being 100 mM NH4OAc 
(pH 5) and solvent B being 100% acetonitrile. Purified fractions were combined and 
lyophilized at least 3 times to remove excess ammonia. Product purity was confirmed via 
LC-MS analysis. 
SUMO-mcGAS was used for large scale synthesis of (2’3’)-cGAMP and (2’3’)-c-
di-GMP. For (2’3’)-cGAMP synthesis, a total of ~5-10 µM enzyme was prepared in cGAS 
reaction buffer [50 mM Tris (pH 7.5), 100 mM NaCl, 5 mM DTT, 10 mM MgCl2, 0.1 mg/mL 
HT-DNA] with 1 mM ATP and 1 mM GTP. For (2’3’)-c-di-GMP synthesis, a total of ~5-10 
µM enzyme was prepared in modified cGAS reaction buffer [50 mM Tris (pH 8), 100 mM 
NaCl, 5 mM DTT, 10 mM MnCl2, 0.1 mg/mL HT-DNA] with 2 mM GTP. Reactions were 
incubated at 37 °C for 16 hours, then quenched and purified as described above. 
LC-MS analysis of CDNs. LC-MS analysis was performed on an Agilent 1260 
Infinity HPLC equipped with a multi-wavelength detector and a 6120 Quadrupole MS. 
Samples were separated on an Agilent Poroshell 120 EC C-18 (2.7 µm particle, 4.6 x 50 
mm) column equipped with a Poroshell 120 EC C-18 (2.7 µm particle, 4.6 x 5 mm) guard 
column. Separation was achieved using a previously published solvent system and 
gradient at a flow rate of 0.4 mL/min (Solvent A = 10 mM NH4OAc with 0.1% acetic acid, 
Solvent B = 100% methanol) (Burhenne and Kaever, 2013). 
Generation of site-saturation mutagenesis libraries. Site-saturation 
mutagenesis libraries were generated as previously described, with minor modifications 
(Kille et al., 2013). Oligonucleotides for each mutation site (3 mutant forward, 1 “silent” 
reverse) were phosphorylated using T4 PNK (NEB) following standard protocols. The 
three phosphorylated mutant primers were mixed in a 12:9:1 ratio (NDT:VHG:TGG) to 
generate the 22c forward primer mix (Table 4.5). An “around-the-horn” PCR was carried 
out using Phusion DNA polymerase (NEB) following standard protocols with ~5 ng 
template DNA and 1.5 µL each of the phosphorylated forward primer mix and 
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phosphorylated reverse primer per 50 µL PCR. After the PCR was complete, the template 
DNA was removed by adding 2 µL DpnI (NEB) per 50 µL reaction and incubating at 37 
°C for >1.5 hours. The desired PCR product was separated by agarose gel 
electrophoresis, extracted, and purified. The gel-purified product was ligated overnight at 
16 °C using T4 DNA ligase (NEB). The reaction was setup following standard protocols, 
except using 2 µL of T4 ligase and ~200 ng DNA per 20 µL reaction. Heat-inactivated T4 
ligase reactions were transformed into chemically competent E. coli Mach1 cells (UC 
Berkeley QB3) (10 µL ligation + 100 µL competent cells). After heat shock and recovery 
in SOC media, a small aliquot of recovered cells was serially diluted (no dilution, 5x 
dilution, 25x dilution) and 10 µL of each dilution was spotted onto LB/Agar plates 
supplemented with 50 µg/mL kanamycin to determine transformation efficiency. For 22c 
libraries at least 100 CFUs are required to ensure sufficient library coverage, however 
>400 CFUs was deemed to be optimal. The remaining rescued cells were used to 
inoculate four 4 mL LB/Kan cultures that were grown overnight at 37 °C. Overnight 
cultures were miniprepped and combined to give the mixed library. Each library was 
sequenced and Qpool values were calculated to ensure the quality (Qpool > 0.7) (Sullivan 
et al., 2013). 
Chemiluminescence measurements. All chemiluminescence measurements 
were performed in opaque white, 96-well LUMITRAC 600 plates (Grenier). Briefly, 
proteins and ligands were added to assay buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 
10 mM DTT, 0.1% BSA] to the given final concentrations in 100 µL reaction volume, then 
incubated at 28 °C for at least 10 min to reach binding equilibrium. All measurements 
using purified YNL biosensor proteins were made using 50 nM protein, except for the 
selectivity measurements in Figure 4.4, which were made using 100 nM protein. 
Chemiluminescent substrate was prepared by diluting coelenterazine-h to 60 µM in 
reagent buffer [50 mM HEPES (pH 7.2), 100 mM KCl, 300 mM ascorbate], and allowing 
the solution to equilibrate to RT for at least 30 min. Chemiluminescence at 28 °C was 
measured on a SpectraMax i3x platereader (Molecular Devices) by injecting 20 µL of 
chemiluminescent substrate, then integrating total chemiluminescent signal for 4 sec after 
a 3 sec delay.  
Lysate-based screening of 22c libraries. The lysate-based assay for biosensor 
activity was carried out as previously described with minor modifications (Dippel et al., 
2018). Single colonies of BL21(DE3) star E. coli cells transformed with pET24-biosensor-
mCherry plasmids were resuspended in 500 μL of P-0.5G non-inducing media [0.5% 
glucose, 25 mM (NH4)2SO4, 50 mM KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4] (Studier, 
2005) supplemented with 100 µg/mL kanamycin in 2.2 mL 96-well deep well plates 
(VWR), then grown at 37 °C, 340 rpm, for 24 h to generate pre-cultures. A 5 µL aliquot of 
each pre-culture was used to inoculate 500 µL of ZYP-5052 auto-induction media [25 mM 
(NH4)2SO4, 50 mM KH2PO4, 50 mM Na2HPO4, 1 mM MgSO4, 0.5% (v/v) glycerol, 0.05% 
glucose, 0.2% α-lactose, 1% tryptone, and 0.5% yeast extract] (Studier, 2005) 
supplemented with 100 µg/mL kanamycin in deep well plates. Plates were grown at 37 
°C, 340 rpm, for 20 h for biosensor expression. Cultures were harvested in the deep-well 
plate by centrifugation at 4700 rpm for 10 min at 4 °C. Supernatant media was removed 
and each cell pellet was resuspended in 350 µL screening buffer [50 mM Tris (pH 7.5), 
100 mM KCl, 5% glycerol, 2 mM EDTA, 300 µg/mL lysozyme, 1 mM PMSF]. Cells were 
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gently lysed for 1 h at 4 °C and lysates were clarified by centrifugation at 6200 rpm for 40 
min at 4 °C.  
To obtain three samples, 90 µL aliquots of clarified lysates were pipetted into three 
wells of opaque white, 96-well LUMITRAC 600 plates (Grenier), being careful not to 
disturb the pelleted cell debris. For initial screening, each aliquot was mixed with 10 µL of 
either buffer, 10 µM c-di-GMP, or 50 µM (3’3’)-cGAMP [in 50 mM HEPES (pH 7.2), 100 
mM KCl] to produce final concentrations of 0, 1 µM c-di-GMP, and 5 µM (3’3’)-cGAMP. 
For later screening rounds, different concentrations of 10x CDNs were used to achieve 
the desired final concentrations. Mixtures were incubated at 28 °C for at least 10 min to 
allow binding to occur, mCherry fluorescence signal (587 nm excitation, 615 nm emission) 
was measured for each well, then chemiluminescence was measured for each well as 
described above. Normalized luminescence (LUM/mCh) was determined for each well by 
dividing the total luminescent signal by the mCherry fluorescence for each well. Any 
clones that showed a LUM/mCh signal in buffer that was <1% of the WT (typically any 
LUM/mCh < 0.05) were classified as “dim” and disregarded from binding analysis. 
LUM/mCh values were used to calulate signal fold-changes for each clone (LUM/mCh 
signal with added ligand divided by LUM/mCh with no added ligand) and % signal with 
(3’3’)-cGAMP over c-di-GMP (see equation below). 
% 𝒔𝒊𝒈𝒏𝒂𝒍 𝒘𝒊𝒕𝒉 (𝟑′𝟑′)𝒄𝑮𝑨𝑴𝑷 𝒐𝒗𝒆𝒓 𝒄 − 𝒅𝒊 − 𝑮𝑴𝑷
=  
(𝑳𝑼𝑴/𝒎𝑪𝒉)𝒄𝑮𝑨𝑴𝑷 − (𝑳𝑼𝑴/𝒎𝑪𝒉)𝒃𝒖𝒇𝒇𝒆𝒓
(𝑳𝑼𝑴/𝒎𝑪𝒉)𝒄−𝒅𝒊−𝑮𝑴𝑷 − (𝑳𝑼𝑴/𝒎𝑪𝒉)𝒃𝒖𝒇𝒇𝒆𝒓
× 𝟏𝟎𝟎 
Any clones that met the desired criteria were streaked from the NI media pre-
culture onto LB/Agar plates supplemented with 50 µg/mL kanamycin to produce single 
colonies for re-screening. Pre-cultures were incubated at 37 °C, 340 rpm for ~1 hr prior 
to use. Single colonies from streak plates (typically 4 biological replicates each for re-
screening) were resuspended in 500 μL of P-0.5G non-inducing media and re-screened 
as described above. 
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TABLES 
Table 4.1 Relative selectivity of YNL-YcgR variants. Relative selectivity of YNL-YcgR 
variants against mixed-linkage and mixed-base CDNs, compared to c-di-GMP. Mixed-
linkage corresponds to (2’3’)-c-di-GMP; mixed-base corresponds to (3’3’)-cGAMP; both 
corresponds to (2’3’)-cGAMP. Data presented in figures 4.4 and 4.5. 
  
  
 
   
 Selectivity against: 
 Mixed linkage Mixed base Both 
TbYcgR 100-fold 100-fold >>2000-fold 
CpYcgR 200-fold 2000-fold >>2000-fold 
CbYcgR 200-fold 2000-fold >>2000-fold 
TmYcgR 2000-fold >>2000-fold >>2000-fold 
 143 
 
Table 4.2 Screening results for sequenced TbYcgR mutants. Lysate screen results 
for sequenced mutants during “re-screen”. Green color signifies increase compared to 
the parent sequence; red color signifies decrease compared to the parent sequence. 
Data presented in graphical form in figures 4.11 and 4.13. Data are from 4 biological 
replicates represented as the mean. aPercent signal value significantly greater than 
100% due to differences in c-di-GMP and (3’3’)-cGAMP binding. 
 Parent Mutation % signal Δ signal 
Round 1  
(5 µM 
cGAMP) 
wt -- 65.5 5.7 
wt R100V 100.3 3.0 
wt R100L 109.5 2.8 
wt R100K 89.7 3.5 
wt R100Ma 182.5 2.1 
wt N102W 92.3 4.4 
wt N102R 70.0 10.2 
wt V136Q 48.7 16.6 
wt S137Q 0.5 53.1 
wt L142Y 7.4 11.3 
Round 2  
(2.5 µM 
cGAMP) 
wt N102W 52.8 3.7 
N102W R100G 61.1 2.9 
N102W R100T 69.9 2.4 
N102W R100M 60.2 2.5 
N102W V136Y 0.7 28.6 
N102W V136Q 6.0 20.4 
N102W S137Q 0.8 17.6 
wt R100V 41.2 4.3 
R100V N102R 50.5 9.8 
R100V N102A 69.7 5.2 
R100V N102K 67.9 7.7 
R100V V174R 58.8 4.9 
R100V V174K 56.4 5.6 
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Table 4.3 c-di-GMP-binding properties of purified YNL-TbYcgR mutants. Binding 
data quantified from graphs shown in Figures 4.15–4.18. Data are from 3 replicates 
represented as the mean. aΔsignal values are the “top” best-fit values calculated by the 
non-linear regression. 
 
  
Sequence KD (nM) Hill slope Δ signala 
wt <50 2.3 7.1 
Single mutants 
N102W <50 2.1 5.0 
R100V 70 1.2 4.1 
R100M <50 1.5 2.4 
N102W double mutants 
N102W, R100G 145 1.8 3.5 
N102W, R100T 171 1.8 2.9 
N102W, R100M 105 1.6 3.1 
R100V double mutants 
R100V, N102R 77 1.9 12.6 
R100V, N102A 64 1.2 5.9 
R100V, N102K 59 1.4 11.8 
R100V, V174R <50 0.9 6.4 
R100V, V174K <50 1.1 7.6 
 145 
 
Table 4.4 (3’3’)-cGAMP-binding properties of purified YNL-TbYcgR mutants. Binding 
data quantified from graphs shown in Figures 4.15–4.18. Data are from 3 replicates 
represented as the mean. aKD values are calculated from “incomplete” curves and may 
not be accurate representations of the true affinity. bΔsignal values are the “top” best-fit 
values calculated by the non-linear regression. 
 
Sequence KD (µM)a Hill slope Δ signalb 
wt 3.1 1.6 6.5 
Single mutants 
N102W 3.7 1.6 5.5 
R100V 4.2 1.3 5.7 
R100M 3.8 1.5 5.5 
N102W double mutants 
N102W, R100G 4.6 1.5 7.1 
N102W, R100T 3.9 1.6 4.2 
N102W, R100M 4.9 1.7 3.8 
R100V double mutants 
R100V, N102R 3.4 1.5 12 
R100V, N102A 2.7 1.7 6.4 
R100V, N102K 5.7 1 16.9 
R100V, V174R 2.8 1.3 7.1 
R100V, V174K 3.6 1.2 10 
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Table 4.5 Oligonucleotides used in this study. Oligos used for 22c library generation 
(all with 22c in the name) were ordered from the Utah HSC core as “40 nmol” synthesis 
to include cartridge purification and increase purity. 
Name Sequence (5' to 3') 
FWD-TbYcgR-seq TTAACCAGAAAGTGGAAGTGC 
FWD-RLuc8-seq GGTACCAAGGTGTACGACC 
FWD-sensor domain-YNL 91-insert GGCAACGGCAGCccat 
REV-sensor domain-YNL 91-insert TGGTCCAGCAGCCTGTAgagc 
FWD-22c-S137-TbYcgR-1 ndtGGCGGCGGCCTGCTGA 
FWD-22c-S137-TbYcgR-2 vhgGGCGGCGGCCTGCTGA 
FWD-22c-S137-TbYcgR-3 tggGGCGGCGGCCTGCTGA 
REV-22c-S137-TbYcgR CACGTTCACGGTTTCGGTGCG 
FWD-22c-N102-TbYcgR-1 ndtTTTGTGCGCGTGCCGGC 
FWD-22c-N102-TbYcgR-2 vhgTTTGTGCGCGTGCCGGC 
FWD-22c-N102-TbYcgR-3 tggTTTGTGCGCGTGCCGGC 
REV-22c-N102-TbYcgR ACGACGTTGGATACGACGAACCGTAC 
FWD-22c-V136-TbYcgR-1 ndtAGCGGCGGCGGCCTG 
FWD-22c-V136-TbYcgR-2 vhgAGCGGCGGCGGCCTG 
FWD-22c-V136-TbYcgR-3 tggAGCGGCGGCGGCCTG 
REV-22c-V136-TbYcgR GTTCACGGTTTCGGTGCGATAAAT 
FWD-22c-G139-TbYcgR-1 ndtGGCCTGCTGATTAAAAGCCCGTTTAAAC 
FWD-22c-G139-TbYcgR-2 vhgGGCCTGCTGATTAAAAGCCCGTTTAAAC 
FWD-22c-G139-TbYcgR-3 tggGGCCTGCTGATTAAAAGCCCGTTTAAAC 
REV-22c-G139-TbYcgR GCCGCTCACGTTCACGGTTTC 
FWD-22c-R100-TbYcgR-1 ndtCGTAACTTTGTGCGCGTGCCG 
FWD-22c-R100-TbYcgR-2 vhgCGTAACTTTGTGCGCGTGCCG 
FWD-22c-R100-TbYcgR-3 tggCGTAACTTTGTGCGCGTGCCG 
REV-22c-R100-TbYcgR TTGGATACGACGAACCGTACTTGGC 
FWD-22c-L142-TbYcgR-1 ndtATTAAAAGCCCGTTTAAACTGAGCGAAGG 
FWD-22c-L142-TbYcgR-2 vhgATTAAAAGCCCGTTTAAACTGAGCGAAGG 
FWD-22c-L142-TbYcgR-3 tggATTAAAAGCCCGTTTAAACTGAGCGAAGG 
REV-22c-L142-TbYcgR CAGGCCGCCGCCGCT 
FWD-22c-V174-TbYcgR-1 ndtCGTGTGGAGGAAAAACGCGAACAG 
FWD-22c-V174-TbYcgR-2 vhgCGTGTGGAGGAAAAACGCGAACAG 
FWD-22c-V174-TbYcgR-3 tggCGTGTGGAGGAAAAACGCGAACAG 
REV-22c-V174-TbYcgR AACTTGACCACGGGCATTAACTGGACC 
FWD-22c-R175-TbYcgR-1 ndtGTGGAGGAAAAACGCGAACAGAGCC 
FWD-22c-R175-TbYcgR-2 vhgGTGGAGGAAAAACGCGAACAGAGCC 
FWD-22c-R175-TbYcgR-3 tggGTGGAGGAAAAACGCGAACAGAGCC 
REV-22c-R175-TbYcgR AACAACTTGACCACGGGCATTAACTGG 
FWD-22c-R100-TbYcgR N102W-1 ndtCGTTGGTTTGTGCGCGTGC 
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FWD-22c-R100-TbYcgR N102W-2 vhgCGTTGGTTTGTGCGCGTGC 
FWD-22c-R100-TbYcgR N102W-3 tggCGTTGGTTTGTGCGCGTGC 
REV-22c-N102-TbYcgR R100V ACGCACTTGGATACGACGAACCGTAC 
REV-22c-N102-TbYcgR R100V ACGCACTTGGATACGACGAACCGTAC 
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